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Research Experience for Undergraduates 
University of Arkansas 
 
 
 The University of Arkansas Department of Chemistry and Biochemistry hosted a 
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer 
program for the 20th year.  The department first hosted an REU in 1959.  The 10-week summer 
program, funded by the National Science Foundation, allowed students an opportunity to gain 
hands-on experience in a chosen research area while introducing them to careers in scientific 
research in areas including analytical chemistry and sensor technology, biochemistry and protein 
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and 
theoretical chemistry. 
 
 Undergraduate chemistry majors, who were sophomores or juniors in fall 2008, applied 
to the program, which took place in the Ozark Mountain Plateau. 
 
 Outside the lab, students met each week to hear presentations from campus experts about 
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to 
make a poster presentation.  A number of social activities took place throughout the summer to 
give students a chance to interact. 
 
 Selected students received a scholarship to pay for room and board and an allowance to 
attend a regional or national chemical conference in the 2009-2010 academic year.  Students 
involved in the program were enrolled as students at the U of A and received one hour of 





Tony Jude Award 
 
 Illinois native Trent Parker was the recipient of the Tony Jude Award for his summer 
research.  He is a student at St. Louis University.  The Tony Judy Award was created in 2002 to 
recognize a student for outstanding research.  It is awarded in memory of a former REU student 
who returned to the University of Arkansas and obtained a doctorate degree. 
 
 Trent Parker, under the direction of Professor Bob Gawley, presented a poster entitled 
“Catalytic Dynamic Thermodynamic Resolution of N-Boc-2-Lithiopiperidine.”   
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Microelectrochemical Detection and Microfluidics for Lab-on-a-





Synthetic and Mechanistic Organ(ometall)ic Chemistry; or 











Biophysical Studies of Single-Span Transmembrane Proteins and 











































Measurement of chemical Communication (Singaling) Molecules, 









Exploring the Influence of the Denatured State upon Protein 
Stability, -or- Isolation, Characterization, and Impact upon Blood 
Clotting of Human Thrombomodulin in Disease 
 
Z. Ryan Tian 
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Matrix-assisted Laser Desorption Fourier Transform Mass 
Spectrometry for Whole-cell Bacteria and Polymer Analysis 
 
Jack Lay 
Director, Statewide Mass 
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Collaborates with other investigators that need mass spectrometry 











UNIVERSITY OF ARKANSAS 
 NSF – CHEMISTRY – REU - SUMMER 2009 
Activities and Events 
Sunday, May 17 
1:00 p.m. – 4:00 p.m. Arrival, Check-In & Registration 
Maple Hill (front desk:  (479)718-2590 
 
6:00 p.m. – 9:00 p.m. Welcome Dinner 
University House, Whole Hog Barbeque 
 
Monday, May 18 
7:00 a.m. – 8:30 a.m. Breakfast 
    Quad Dining Room  
 
8:45 a.m.   Meet in quad lobby to go to university together 
 
9:00 a.m. – 10:00 a.m. Group Photo 
Front of Library 
 
9:45 a.m. – 11:45 a.m. Campus Logistics (Concurrent Sessions) 
 
RED  Session I:    9:45-10:30 a.m.    Session II:  10:45-11:30 a.m.  (Carver & MEEG) 
YELLOW  Session II:   9:45-10:30 a.m.    Session I:   10:45-11:30 a.m.  (CHEM, Phys, & Food 
Sci) 
Session I:    Cash Checks, ID Cards Issued 
Arkansas Union  
Parking and Transit available:  $27 per parking tag. 
May park in lot 41 (near Reid Hall) Monday.  Tag 
needs to be displayed by Tuesday to avoid ticketing. 
Session II:   Library Orientation 
University of Arkansas Mullins Library 
 
11:45 a.m. - 1:30 p.m. Opening Luncheon 
    Place:  Student Union Ballroom 
Speaker:  Dr. Don Pederson, Vice Chancellor, Professor of 
Physics 
 
1:30 p.m. – 2:30 p.m. Campus Tour  
    Meet in Ballroom with campus ambassadors 
 
2:30 p.m. – 4:30 p.m. Departmental Logistics 
Place:  Chemistry Building Room 105 
    Meet your Mentor: Refreshments will be served 
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    Get Keys, Take Photos 
 
Tuesday, May 19 
8:00 a.m. – 10:00 a.m. Safety Briefing: Bill Durham, Department Chair 
 CHEM 105 
 
11:00 a.m. – 12:00 a.m. CHEMISTRY Library Tour 
 Place:  MULLINS 102, moving to CHEM Library 
 Librarian:  Luti Salisbury 
 
12:00 noon   Go to Your Lab and Get Started! 
 
Wednesday, May 20  
8:00 a.m.   Report to your lab 
 
5:30 p.m. – 7:00 p.m. Dinner & Dialogue 
    Place: Reynolds Center, Seminar Room A 
Speaker:  Dr. Dennis Brewer, Assoc. Vice Provost for 
Research  
Topic:  Research and Ethics  
 
Friday, May 22  REU Meeting 
1:00 p.m.   CHEM 105 
    Organizational Meeting  
 
Saturday, May 23 – Monday May 25   Free for Memorial Day Weekend 
 
Wednesday, May 27 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:  Alumni House 
    Speaker:  Dr. Collis Geren, Dean of the Graduate School 
Topic:  Little Brown Spider 
     
Friday, May 29  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Robert Gawley 
Title:  Why did Alice say to Kitty: “Perhaps looking glass milk 
isn’t good to drink.”  A guided tour from Lineland to 
Spaceland. 
     
Thursday, June 4  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host: Chemistry 
    Location:  Devil’s Den State Park (bring swim suit!) 
 
Friday, June 5  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Professor Ingrid Fritsch 
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Title:  For the Love of Science… 
 
Monday-Tuesday, June 8-9 
    NCTR Tour 
    Jefferson, AR 
    Overnight stay in Little Rock, Dinner w/ INBRE students 
    
Wednesday, June 10 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:  Reynolds Center, Seminar Room A 
    Speaker:  Dr. Chris Evans<ceevans@sfc-fluidics.com> 
Topic:  New Technology Companies 
 
Thursday, June 11  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host:  Carver 
    Location:  Arvest Ballpark, Springdale, AR 
 
Friday, June 12  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Professor T.K.S. Kumar 
    Title:  Molecular Interactions that Sustain Life 
 
Wednesday, June 17 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:   Reynolds Center, Seminar Room A 
    Speaker:  Dr. Lynn Meade 
    Topic:  Public Speaking     
     
Thursday, June 18  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host:  Mechanical Engineering 
    Location:  Ozark Lanes 
     
Friday, June 19  REU Meeting 
1:00 p.m.   CHEM 105 
Speaker: Prof. Lothar Schafër 
Topic: Science and Divine Reality 
 
Saturday, June 20  Practice GRE and GMAT test offered 
10 a.m.   Testing is FREE  
    Participation requires pre-registration  
    Location:  Maple Hill South, Room 145 
 
Monday, June 22  Canoe Trip 
 
Wednesday, June 24 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:  Reynolds Center, Seminar Room A 
    Speaker:  Shani Farr & Vicky Hartwell 





Thursday, June 25  Evening Entertainment 
6:00 p.m.- 9:00 p.m. Host:  Physics 
    Location:  Movie Night 
 
Friday, June 26  REU Meeting 
1:00 p.m.   CHEM 105 
Half-way Progress Report Presentation 
Progress Reports Due 
 
Wednesday, July 1 Dinner & Dialogue 
5:30 – 7:00 p.m.  Place:  Reynolds Center Seminar Room A 
    Speaker:  Dr. Suzanne McCray 
    Topic:  How to Apply for NSF Predocs & Other Awards 
 
Friday, July 3 – Sunday, July 5   Free for Independence Day Weekend 
    You must return to Fayetteville by 8:00 a.m., July 6 
    
Wednesday, July 8 Final Carver Presentations 
3:00p.m. – 7:00 p.m.   
 
Friday, July 10  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Professor Matt McIntosh & Liz Williams 
    Topic:  Applying to Chemistry Graduate School 
 
Friday, July 17  REU Meeting 
1:00 p.m.   Chem 105 
How to Make a Poster 
    David Paul  
 
Thursday, July 23  Meeting in Miniature, Lunch Served 
10:00 a.m.      CHEM 105 
  
Friday,  July 24  End of Program 
5:00 p.m.    Final reports due   
Dorm check-out 
 
Saturday, July 25  End of Program 






Characterization of Cdc42 and Mutant Cdc42(T35A) 





Discovering the role of oncogenic ras proteins can give understanding to the pathogenesis 
of human cancer. Ras proteins control cycling between guanosine triphosphate (GTP) 
where the protein is in its active state and guanosine diphosphate (GDP) where the protein 
is in its inactive state. When the Ras protein exists in an over-active state, caused by 
abnormal cycling between GTP- and GDP-bound states, cell proliferation and 
transformation can occur. The protein cell division cycle protein Cdc42, a member of the 
Rho subfamily of Ras proteins, is involved in cell morphogenesis through a Ras GTPase 
cycle to activate basic cellular functions. The protein has been shown to stimulate DNA 
synthesis and initiate a protein cascade that begins with the activation of the p21-activated 
serine/theorine kinases (PAK). Cdc42Hs has been shown to interact with a minimal 
GTPase-binding domain peptide of p21-activated kinase, PBD46, with a KD of 
approximately 20nM. An important amino acid in the Switch I binding region of Cdc42, 
theorine-35, is believed to play a role in protein stabilization that might affect its ability to 
interact with PBD46. This goal of this work was to express, purify, and label a mutant 
protein, Cdc(T35A), with a site-specific fluorophore, sNDB, in order to examine the mutant 




Ras genes have been the focus of research since 1982 when their transforming alleles 
were identified in human tumors .Derived from the words rat sarcoma, these genes were first 
found as strains of rat sarcoma viruses (Barbacid 1987). Discovering the role of oncogenic ras 
proteins can give understanding to the pathogenesis of human cancer. Ras proteins interact with 
specific effectors to activate basic cellular functions. These proteins control cycling between 
guanosine triphosphate (GTP) where the protein is in its active state and guanosine diphosphate 
(GDP) where the protein is in its inactive state, which function as molecular timing switches in 
signal transduction pathways(Adams and Oswald 2007). The hydrolysis and rebinding of the 
nucleotide in the cycle is slow. Therefore, the ras protein signaling can be over active causing 
cell proliferation and transformation, because the cell is bound more to GTP than GDP. The 
cycle activity is controlled by different regulatory proteins. Guanine nucleotide exchange factors 
(GEFs) catalyze nucleotide exchange, GTPase activating proteins (GAPs) stimulate hydrolysis 
and GDP dissociation inhibitors (GDI) inhibit GTP hydrolysis and dissociation (Nomanbhoy et 
al. 1996). 
 
The Rho subfamily, of which Cdc42Hs is a member, is involved in cell morphogenesis 
through a Ras GTPase cycle involved in cell growth, differentiation, cytoskeletal organization, 
protein trafficking and secretion(Guo et al. 1998). The protein as been shown to stimulate DNA 
synthesis and initiate a protein cascade that begins with the activation of the p21-activated 
serine/theorine kinases (PAK)(Guo et al. 1998). Cdc42 partakes in cellular proliferation or 
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transformation by mutations altering the GTPase activity and altered interactions with effectors. 
Because Cdc42 contributes to different cellular functions, it is an excellent model to probe the 
structure-function relationships of cell-signaling process in Ras proteins(Adams and Oswald 
2007). The binding of both effectors and regulators occurs at the Switch I and Switch II regions. 
The Switch I region is residues 28-40 and the Switch II region is residues 57-74. The Switch 
regions of Cdc42 were found to be flexible using NMR spectroscopy by binding 
sNBD(succinimidyl-6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]hexanoate)-Cdc42Hs to PBD, 
46 amino acids of PAK(Adams and Oswald 2007). PBD binds with Cdc42Hs with a KD of 
approximately 20nM and inhibits GTP hydrolysis(Guo et al. 1998). The flexibility of the Switch 
I region in Cdc42 and its mutant is shown in Figure 1. One residue in the Switch I region, T35, 
plays a major role in the conformation. By replacing T35 with alanine, fluorescence spectroscopy 
can be used to show that Cdc42(T35A) binds a minimal-binding domain effector peptide of PAK 
(PBD 46) at a lower affinity relative to the wild type Cdc42 (Adams and Oswald 2007).  
 
 
Figure 1. The Switch I region of Cdc42 (A) and Cdc (T35A) (B). 
 
The findings of nucleotide binding with ras proteins can effect the cycling between 
effectors. This research is important because it makes a better understanding of the structure and 
interaction of ras proteins. With more knowledge, Cdc42 mutants can be made to ultimately 
suppress cell proliferation, increase apoptotic events, or trigger cell invasion which will lead to 




The proteins Cdc42, Cdc42(T35A), and PBD46 have been expressed. Cdc42Hs was 
expressed as a hexa-histidine-tagged protein in Escherichia coli strain BL21 from pET-15b-
Cdc42Hs. A single colony was grown overnight in a 50 ml of LB medium with 50 μg/mL 
ampicillin. The flask was incubated overnight. 1% of the overnight seed culture was placed into 
two 2L of LB Broth. The 2L cultures were grown to optical density at 600nm between .5-.8. 
After three hours, the cultures were induced with 1mM IPTG and left in the incubator until the 
next day. The cells were harvested by centrifugation at 10000g for 15 min at 4°C and   
resuspended in 50 ml of binding buffer (20 mM Tris Base, 50 mM NaCl, 25 mM Imidazole, and 
10 mM MgCl2). Afterwards, the resuspended pellet was stored in -80°C. While Cdc(T35A) was 
expressed using the same method, PBD46 was expressed as a GST fusion protein (pGEX-2T-
PBD46) in Escherichia coli strain. Expression for PBD46 was obtained in the same manner as 




For protein purification the lysate was thawed. On ice, 0.1mg/1ml of lysozyme was added 
and sonicated 40-50 times. After an hour of incubation, the lysate was centrifuge at 18,000g for 
30 minutes. After filtration, the protein was ready to be purified using the FPLC. 0.1ml thrombin 
was added to GST-PBD46 and left on the shaker in the cold room. GST-PBD46 cleaved was 
poured on the desalting column. PBD46 was collected in the flow through. The thrombin was 
cleaved off using a Heparin column. The column was packed and washed with DDI water. 10 ml 
of binding buffer was poured over the column. Afterwards, the liquid sample was poured over 
the column. Then the column was washed with 5 ml of binding buffer and 10 ml of elution 
buffer. The lysate was freeze with liquid nitration. 
 
A nucleotide exchange was performed by lypholyzing the protein with water to 2.5ml. 
GMPPCP was added to the mixture to have a final concentration of 0.5mM. EDTA was added to 
have a final concentration of 5mM. The mixture was incubated for an hour. To remove excess of 
the nucleotide and EDTA the solution was passed through a PD-10 desalting column. Using the 
gravity flow technique, the protein sample was poured over the column after it was equilibrated. 
The sample was collected after 3.5 ml of elution buffer was poured onto the column. MgCl2 was 
added to have a final concentration of 10 mM. A total of 200 μl of succinimydyl 6-[7-nitrobenz-
2-oxa-1,3-diazol-4-yl) amino] hexanoate (sNBD) in DMF was reacted with 1ml of 1mM Cdc42-
GMPPCP at room temperature four a hour. The solution was centrifuged for 20 minutes at 
10,000 rpm to clear precipitate and unreactive sNBD. The supernatant was passed through a PD-
10 desalting column using the gravity flow technique changing the buffer to 25mM NaCl, 5mM 
NaH2PO4, 5mM MgCl2, 1mM NaN3 pH 7.2 (NMR Buffer). 
 
Results and Discussion 
 
 Cdc42 has been characterized while its mutant’s interactions have been the focus of our 
lab. The lab successful expressed proteins by first streaking LB plates with e. coli containing 
DNA that encodes for Cdc42, Cdc(T35A), and PBD46. Cdc42 and Cdc(T35A) were expressed 
overnight. The cells were harvested and stored in -80°C. PBD46 was expressed for 4 hours 
maximum. The cells were harvested and stored in -80°C. Protein expression was induced when 
the optical density of the broth was between 0.5-0.8 Absorbance units. To make sure the cells 
were expressed sufficiently a sodium dodecyl sulfate polyacrylamide gel electrophoresis (sds-





Figure 1. SDS-PAGE was used to show the continuation of protein throughout the experiment. The protein 
expression gel shows good banding for successful cultures. 
After PBD46 was expressed and harvested, the protein was purified using the FPLC. 
GST (glutathione S-transferase)-PBD46 was poured on the desalting column to remove 
containments. Purified GST-PBD46 was cleaved using dialysis. The sample was then poured on 
the desalting column cleaving GST leaving PBD46 and thrombin. Thrombin was removed by the 
heparin column leaving purified PBD46. SDS-PAGE was done for samples of each stage in the 
protein purification. The gel expressed clear banding of GST-PBD46 and GST, however the 
band for PBD46 was not able to be seen (Figure 2). After noticing no band for the protein using 
dialysis, thrombin was added to remove the protein instead. Faint banding for PBD46 was seen 
around 6 kDa (Figure 3). 
 
 









After a purified protein have been obtained, the protein was lyophilized to 2.5ml. 
GMPPCP was added to have a final concentration of 0.5mM. EDTA was added to have a final 
concentration of 5mM to remove Mg+2 for the binding of GMPPCP to the protein. The solution 
was incubated for an hour. To remove excess of nucleotide and DNA, the sample was poured 
over a PD10 column. MgCl2 was added to the elution to have a final concentration of 10mM to 
stabilize the protein. Organic chemistry was used to bind, an extrinsic probe, sNBD for 
fluorescence activity. 1 mM Cdc42-GMPPCP was reacted with sNBD at room temperature for 1 
hour on a shaker. The solution was centrifuged to clear precipitate and unreactive sNBD at 
10,000 rpm for 20 min. The supernatant combined with water to make 2.5ml was poured on 
PD10 column using the gravity flow technique to exchange the protein into NMR buffer. 




The author would like to acknowledge the following contributors: National Science Foundation 
CHE-0851505  and NIH grant 1-K01CA113753-01A2 (to Dr. Adams) for funding my project; 
Dr. David Paul, for allowing me to participate in the NSF-REU program and directing the 
program; Dr. Paul Adams, for his mentoring and allowing use of his lab; Dr. Huimin Liu, for her 
teaching of lab protocols and equipment; Dr. James Maliekal, Jeremy Durchman, and Brandon 
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Fragmentation of Multiply-Charged Polymers using ESI-FTMS 





Fourier transform mass spectrometry was used with quadrupole collision-induced 
dissociation (QCID) and electron capture dissociation (ECD) to fragment multiply-
charged, high mass polyacrylate oligomers produced using an external electrospray 
ionization (ESI) source. The fragmentation of oligomers of varying size were studied using 
either Li, Na, or Cs as the cation. Poly(ethylene glycol) was used as a standard for the 
QCID method of fragmentation. QCID is shown to be an unsuitable method for unknown 
polymer analysis because the fragments in the gas phase combine to form longer and more 
highly charged oligomers than the initially isolated and fragmented ion. However, the ECD 
method, however can potentially be used for an unknown analysis and has potential for end 




 In recent years, many fragmentation techniques have been developed for use with Fourier 
transform mass spectrometry (FTMS) in sequencing peptides and polymers. The most commonly 
used techniques include sustained off-resonance irradiation collision-induced dissociation 
(SORI-CID) [1,2], infrared multiphoton dissociation (IR MPD) [3], and electron capture 
dissociation (ECD) [3,4]. Recently, the Bruker Corporation introduced the FTMS-quadrupole 
collision-induced dissociation (FTMS-QCID) MS/MS technique [5] for sequencing peptides and 
polymers by fragmentation, which is the focus of the current study.   
 
Until now, most of the literature on MS/MS analysis has discussed peptide or protein 
sequencing [1,3-4], but this research has dealt with the more challenging feat of sequencing 
polymers. Some polymers have greater bond stability than peptides due to the presence of 
hydrocarbon chains that typically compose the backbone of the polymer. As an introduction to 
the QCID method, poly(ethylene glycol) (PEG) was used because it has an ether group in its 
precursor monomer, giving the backbone of the polymer a slightly lower stability than polymers 
with hydrocarbon backbones and allowing many fragments to form. PEG fragmentation has also 
been heavily investigated using the previously mentioned techniques [2,6-10], providing a source 
of comparison for this study’s results. The main focus of this research, however, was on 
polyacrylates because of their growing importance in industry. Specifically, the homopolymer 
poly(methyl methacrylate) (PMMA) and the random copolymer methyl methacrylate-butyl 
methacrylate (rMMABMA) were studied. A previous study performed on polyacrylates by 
Jackson, Slade, and Scrivens showed that different ionization agents vary the fragmentation 
patterns of multiply-charged oligomers fragmented and analyzed using quadrupole orthogonal 
time-of-flight [11]. Using a QCID-FTMS and larger oligomers, this research studies the effect of 




ECD has already been used with several polymers [12-13], including PEG [9-10]. 
However, polyacrylates have yet to be examined using this method, so only the two 




 All polymer-cation solutions used were of a concentration ratio of 8μM polymer: 200μM 
cation in methanol. The methanol used was purchased from EMD Chemicals. The poly(ethylene 
glycol) (PEG) and poly(methyl methacrylate) (PMMA) had average molecular weights of 
3000g/mol and 5000g/mol, respectively, and were both purchased from Fluka. The random 
copolymer of methyl methacrylate and butyl methacrylate monomers (rMMABMA) was made 
for this study by Dr. Simonsick of Dupont and had an average molecular weight of 3000g/mol. 











































Scheme 1. Structures of (a) poly(ethylene glycol) (PEG), (b) poly(methyl methacrylate) 
(PMMA), and (c) random poly(methyl methacrylate-butyl methacrylate) (rMMABMA). 
 
The lithium chloride and sodium chloride used were purchased from Sigma, while the 
cesium chloride was purchased from Shelton Scientific. Lithium and cesium were chosen for this 
study because they are the smallest and largest, respectively, of readily available alkali metals. 
Sodium was chosen as the middle ion because, as a ubiquitous element, it is often a contaminant 
of the polymers during their synthesis and sodiated peaks are often present on spectra even when 
no sodium has been added [14]. Thus, the charged oligomers are all from a single cation when 
sodium is used, making the abundance of the desired oligomers greater. 
  
 The studies presented here were performed on a 9.4 Tesla Bruker APEX-Qe FTMS. This 
instrument has both matrix-assisted laser desorption ionization (MALDI) and electrospray 
ionization (ESI) external sources available, but this study only required the use of ESI. The same 
instrument was used for both quadrupole collision induced dissociation (QCID) and electron 





Figure 1. Schematic of a 9.4 Tesla Bruker APEX-Qe FTMS with an external ESI source [5]. 
 
For each polymer-cation analysis, the method consisted of obtaining a full spectrum of 
the polymer and selecting an oligomer of strong abundance to isolate and fragment. This 
oligomer was isolated using a hexapole ion filter and fragmented using the desired method 
(QCID or ECD). For QCID, the pressure of argon gas within the collision cell was held at 10-2 
mbar. The collision voltages in QCID and the electron energy in ECD were chosen to obtain the 
highest fragmentation efficiency. For QCID, the collision energies were between 35eV and 
70eV, as calculated by using the laboratory frame, and for ECD, the electron energy held 
between 3eV and 4 eV.  
 
Results and Discussion 
 
PEG 3000 ESI-QCID 
  For the initial ESI-QCID analysis using a PEG-Na solution, the doubly-charged 
oligomer consisting of 62 PEG monomers and having end groups of H and OH (m/z = 1397.3) 
was selected. The spectrum of the fragmented oligomer is shown in Figure 2. All ninety-eight of 
the fragments present were either singly- or doubly-charged and were assigned using monomer 
units and losses of either H2 or H2O with an average error of 4.08ppm. Six of the doubly-charged 
fragments show the interesting result of consisting of a longer monomer chain than the parent ion 
with no hydrogen or water losses. The inset figure in Figure 2 shows one of these fragments, 





Figure 2. ESI Mass spectra of [H-(PEG)62-OH Na2]2+ (m/z=1397.3); enlargement of  fragment 
corresponding to [H-(PEG)69-OH Na2]2+. 
 
 Previous reports of PEG fragmentation patterns only show observed monomer losses [6-
8] from the ends of the initial chain. Ionic mechanisms, rather than radical mechanisms, have 
previously been proposed [7-8,15]], so the mechanism proposed in Scheme 2 for the 








































































Scheme 2: Series A, No Loss
 









































Scheme 2: Series C, Loss of H2  
Scheme 2. Proposed mechanism for fragmentation of [H-(PEG)62-OH Na2]2+. 
 
 Series A in Scheme 2 is the fragmentation mechanism that would produce the 
exceptionally long fragments when x+y+1>62. Series B and C produce a loss of H2O or H2, 
respectively. These account for the other fragments observed when either one or two Na cations 
are present on the reactant chain and the nucleophile is either the O--[CH2CH2O]y-H, a product of 
the initial collision, or H:-, a product of Series C. 
 
PMMA 5000 ESI-QCID 
 Before looking at the more complicated random copolymer using QCID, PMMA was 
analyzed using lithium, sodium, and cesium cations. Each cation analysis was performed twice, 
first isolating the doubly-charged oligomer consisting of 37 MMA monomers with hydrogen end 
groups and then isolating the triply-charged oligomer consisting of 50 MMA monomers with 
hydrogen end groups. The 50 monomer chain was chosen because it represented the average 
weight of the polymer used, but the doubly-charged oligomer of that length produced a mass-to-
charge ratio too large for the quadrupole to isolate efficiently. Thus, the abundant and easily 





Figure 3. Fragmentation of [H-(MMA)37-H M2]2+, where M=Li, Na, and Cs in spectra (a), (b), 

















Li 1 H H 13-18 5.26 
  3 H, H - 39-55 1.95 
  2 H, H - 27-37 5.63 
  4 H, H - 56, 58, 60-67 3.23 
  3 H, OH - 45-55 5.61 
  2 H, H CH3OH, C2O 32 0.23 
  2 H, H 2(CH3OH), CH4, 2(H2) 37 6.57 
Na 1 H H 12-26 2.69 
  2 H, H - 26-33, 35-50, 52-53 4.13 
  3 H, H - 38-62, 64 2.83 
  4 H, H - 54-55, 57-68, 70-71 4.06 
Cs Charge (x) 
End 





  1 H Cs 28, 32-33, 37 10.48 
  2 H, H Cs, Na 51-52, 55 4.98 
  2 H, H Cs, Na, Addition of H2 38 0.26 
  2 H, H Cs2, Addition of H6 52 15.71 
  2 H, H,  Cs2 37, 42-55, 60 3.84 
 
 Figure 3 above shows the fragmentation of the doubly-charged 37-mer using each cation, 
while Table 1 displays all of the fragments present in each spectra. The QCID process of 
fragmentation has previously been reported to be ergodic [15], meaning that the energy from the 
collision is spread out across the oligomer, breaking the weakest bond. The large size and low 
charge density of Cs would make its bonds with the carbonyl groups along the chain weak [15]. 
Thus, it is quite favorable for a Cs ion to be removed by a collision and is why the peak 
corresponding to the loss of one Cs ion (m/z=3838.927) is larger than those corresponding to 
other fragments. The larger ppm error for Cs is due to the larger mass of the Cs fragments. There 
is also evidence of Na in the Cs spectra even though the Cs parent ion was well isolated. This is 
similar to the previous reports of Na contaminating samples [14]. 
  
 In all three spectra, there are fragments present that are longer or more highly charged 
than the parent ion. This indicates that some of the fragments produced by the collision combine 
while still in the gas phase. Depending upon the lengths and number of ions present on the 
fragments, longer, highly charged oligomers result. This result is more frequent when Li and Na 
are used because the cations are not as easily removed as the Cs, as they are smaller and have a 




Figure 4. Fragmentation of [H-(MMA)50-H M3]3+, where M=Li, Na, and Cs in spectra (a), (b), 





Table 2. Fragmentation Pattern of [H-(MMA)50-H M3]3+, Fragments of Form: [H-(MMA)n-H 
Mz]z+ 
M Charge (x) 
End 
Groups Loss Monomer Lengths Present (n) 
Average 
Error (ppm) 
Li 1 H H 15-16 3.45 
2 H, H CH3OH, H2O 26-27 3.75 
2 H H 27, 29, 31-33 2.39 
3 H, H - 38-50 1.88 
3 H, OH - 42-49 6.49 
3 H, H CH3OH 48 30.65 
4 H, H - 51-66 2.87 
4 H, OH - 56-57, 66 8.92 
Na 1 H H 11-12, 14-25 2.84 
1 H CH4 12, 14-20 2.28 
2 H H 25-50 2.49 
2 H CH4 27-33, 35, 37 2.50 
2 H CH2, 2H2O 29 0.45 
3 H, H - 37-63, 66 3.55 
4 H, H - 52-63, 65-66 4.15 
Cs Charge (x) 
End 
Groups Cations Present Monomer Lengths Present (n) 
Average 
Error (ppm) 
1 H Cs 26 2.61 
 2 H, H Cs2 
30-31, 36-37, 40-46, 50-51, 55-57, 
60-61, 65 3.78 
 2 H 
Cs2, Loss of 
CH4 32 3.50 
2 H, H Cs, Na 45-46, 51 0.91 
3 H, H Cs3 50, 60-61, 65 3.05 
3 H, H Cs2, Na 51, 66 5.21 
 
 The results of the fragmentation of the triply-charged 50-mer using each cation are shown 
in Figure 4 and Table 2 above. These are similar to the results of the doubly charged 37-mer in 
that it again shows Cs readily losing a cation and fragmenting less than either Li or Na and Na 
contamination in the Cs spectrum. However, more fragments are present for Cs with the 50-mer 
than there were with the 37-mer and no peak representing the loss of two Cs ions (no side chains) 
is present. This is consistent with reports that Cs is more stable with longer oligomers [15, 18]. It 
has also been shown that longer oligomers require larger cations or more charges [19]. The 
results shown here are consistent with that conclusion since there are fewer fragments with Li on 
the 50-mer than on the 37-mer.  
  
 These observations, much like with the PEG, have most likely not been observed before 




rMMABMA 3000 ESI-QCID 
 For the random copolymer (rMMABMA), two different oligomers were each isolated and 
fragmented with Li, Na, and Cs used as cations. The oligomers were of compositions of 12 
MMA monomers/11 BMA monomers and 13 MMA monomers/12 BMA monomers with H end 
groups. The fragmentation spectra of these oligomer are shown in Figures 5 and 6, while the 
fragment assignments are shown in Tables 3-8. 
 
 
Figure 5. Fragmentation of [H-(MMA)12-(BMA)11-H M2]2+, where M=Li, Na, and Cs in spectra 





Table 3. Fragmentation of [H-(MMA)12-(BMA)11-H Li2]2+; fragments of form [H-(MMA)x-
(BMA)y-H Liz]z+ 
m/z z m (observed) #MMA (x) 
#BMA 





1097.70512 2 2195.41024 9 9 2195.41394 0.004 1.69 
1118.72746 2 2237.45492 8 10 2237.46089 0.006 2.67 
1118.72746 1 1118.72746 4 5 H 1118.73045 0.003 2.67 
1126.707939 2 2253.415878 11 8 2253.41942 0.004 1.57 
1139.75406 2 2279.50812 7 11 2279.50784 0.000 -0.12 
1147.23464 2 2294.46928 10 9 H 2294.45855 -0.011 -4.68 
1168.75534 2 2337.51068 9 10 2337.51332 0.003 1.13 
1176.7356 2 2353.4712 12 8 2353.47185 0.001 0.28 
1176.7356 1 1176.7356 6 4 H 1176.73592 0.000 0.27 
1189.77781 2 2379.55562 8 11 2379.56027 0.005 1.95 
1197.7552 2 2395.5104 11 9 2395.5188 0.008 3.51 
1218.77701 1 1218.77701 5 5 H 1218.78288 0.006 4.82 
1218.77701 2 2437.55402 10 10 2437.56575 0.012 4.81 
1239.80423 2 2479.60846 9 11 H 2479.6127 0.004 1.71 
1247.78437 2 2495.56874 12 9 2495.57123 0.002 1.00 
1260.82756 2 2521.65512 8 12 CH4 2521.65965 0.005 1.80 
1260.82756 1 1260.82756 4 6 H 1260.82983 0.002 1.80 
1268.80653 2 2537.61306 11 10 2537.61818 0.005 2.02 
1276.78277 2 2553.56554 12 11 2C4H9O, 2CH3O, CH4, H2 2553.55558 -0.010 -3.90 
1289.82963 2 2579.65926 10 11 2579.66513 0.006 2.28 
1297.80698 2 2595.61396 12 11 2C4H9O, 2H2O, H2 2595.60253 -0.011 -4.40 
1303.88082 1 1303.88082 3 7 1303.8846 0.004 2.90 
1318.83222 1 1318.83222 6 5 H 1318.8353 0.003 2.34 
1318.83222 2 2637.66444 12 10 2637.67061 0.006 2.34 
1324.81452 2 2649.62904 12 11 C4H9OC4H9 2649.63422 0.005 1.95 
1326.818 2 2653.636 12 11 CH4, CH3, 3(OCH3) 2653.64439 0.008 3.16 
1339.85506 2 2679.71012 11 11 2679.71756 0.007 2.78 
1345.92842 1 1345.92842 2 8 1345.93155 0.003 2.33 
1345.83819 2 2691.67638 12 11 CH3OC4H9 2691.68117 0.005 1.78 
1360.87785 2 2721.7557 12 11 C2H2O2 2721.76451 0.009 3.24 
1361.85115 2 2723.7023 12 11 C4 H8 2723.70739 0.005 1.87 





Table 4. Fragmentation of [H-(MMA)12-(BMA)11-H Na2]2+; fragments of form [H-(MMA)x-
(BMA)y-H Naz]z+ 
m/z z m (observed) #MMA (x) 
#BMA 





1084.67517 2 2169.35034 9 9 C2H2O2 2169.35599 0.006 2.60 
1113.6782 2 2227.3564 9 9   2227.36147 0.005 2.28 
1134.1861 2 2268.3722 8 10 H 2268.4006 0.028 12.52 
1142.68126 2 2285.36252 11 8   2285.36695 0.004 1.94 
1153.70506 3 3461.11518 14 14   3461.11029 -0.005 -1.41 
1163.70525 2 2327.4105 10 9   2327.4139 0.003 1.46 
1171.68246 2 2343.36492 12 8 C3H6 2343.37243 0.008 3.20 
1173.03886 3 3519.11658 16 13   3519.11577 -0.001 -0.23 
1192.37385 3 3577.12155 18 12   3577.12125 0.000 -0.08 
1205.75027 2 2411.50054 8 11   2411.5078 0.007 3.01 
1213.72756 2 2427.45512 11 9   2427.46633 0.011 4.62 
1226.72098 2 2453.44196 10 11 C4H9OCH3, C5H10 2453.4456 0.004 1.48 
1234.75409 2 2469.50818 10 10   2469.51328 0.005 2.07 
1248.76743 3 3746.30229 14 16   3746.3125 0.010 2.73 
1255.77858 2 2511.55716 9 11   2511.56023 0.003 1.22 
1263.75738 2 2527.51476 12 9   2527.51876 0.004 1.58 
1276.80142 2 2553.60284 10 11 C2H2O2 2553.60718 0.004 1.70 
1284.78099 2 2569.56198 11 10   2569.56571 0.004 1.45 




2585.50311 -0.012 -4.75 
1305.80189 2 2611.60378 10 11   2611.61266 0.009 3.40 




2627.55006 -0.011 -4.10 
1319.34556 2 2638.69112 13 10 2(C2H2O2), CH3 2638.63614 -0.055 -20.84 
1334.80622 2 2669.61244 12 10   2669.61814 0.006 2.14 
1340.78851 2 2681.57702 12 11 C4H9OC4H9 2681.58175 0.005 1.76 
1347.851 2 2695.702 12 11 2(C2H2O2) 2695.70656 0.005 1.69 
1355.82537 2 2711.65074 11 11   2711.66509 0.014 5.29 
1361.81083 2 2723.62166 12 11 C4H9OCH3 2723.6287 0.007 2.58 
1368.15333 3 4104.45999 19 15   4104.4753 0.015 3.73 
1376.85234 2 2753.70468 12 11 C2H2O2 2753.71204 0.007 2.67 
1384.83162 2 2769.66324 12 11 C3H6 2769.67057 0.007 2.65 
1387.49123 3 4162.47369 21 14   4162.4807 0.007 1.68 
1397.87662 2 2795.75324 12 11 CH4 2795.75899 0.006 2.06 
1405.85608 2 2811.71216 12 11   2811.71752 0.005 1.91 
1426.87958 2 2853.75916 11 12   2853.76447 0.005 1.86 
1455.88066 2 2911.76132 13 11   2911.76995 0.009 2.96 
1476.90308 2 2953.80616 12 12   2953.8169 0.011 3.64 
1477.9085 1 1477.9085 6 6   1477.91627 0.008 5.26 
1484.88674 2 2969.77348 15 10   2969.77543 0.002 0.66 
1519.45327 2 3038.90654 10 14   3038.9142 0.008 2.52 
1547.95804 2 3095.91608 12 13   3095.91628 0.000 0.06 
27 
 
1568.97646 2 3137.95292 11 14   3137.96323 0.010 3.29 
1576.95525 2 3153.9105 14 12   3153.92176 0.011 3.57 
1597.4809 2 3194.9618 13 13 H 3194.96088 -0.001 -0.29 
1619.00049 1 1619.00049 6 7 H 1619.00783 0.007 4.53 
1619.00049 2 3238.00098 12 14   3238.01566 0.015 4.53 
1626.97899 2 3253.95798 15 12   3253.97419 0.016 4.98 
1690.04769 2 3380.09538 12 15   3380.11504 0.020 5.82 
1719.55924 2 3439.11848 14 14   3439.1239 0.005 1.58 
1719.05971 1 1719.05971 7 7 H 1719.06026 0.001 0.32 
1748.0614 2 3496.1228 16 13   3496.126 0.003 0.92 
1861.15642 1 1861.15642 7 8 H 1861.15964 0.003 1.73 
2773.76533 1 2773.76533 12 11 CH3 2773.70428 -0.061 -22.01 
2788.73396 1 2788.73396 12 11   2788.72775 -0.006 -2.23 
 
Table 5. Fragmentation of [H-(MMA)12-(BMA)11-H Cs2]2+; fragments of form [H-(MMA)x-
(BMA)y-H Csz]z+ 
m/z z m (observed) #MMA (x) 
#BMA 





1515.7607 2 3031.5214 12 11   3031.53576 0.014 4.74 
1887.97177 1 1887.97177 9 6   1887.98268 0.011 5.78 
2042.12485 2 4084.2497 14 17   4084.23689 -0.013 -3.14 
2056.17045 1 2056.17045 5 10   2056.17048 0.000 0.01 
2121.13255 2 4242.2651 17 16   4242.2948 0.030 7.00 
2172.17832 1 2172.17832 9 8   2172.18144 0.003 1.44 
2208.15466 2 4416.30932 23 13   4416.31124 0.002 0.43 
2230.18355 1 2230.18355 11 7   2230.18692 0.003 1.51 
2398.36527 1 2398.36527 7 11   2398.37472 0.009 3.94 
2557.43175 1 2557.43175 10 10   2557.4361 0.004 1.70 
2730.4279 1 2730.4279 12 10 3(C4H8) 2730.44907 0.021 7.75 





Figure 6. Fragmentation of [H-(MMA)13-(BMA)12-H M2]2+, where M=Li, Na, and Cs in spectra 





Table 6. Fragmentation of [H-(MMA)13-(BMA)12-H Li2]2+; fragments of form [H-(MMA)x-
(BMA)y-H Liz]z+ 









1126.70839 2 2253.41678 11 8   2253.41942 0.003 1.17 
1139.75406 2 2279.50812 7 11   2279.50784 0.000 -0.12 
1147.72956 2 2295.45912 10 9   2295.46637 0.007 3.16 
1168.75495 2 2337.5099 9 10   2337.51332 0.003 1.46 
1197.76117 2 2395.52234 11 9   2395.5188 -0.004 -1.48 
1218.77908 1 1218.77908 5 5 H2O 1218.78288 0.004 3.12 
1218.77908 2 2437.55816 10 10   2437.56575 0.008 3.11 
1247.78669 1 1247.78669 7 4 CH2O 1247.78561 -0.001 -0.87 
1247.78669 2 2495.57338 12 9   2495.57123 -0.002 -0.86 
1260.82774 2 2521.65548 8 12   2521.65965 0.004 1.65 
1268.80703 2 2537.61406 11 10   2537.61818 0.004 1.62 
1289.82842 2 2579.65684 10 11   2579.66513 0.008 3.21 
1297.80835 2 2595.6167 13 9   2595.62366 0.007 2.68 
1310.8527 2 2621.7054 9 12   2621.71208 0.007 2.55 
1318.83405 2 2637.6681 12 10   2637.67061 0.003 0.95 
1318.83405 1 1318.83405 6 5 H2O 1318.8353 0.001 0.95 
1339.85485 2 2679.7097 11 11   2679.71756 0.008 2.93 
1360.87883 2 2721.75766 10 12   2721.76451 0.007 2.52 
1381.90491 2 2763.80982 11 12 C2H2O2 2763.81146 0.002 0.59 
1389.88108 2 2779.76216 12 11   2779.76999 0.008 2.82 
1397.86296 2 2795.72592 13 12 H2O, 2(C4H9OC4H9) 2795.74377 0.018 6.38 
1439.90872 2 2879.81744 13 11   2879.82242 0.005 1.73 
1460.93403 2 2921.86806 12 12   2921.86937 0.001 0.45 
1466.90851 2 2933.81702 13 12 CH4, OC4H9 2933.83298 0.016 5.44 
1468.90952 2 2937.81904 13 12 CH3OCH3, CH3OH, 3H2 2937.80677 -0.012 -4.18 
1477.8893 2 2955.7786 13 12 4CH4, H2 2955.78095 0.002 0.80 
1482.92456 2 2965.84912 13 12 C4H8 2965.8592 0.010 3.40 
1481.95185 2 2963.9037 13 12 C2H2O2 2963.91632 0.013 4.26 
1489.43374 2 2978.86748 13 12 C3H8 2978.86702 0.000 -0.15 





Table 7. Fragmentation of [H-(MMA)13-(BMA)12-H Na2]2+; fragments of form [H-(MMA)x-
(BMA)y-H Naz]z+ 









1063.65475 2 2127.3095 8 9   2127.30904 0.000 -0.22 
1084.67553 2 2169.35106 7 10   2169.35599 0.005 2.27 
1092.65383 2 2185.30766 10 8   2185.31452 0.007 3.14 
1113.679 2 2227.358 9 9   2227.36147 0.003 1.56 
1121.6554 2 2243.3108 12 7   2243.32000 0.009 4.10 
1140.02016 3 3420.06048 15 13   3420.06680 0.006 1.85 
1142.68058 2 2285.36116 11 8   2285.36695 0.006 2.53 
1163.70078 2 2327.40156 10 9   2327.41390 0.012 5.30 
1205.75041 2 2411.50082 8 11   2411.50780 0.007 2.89 
1213.72993 2 2427.45986 11 9   2427.46633 0.006 2.67 
1215.41834 3 3646.25502 13 16   3646.26000 0.005 1.37 
1234.75316 2 2469.50632 10 10   2469.51328 0.007 2.82 
1254.08653 3 3762.25959 17 14   3762.27100 0.011 3.03 
1255.77614 2 2511.55228 9 11   2511.56023 0.008 3.17 
1263.75667 2 2527.51334 12 9   2527.51876 0.005 2.14 
1273.41798 3 3820.25394 19 13   3820.27650 0.023 5.91 
1276.80138 2 2553.60276 8 12   2553.60718 0.004 1.73 
1276.80138 1 1276.80138 4 6 H 1276.80359 0.002 1.73 
1284.78088 2 2569.56176 11 10   2569.56571 0.004 1.54 
1292.75925 2 2585.5185 13 10 C4H9OC4H9, CO, C2H2 2585.52424 0.006 2.22 
1305.80279 2 2611.60558 10 11   2611.61266 0.007 2.71 
1313.78233 2 2627.56466 13 9   2627.57119 0.007 2.49 
1315.13307 3 3945.39921 16 16   3945.41391 0.015 3.73 
1321.76484 2 2643.52968 10 12 C4H9OCH3, CH4, 3H2 2643.54498 0.015 5.79 
1326.82598 2 2653.65196 9 12   2653.65961 0.008 2.88 
1329.48476 3 3988.45428 15 17   3988.46420 0.010 2.49 
1334.80388 2 2669.60776 12 10   2669.61814 0.010 3.89 
1334.80388 1 1334.80388 6 5 H 1334.80907 0.005 3.89 
1334.47184 3 4003.41552 18 15   4003.41939 0.004 0.97 
1355.82866 2 2711.65732 11 11   2711.66509 0.008 2.87 
1363.81433 2 2727.62866 12 11 2CH3OH, H2O, H2 2727.63888 0.010 3.75 
1376.85144 2 2753.70288 10 12   2753.71204 0.009 3.33 
1384.83257 2 2769.66514 13 10   2769.67057 0.005 1.96 
1390.86295 3 4172.58885 14 19   4172.61060 0.022 5.21 
1397.87587 2 2795.75174 13 11 2(C2H2O2) 2795.75899 0.007 2.59 
1405.85476 2 2811.70952 12 11   2811.71752 0.008 2.85 
1410.20206 3 4230.60618 16 18   4230.61610 0.010 2.34 




2827.65492 -0.015 -5.28 
1426.87853 2 2853.75706 11 12   2853.76447 0.007 2.60 
1429.53715 3 4288.61145 18 17   4288.62160 0.010 2.37 




1434.85756 1 1434.85756 7 5 H 1434.86150 0.004 2.75 
1439.92245 2 2879.8449 13 12 3(C2H2O2) 2879.85289 0.008 2.77 
1442.83135 2 2885.6627 13 12 C4H9OC4H9, CH3OH, 3H2 2885.66040 -0.002 -0.80 
1447.9032 2 2895.8064 12 12 C2H2O2 2895.81142 0.005 1.73 
1448.54055 3 4345.62165 20 16   4345.62362 0.002 0.45 
1455.88266 2 2911.76532 13 11   2911.76995 0.005 1.59 
1461.86157 2 2923.72314 13 12 C4H9OC4H9 2923.73356 0.010 3.56 
1463.85855 2 2927.7171 13 12 C9H18 2927.72848 0.011 3.89 
1468.20325 3 4404.60975 22 15   4404.63250 0.023 5.17 
1468.92453 2 2937.84906 13 12 2(C2H2O2) 2937.85837 0.009 3.17 
1476.90564 2 2953.81128 12 12   2953.81690 0.006 1.90 
1482.88815 2 2965.7763 13 12 C4H9OCH3 2965.78051 0.004 1.42 
1497.92832 2 2995.85664 13 12 C2H2O2 2995.86385 0.007 2.41 
1506.9078 2 3013.8156 13 12 C3H4 3013.83803 0.022 7.44 
1518.94876 1 1518.94876 5 7 H 1518.95540 0.007 4.37 
1518.94876 2 3037.89752 10 14   3037.91080 0.013 4.37 
1526.93075 2 3053.8615 13 12   3053.86933 0.008 2.56 
1547.95804 2 3095.91608 12 13   3095.91628 0.000 0.06 
1568.97646 2 3137.95292 11 14   3137.96323 0.010 3.29 
1576.9611 2 3153.9222 14 12   3153.92176 0.000 -0.14 
1598.48098 2 3196.96196 13 13   3196.97210 0.010 3.17 
1605.97201 2 3211.94402 16 11   3211.92724 -0.017 -5.22 
1647.51114 2 3295.02228 14 13 H 3295.01331 -0.009 -2.72 
1669.52929 2 3339.05858 13 14   3339.07150 0.013 3.87 
1677.00677 1 1677.00677 8 6 H 1677.01331 0.007 3.90 
1677.00677 2 3354.01354 16 12   3354.02662 0.013 3.90 
1691.05712 1 1691.05712 7 7 CHO 1691.06534 0.008 4.86 
1690.05712 2 3380.11424 12 15   3380.11504 0.001 0.24 
1698.02909 2 3396.05818 15 13   3396.07357 0.015 4.53 
1719.04813 2 3438.09626 14 14   3438.12052 0.024 7.06 
1719.04813 1 1719.04813 7 7 H 1719.06026 0.012 7.06 
1862.15505 1 1862.15505 7 8   1862.16746 0.012 6.66 
1920.16064 1 1920.16064 9 7   1920.17294 0.012 6.41 





Table 8. Fragmentation of [H-(MMA)13-(BMA)12-H Cs2]2+; fragments of form [H-(MMA)x-
(BMA)y-H Csz]z+ 









1636.84526 2 3273.69052 13 12   3273.68757 -0.003 -0.90 
1971.06032 2 3942.12064 14 16   3942.13751 0.017 4.28 
2050.09012 2 4100.18024 17 15   4100.19542 0.015 3.70 
2130.12939 1 2130.12939 10 7   2130.13449 0.005 2.39 
2221.19916 2 4442.39832 19 16   4442.39966 0.001 0.30 
2298.31087 1 2298.31087 6 11   2298.32229 0.011 4.97 
2385.30262 2 4770.60524 18 19   4770.6566 0.051 10.77 
2392.28518 2 4784.57036 21 17   4784.6039 0.034 7.01 
2414.33181 1 2414.33181 10 9   2414.33325 0.001 0.60 
2472.32193 1 2472.32193 12 8   2472.33873 0.017 6.80 
2640.53304 1 2640.53304 8 12   2640.52653 -0.007 -2.47 
2798.58158 1 2798.58158 11 11 3(C2H2O2) 2798.58444 0.003 1.02 
2967.76759 1 2967.76759 13 12 3(C4H8) 2967.7756 0.008 2.70 
2972.60989 1 2972.60989 17 8   2972.60088 -0.009 -3.03 
3140.7609 1 3140.7609 13 12   3140.78868 0.028 8.84 
 
 The fragmentation patterns of both oligomers were quite similar. In both cases, the Cs 
spectra show fewer fragments than the Li spectra, which show fewer fragments than the Na 
spectra. Neither of the Cs or Li spectra show triply charged fragments, but all four spectra do 
show the presence of fragments that contain more MMA monomers and/or BMA monomers than 
the isolated oligomers. The Na spectra show evidence of fragments that are both triply charged 
and have the extra monomers. With all three ions, there are fragments present that show losses of 
various end groups or pendant chains.  
 
PMMA 5000 and rMMABMA 3000 ESI-ECD 
 The study performed using electron capture dissociation was done using both PMMA and 
rMMABMA with Na as the cation. For both polymers, two different oligomers were selected to 
be fragmented. Each spectrum showed few fragments. The spectra of these trials, shown in 
Figure 8 parts (a)-(c), each have the parent ion and fragment ions labeled. The other visible peaks 




Figure 8. Fragmentation of (a) [H-(MMA)44-H Na2]2+, (b) [H-(MMA)43-H Na3]3+, and (c) [H-
(MMA)13-(BMA)11-H Na2]2+  using ESI-ECD. 
 
 The Na ECD spectra show that the only losses the parent ion sustains when it undergoes 
ECD are those of the possible side chains or end groups. Similar results were obtained using Li 
as the cation and no fragments were present when Cs was used [data not shown here]. While it is 
unclear which group has been lost, it is important to note that no fragment combinations were 
observed when fragmenting multiply-charged oligomers using this method. This indicates that it 




 Both QCID and ECD can be used to fragment multiply-charged oligomers formed using 
ESI, although the fragmentation patterns are significantly different. QCID produced many 
fragments corresponding to various combinations of losses of monomers, end groups, and side 
chains, when present. This method also showed evidence of the combination of fragments in the 
gas phase, making this method unsuitable for the analysis of an unknown polymer. These 
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fragments that are longer or more highly charged than the parent ion have not, to my knowledge, 
been reported elsewhere and are under further investigation.  
 The ECD spectra showed only the losses of methyl and butyl groups, indicating either 
side chian or end group cleavages. Further study using a homopolymer with two end groups not 
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Computer Modeling of Microdialysis 
Chris Keathley, John Brown University 




Microdialysis is an important tool in the study of neurochemistry.  However, as more 
knowledge is acquired about the subject of microdialysis questions about the effects of 
implantation in tissue samples have to be answered.  Researchers need to know how 
implantation trauma is going to affect uptake of neurotransmitters.  The research in this 
paper focuses on attempting to create a working model of microdialysis in the computer 
software program COMSOL Multiphysics.  This model attempts to accurately represent 




Microdialysis is an invasive sampling method that takes advantage of diffusion, and it has 
become one of the primary ways that scientists measure neurotransmitter concentrations.  
However as this method becomes more popular, questions about the effects of its invasive nature 
have to be answered.  To help answer those questions several mathematical models have been 
created (Bungay et al., Chen et al.).  The aim of this research was to take the various models that 
already exist and create a working simulation using computer aided design (CAD).  The CAD 
software that was chosen was COMSOL multiphysics version 3.4 (henceforth referred to as 
COMSOL).  COMSOL is designed to model multiple physics engines and simulations 
simultaneously.  These simulations can be linked together by using constants from other physics 
engines and by incorporating separate equations.  This allows the user to very quickly implement 
fluid flow, heat transfer, diffusion, or any other physics simulation very quickly and very 
accurately.  COMSOL is also a very powerful and efficient piece of software.  This efficiency 
allows for very fast testing and correction.  This model will serve several purposes.  The first is 
as a visual aid to other researchers.  This visual understanding will help give a clearer view of 
microdialysis, and to begin to see any potential errors or difficulties that may occur when doing 
real world testing.  The second benefit to having a working computer model is that it can be 
quickly altered to serve as a theoretical benchmark for a large number of experiments.  This 
means that researchers can begin to refine their experiments and will allow for a faster means of 




 In order to create an accurate model including implantation trauma, a model of just 
microdialysis needed to be created first.  This meant that the model needed to contain three 
sections, a section representing the probe, a section representing the probe membrane, and a 
section representing the extracellular tissue space (ECS).  The model was built symmetrically, 
meaning that only one half of it needed to be constructed.  This allowed for more efficient use of 
computer resources, and sped up the model creation process.  The dimensions for the model can 
be seen in Figure 1 below.  The dimensions for the model were based on information given by 















It was decided to use multicomponent for this model.  This meant that each section would have 
its own individual physics engines.  This would allow for customizability in each of the sections.  
The probe section needed to have fluid flow and mass transport engines, while the membrane 
and the ECS sections needed to have only the mass transport engines.  To fit the needs of the 
probe section a laminar fluid flow engine and a diffusion and convection engine were used.  In 
order to link the laminar fluid flow with the diffusion and convection engine, the velocity 
constants from the fluid flow engine were used in the diffusion and convection engine's 
equations. The probe section had an initial concentration of .1[mol/liter].  A diffusion engine was 
used for the membrane and a diffusion and convection engine was used for the ECS section.  An 
initial concentration in the ECS section was set to 1 [mol/liter].  Each of the sections needed their 
own diffusion coefficients.  These were chosen based on advice from Dr. Julie Stenken and from 
Dr. Kevin C. Chen's article "Effects of tissue trauma on the characteristics of microdialysis zero-
net-flux method sampling neurotransmitters" published June 2005.  The diffusion coefficients 






The boundaries of the model also needed to be defined.  In the probe section the bottom 
boundary is both an inflow boundary and a concentration boundary.  The inflow velocity was set 
to .000663 [m/s] and the concentration to .1 [mol/liter]. The top boundary is an outflow boundary 
and a convective flux boundary.  This allows the fluid to flow from the bottom of the model to 
the top of the model.  The left boundary is a symmetry boundary.  This tells the software that this 
is the axis to revolve around.  The right boundary is a flux boundary.  In the membrane section 
the left and right boundaries are flux boundaries and the top and bottom boundaries are 
insulation boundaries, meaning that they don't affect the model.  In the ECS section the left 
boundary is a flux boundary, the right boundary is a concentration boundary and the top and 
bottom boundaries are insulation boundaries.  The concentration was set to 1 [mol/liter].  
Because this is a multicomponent model the flux boundaries between each section needed to be 
defined in order for each section to interact with each other.  To do this the stiff-spring method 
was used based on the COMSOL Multiphysics Chemical Engineering Module Model Library.  










In these equations M is a theoretical velocity, K is the partition coefficient, C1 is the 
concentration in the probe, C2 is the concentration in the membrane, and C3 is the concentration 
in the ECS.  As long as M is sufficiently large a continuous flux is created across each of the 
sections.  For this model M was set to be 10000[m/s] and K was set to .7.  Using this information 
the model could then be tested to see if it worked correctly.  
 
Initial Model Testing 
  
 Once this model was created it was then tested.  The model was solved several times to 
see if it gave accurate results.  The results can be seen below in Figures 2 and 3.  The lighter 
colors show areas of high concentration and the darker colors show areas of lower concentration. 
 
Figure 2 – Microdialysis simulation 
 
It is clear from this image that diffusion is taking place throughout the model.  Figure 3 below 
shows only the probe section.  It is easier to see the concentration gradient for the probe in this 




Figure 3 – Microdialysis simulation showing only probe concentration 
These results appeared to be reasonable and the next step was to implement the trauma layer 
around the membrane.   
 
Model Alterations and Additions 
 
 In order to create a trauma layer around the membrane section it was decided to split the 
membrane layer in half.  One half would become the new membrane section and the other would 
become the trauma layer.  This decision was made because of time constraints and because of the 
ease with which this could be implemented.  To achieve this conceptually a line was simply 
drawn between the two halves.  This effectively separated the membrane into two parts.  The 
outside boundaries remained the same and the new separating line became a flux continuity 
between the membrane and the trauma layer.  A new diffusion coefficient was made for the 




(Chen et. al, 2005).  Using this new model the same test was run.  The results can be seen below 




Figure 4 – Microdialysis simulation including trauma layer 
 
Results and Discussion 
 
 It is clear from this simulation that there is something wrong with the model.  As shown 
in Figure 4 the concentration simply changes in the trauma layer.  If the model was correct there 
should be a small gradient at the trauma layer as the concentration transitions from high to low.  
There are several possible reasons for why the model does not work correctly.  It could be due to 
an error in the stiff spring equations.  This would mean that there is an error in the boundary 
conditions separating the trauma layer from the remaining ECS section.  Based on the behavior 
of the model this seems to be the most likely possibility.  A possible solution to this error would 
be to recreate the model, but instead of using a multicomponent model, use a single diffusion 
engine for the entire model.  This would allow for creation of a simpler test bed and would let 




 Unfortunately the model presented in this paper does not correctly implement insertion 
trauma as it was designed to do.  However, despite this failure we can still draw some 
conclusions about microdialysis.  Based on the microdialysis model sans insertion trauma we can 
see that the concentration is highest by the edge of the probe.  While this is not unexpected it 
does show us that much of the fluid in the probe will not be mixing with the extracellular fluid 
that has diffused through the membrane.  This is also a good step forwards despite the failure.  It 
allows us to have a better understanding of how to implement these types of models in 
COMSOL.  Hopefully if COMSOL becomes a more popular method of modeling then this may 
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Catalytic Dynamic Thermodynamic Resolution of N-Boc-2-Lithiopiperidine 
Trent Parker, Saint Louis University 




A rare case of a catalytic dynamic thermodynamic resolution using a chiral 











 Chirality in molecules is cause for great concern in medical applications. Stereospecific 
biochemical interactions determine the physiological effect of pharmaceutical drugs. One 
enantiomer may provide the desired therapeutic effect, whereas the other may produce undesired 
harmful effects1. The United States Food and Drug Administration now requires most new drugs 
to be sold in highly enantiopure form2. For many drugs, pharmaceutical companies now 
synthesize racemates, discarding half the yield as the undesired enantiomer. Asymmetric 
synthesis provides an opportunity to increase efficiency over this massive waste of material. 
Accordingly, asymmetric synthesis has become a highly important area of research in organic 
chemistry3. 
  
 Substitution at the 2 position in nitrogen heterocycles induces a chiral center. 
Asymmetric induction at this carbon via organolithium intermediates can be achieved by either 
asymmetric deprotonation4 or asymmetric substitution5. Dynamic resolutions are examples of 
asymmetric substitution reactions. Dynamic thermodynamic resolution (DTR) employs chiral 
racemic organolithium intermediates to produce a high yield of an enantioenriched product in 
situ6. DTR can occur when a chiral racemic organolithium is placed in a chiral environment 
either by a chiral ligand, chiral auxiliary, or chiral solvent. When the enantiomeric substrates are 
bound by a chiral ligand, the resulting diastereomeric complexes may have differing 
thermodynamic stabilities. If the organolithium can surpass the barrier to carbanion inversion, 
the diastereomeric complexes can achieve a thermodynamic equilibrium at the chiral center 
(Scheme 1). Once maximum resolution has been achieved, the reaction is cooled to a 
temperature low enough to prohibit inversion, freezing the enantiomeric ratio (er) in place, 
allowing equilibration and resolution to occur in separate controllable steps. Product er depends 
on percent conversion to products as well as the kinetic preference of electrophile with the 




















 The half life DTR is determined by the variables of temperature, diastereomeric complex 
free energy difference (ΔG°), and the barrier of carbanion inversion (ΔGǂ) for diastereomeric 
equilibration (Equation 1). Thus, knowing the barriers to inversion is critical for optimization of 
conditions for a DTR. These kinetic parameters have been measured8, revealing significant 
variation of ΔGǂ with temperature for the processes of resolution and racemization (Figure 1). At 
218 K, (-55 °C) DTR occurs with a barrier ~1 kcal / mol lower than racemization with TMEDA.  
At lower temperatures, DTR is slower, lowering yield due to organolithium decomposition. At 
higher temperatures, racemization is faster than DTR, precluding any enantioenrichment. 
Therefore, 218 K is the optimum temperature for the DTR of the 4·6 complex with TMEDA in 
ether. 
 
Examples of DTR using stoichiometric amounts of chiral ligand have been well 
documented9. Much more scarce are examples of catalytic DTR, employing substoichiometric 
amounts of chiral ligand10. This is a critical achievement, as the chiral ligand is often the most 
expensive reagent in the mixture, so using only a catalytic amount provides a considerable 
benefit. Our efforts here focus on the goal of rendering the DTR of 4·6 catalytic. 
 
 





































































1.2 eq TMEDA, Et2O








 N-Boc-Piperidine. To a flask containing piperidine (8.4 g, 100 mmol, 1.0 equiv.), di-tert-
butyl dicarbonate (20.7 g, 95 mmol, 0.95 equiv.) in CH2Cl2 (100 mL) was added slowly by 
means of a dropping funnel at 0 oC. The mixture was stirred for 3 h and then was washed with 
saturated NaCl (3 x 50 mL) and with H2O (2 x 50 mL). The combined organic layers were dried 
with anhydrous MgSO4, filtered and evaporated to give N-Boc-piperidine 2 as a colorless oil. 
 
 N-Boc-2-(Tributylstannyl)-Piperidine. An oven-dried flask containing 2 (0.84 g, 10 
mmol, 1.0 equiv.) was capped with a rubber septum and placed under an Argon atmosphere.  
Distilled anhydrous diethyl ether (Et2O) (20 mL) and N,N,N`,N`-tetramethylethylenediamine 
(TMEDA) (1.4 g, 12 mmol, 1.2 equiv.) were added. The flask was cooled to -78 °C and sec-
butyl lithium (sec-BuLi) (8.6 mL, 1.4 M, 12 mmol, 1.2 equiv.) was added slowly over 20 min. 
The reaction mixture was allowed to stir for 5 h before addition of tributyltin chloride (Bu3SnCl) 
(3.9 g, 12 mmol, 1.2 equiv.). The reaction mixture was warmed to room temperature overnight 
before quenching with HCl (30 mL, 2 M). After stirring for 30 min, the organics were extracted 
into Et2O (3 x 100 mL) and dried with anhydrous MgSO4. The solvents were removed in vacuo 
to produce crude N-Boc-2-(tributylstannyl)-piperidine 3 as a semi-viscous pale yellow oil. The 























 N-Boc-L-Proline. L-proline 7 (1.0 g, 11 mmol, 1.0 eq) was dissolved in 20 mL CH2Cl2 









(1.65 mL, catalytic amount). Boc2O (2.72 g, 13 mmol, 1.2 eq) was dissolved in 1 mL CH2Cl2 in 
a separate vial. The solutions were combined and left to stir for 2.5 h. After quenching with 
saturated citric acid (5 mL) the organic phase was washed with saturated NaCl (2 x 10 mL) and 
H2O (1 x 10 mL). The organics were dried with anhydrous Na2SO4 and solvents were removed 
in vacuo to give the crude product as a solid white mass. This solid was dissolved in minimal hot 
EtOAc (~3 mL) and recrystallized with hexanes (50 mL). After overnight refrigeration, the 
recrystallized product was filtered to give N-Boc-L-proline 8 as thin, filamentous white crystals. 
 
 10. N-(3-dimethylaminopropyl)-N`-ethylcarbodiimide (EDCI) (0.90 g, 5.3 mmol, 1.0 eq) 
and N-hydroxybenzotriazole (HOBT) (0.72g, 5.3 mmol, 1.0 eq) were added to a flask containing 
8 (1 g, 5.3 mmol, 1.0 eq) dissolved in CHCl3 (10 mL). L-proline methyl ester hydrochloride 9 
was dissolved in Et3N (2 mL) and CHCl3 (5 mL) in a separate vial before addition to the flask. 
The reaction was capped with a rubber septum and placed under an Argon atmosphere.  The 
reaction was stirred overnight before removing solvents in vacuo. Ethyl acetate (EtOAc) (20 mL) 
was added and allowed to stir for 20 min.  The solids were removed by gravity filtration and the 
filtrate was washed with 10 % citric acid (2 x 10 mL) and 10 % NaHCO3 ( 2 x 10 mL). The 
organic phase was dried with anhydrous Na2SO4 and the solvents were removed in vacuo to give 
10 as a yellow oil. 
 
 11. LiAlH4 (1.5 g, large excess) was added to an oven-dried flask and dissolved in 
distilled anhydrous tetrahydrofuran (THF) (10 mL). 10 (1.0 g, 3.1 mmol, 1.0 eq) was dissolved 
in THF (2 mL) in a separate vial. The flask was cooled to -5 °C before slow addition of 10. After 
cooling for several minutes, the reaction was transferred to an oil bath to reflux for 4 h. The 
condenser was loosely capped and placed under an Argon atmosphere with a vent. The flask was 
then cooled to -5 °C and quenched with 50 % KOH (20 mL) dropwise until all grey solids 
appeared white. The product was extracted into EtOAc (2 x 30 mL) and concentrated to 20 mL 
in vacuo. The product was extracted into 2 M HCl (3 x 20 mL) and cooled to 0 °C.  The solution 
was basified to pH 14 with 50 % KOH dropwise. The product was extracted into EtOAc (3 x 20 





 Kinetic solutions were prepared as follows. Oven-dried molecular sieves were placed in 
three oven-dried 20 mL vials.  Rac-3 (284 mg, 0.6 mmol) was added to the first vial. Freshly 
distilled TMEDA (70 mg, 0.6 mmol) was added to the second vial. Freshly distilled 11 (120 mg, 
0.6 mmol) was added to the third vial.  Et2O (10 mL) distilled from calcium hydride was added 
to each vial to produce 0.06M solutions of each. 
 
The desired number of 10 mL test tubes were oven-dried with stir bars overnight, capped 
with rubber septa, and sealed with Parafilm. Rac-3 (0.5 mL, 0.06 M, 30 μmol, 1.0 eq) was added 
to each tube. TMEDA (desired eq) was added to each tube. The tubes were cooled to -78 °C and 
treated with n-BuLi (15 μL, 1.4 M, 36 μmol, 1.2 eq) for 1 h to affect tin-lithium exchange, 
affording rac-4. A separate oven-dried, capped, sealed tube was treated with 11 (needed amount) 
and cooled to -55 °C. The tube was treated with sec-BuLi (2.5 M, 1.2 eq) to deprotonate 11, 
45 
 
  Figure 2. Observed and Statistical mole fraction (S)-4 vs. [4] 
affording 6. The tubes with rac-4 were warmed to -55 °C, and quickly treated with 6 (75 μL, 0.06 
M, 4.5 μmol, 0.15 eq). Time starts with the addition of 6 to each tube. 
 
At the desired times, tubes were cooled to -78 °C and rapidly quenched with a large 
excess of trimethylsilyl chloride (TMSCl) (0.5 mL, ) to afford enantioenriched N-Boc-2-
(Trimethylsilyl)-Piperidine 5. After 4 h at -78°C, the tubes were quenched with MeOH (1mL). 
The organics were extracted into Et2O (5 mL), and chromatographed in a flash column (0.5% 
EtOAc / hexanes) to remove Bu4Sn and flushed (2 % EtOAc / hexanes). The collected fractions 
were analyzed by chiral stationary phase GC.  (S)-5 elutes before (R)-5. Integration of the 
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Observed er (squares) and predicted er (circles) vs Amount of 
chiral ligand 6 for DTR of 4.6 in the presence of TMEDA (1.2 equiv.) 
































































Catalytic DTR of N-Boc-2-lithiopiperidine with 0.15 equiv. 6 and 1.2 















Determination of Kinetic order in TMEDA for the catalytic DTR of N-Boc-2-











































 For substoichiometric quantities of chiral ligand in DTR, the statistically predicted er is 
given by Equation 2. The equilibrium constant for DTR of 4 via 6 is 77:23 (S:R) (XS (Eq) = .77, 
XR (Eq) = .23)10. If 15 mole % 6 is used (X6 = .15), then theoretically 85 % 4 should be racemic, 
and only 15 % 4 should achieve a 77:23 (S:R) equilibrium given proper conditions. This provides 
a statistical er of 54:46 (S:R).  Any er significantly above this value with significant yield is 
indicative of catalysis. 
 
XS (Stat) = (XS (Eq))(X6) + (1 – X6) / 2 
XR (Stat) = (XR (Eq))(X6) + (1 – X6) / 2 
Equation 2 
 
 Figure 2 shows the statistically predicted trend (circles) versus the observed er of 11 after 
5 h at 218 K. At all substoichiometric quantities of 6, the observed er is higher than statistically 
predicted, indicative of a catalytic DTR. For 15 mole % 6, the value of 63:37 (S:R) at 5 h is 
promising, leading us to follow a time evolution under these conditions. 
 
  The time evolution 4 (Figure 3) demonstrates steady buildup of (S)-4, achieving full 
equilibrium er of 77:23 (S:R) after 9 h. This buildup of (S)-4 is configurationally stable, retaining 
the equilibrated er throughout the entire experimental span of 24 h. A catalytic DTR is possible 
with 15 mole % 6, but 9 h for equilibration allows for too much organolithium decomposition. 
We therefore investigate the effect of excess TMEDA with the goal of reducing equilibration 
time. 
 
 The kinetic order of TMEDA was determined by measuring rate constants at 0 eq, 1.2 eq, 
2.0 eq, and 4.0 eq TMEDA (Figure 5). These data indicate a second-order dependence on 
[TMEDA], attributed to both faster DTR and slower racemization with excess TMEDA. 
Catalytic DTR of 4 with 0.15 eq 6 and 4.0 eq TMEDA can achieve the equilibrated er of 77:23 
(S:R) at 218 K in 4 h. 
 
 These conditions are optimal for the dynamic resolution of 4. Use of the chiral ligand 6 is 
minimized to one sixth of stoichiometric amounts, and equilibration is achieved as rapidly as 
stoichiometric DTR by excess of the economical TMEDA, minimizing organolithium 




 DTR with substoichiometric 6 gives higher er than is predicted statistically. (S)-4 builds 
up and maintains configurational stability under the conditions of catalytic DTR. 4·6 can achieve 
a catalytic DTR with a second-order dependence on [TMEDA]. Catalytic DTR of 4 with 0.15 eq 
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Synthesis Toward Antascomicin B 





A recurring problem encountered with the opening of the epoxide ring in the synthesis 
towards antoscomicin B is the perpetually low yields resulting from the current reaction 
conditions.  The high temperature at which the reaction is carried out, along with the 
prolonged reaction time, leads to a number of possible side reactions along with a great 
deal of decomposition.  Current literature reports the greatest yield of this reaction to be 
41% (1).  Within this study the reaction conditions for the opening of the epoxide were 
modified through the addition of the use of a microwave reactor as a reacting medium.  
The conditions were varied through time, temperature, and the addition of a Lewis Acid 
catalyst.  It was found that through the addition of a Lewis Acid catalyst in a microwave 
reactor the yield of the epoxide opening decreased to 36% but under standard conditions in 




 Antoscomicin B, part of the antascomicin family, actually belongs to a larger group of 
compounds known as macrolides.  The natural source for macrolides is found in antimicrobial 
matter.  Originally, compounds with the suffix mycin which derived from the macrolide family 
were used as a penicillin replacement (2).  As research expanded within the study of macrolides, 
different capabilities of compounds within this family were discovered.  Part of that research 
revealed immunosuppressant capability, and from this discovery a new source of anti-rejection 
medications for transplantation was formed.  Antoscomicin B possesses FKBP12 binding 
activity but lacks the effector domains to bind to mTOR or calcineurin.  These domains are 
possessed by rapamycin and FK-506, two current immunosuppressants (3).  Current studies on 
the application of antascomicins has shown an exhibition of neuroregenerative properties which 


















































































































































































































































Table of Reagents/Products 
Reaction 1 
Compound Dicyclopentadiene Cyclopentadiene 
Formula C10H12 C5H6 
Molar Mass (g/mol) 132.196 66.10 
B.P. (oC) 170 41 
M.P. (oC) 32.5 -85 
Density (g/mL) 0.98 0.81 
Amount 170 mL A:   85 mL 
T: 103 mL 
Moles (mol) 1.260 A: 1.042  
T: 1.260 
Molar Ratio 1 1 
Percent Yield - 82.70% 
 
Reaction 2 
Compound 1,4-benzoquinone Cyclopentadiene Methylene Chloride A 
Formula C6H4O2 C5H6 CH2Cl2 C11H8O2 
Molar Mass (g/mol) 108.095 66.10 84.93 174.19 
B.P. (oC) Sublimes 41 40 - 
M.P. (oC) 115 -85 -96.7 - 
Density (g/mL) 1.318 0.81 1.326 - 
Amount               105.72 g 83 mL 350 mL A:  61.78 g
T: 170.36 g




Molar Ratio 1 1.04 - 1 
Percent Yield      - - - 36.25% 
 
Reaction 3 




Formula C11H8O2 (CH3)3COOH C10H16NOH C6H6 C11H10O3 
Molar Mass (g/mol) 174.19 90.12 167.248 78.11 190.19 
B.P. (oC) - 91 - 80.1 - 
M.P. (oC) - -1 - 5.5 - 
Density (g/mL) - 0.94 (70% aq. Soln.) 1 (20% aq. Soln.) 0.879 - 
Amount                 116.63 g 102.73 mL 23.39 mL 435 mL A: 69.93 g
T: 127.35 g
Moles (mol)          0.6684 1.0714 0.1399 4.896 A: 0.3677
T: 0.6684
Molar Ratio 1 1 0.028 - 1 
Percent Yield        - - - - 55.01% 
 
Reaction 4 






Formula C11H10O3 (C4H9)4NBH4 CH3OH CH2Cl2 C11H12O3 
Molar Mass (g/mol) 190.19 257.31 32.05 84.93 192.206 
B.P. (oC) - - 64.7 40 - 
M.P.(oC) - 126-131 -97 -96.7 - 
Density (g/mL) - - 0.792 1.326 - 








Moles (mol)          
 
0.3078 0.1704 12.36 7.81 A: 8.985E-2
T:     0.3078
Molar Ratio 1 0.55 - - 1 
Percent Yield        - - - - 29.19% 
 
Reaction 5 
Compound C Diphenyl 
ether 
D 
Formula C11H12O3 C12H10O C6H6O3 
Molar Mass (g/mol) 192.206 170.210 126.108 
B.P. (oC) - 259 - 
M.P.(oC) - 25-26 - 
Density (g/mL) - 1.073 - 
Amount                 14.83 g 220 mL A: 6.33 g 
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T: 9.73 g 
Moles (mol)          7.72E-2 1.39 A: 5.502E-2 
T:   7.72E-2 
Molar Ratio 1 10-15 mL/g 1 
Percent Yield       - - 65.02% 
 
Reaction 6: Option 1 
Compound D Water E 
Formula C6H6O3 H2O C6H8O4 
Molar Mass (g/mol) 126.108 18.016 144.124 
B.P. (oC) - 100 - 
M.P.(oC) - 0 - 
Density (g/mL) - 1 - 
Amount        
 
0.1583 g 3 mL A: 0.1037 g 
T: 0.1809 g 
Moles (mol)          
 
1.255E-3 54.058 A: 7.195E-4  
T: 1.255E-3 
Molar Ratio 1 20 mL/g 1 
Percent Yield        - - 57.33% 
 
Reaction 6: Option 2 
Compound D Water Ytterbium(III)triflate E 
Formula C6H6O3 H2O Yb(OTf)3 C6H8O4 
Molar Mass (g/mol) 126.108 18.016 620.25 144.124 
B.P. (oC) - 100 64.7 - 
M.P.(oC) - 0 -97 - 
Density (g/mL) - 1 0.792 - 
Amount        
 
0.1498 g 3 mL 0.0775 g A: 0.0607 g
T: 0.1712 g
Moles (mol)          
 
1.187E-3 54.058 1.250E-4 A: 4.212E-4 
T: 1.187E-3
Molar Ratio 1 20 mL/g  .1  1 
Percent Yield        - - - 35.69% 
 
Experimental Procedures 
 Reaction 1 
 Dicyclopentadiene (170 mL) was placed in a 250 mL round bottom flask (RBF) equipped 
with a magnetic stir bar and placed in an oil bath atop a magnetic stir plate.  A vigoro distillation 
column was then connected to the RBF.  A thermometer was then connected to the column along 
with a reflux condenser, which was connected to an H2O source.  A claisen adapter was then was 
then connected to the reflux condenser which was then attached to another 250 mL RBF which 
acted as a collection flask.  The claisen adapter was also connected to an N2 (g) line.  The 
collection flask was then placed in a dry ice/acetone bath and cooled to -78oC.  The oil bath was 
then heated to 230oC.  After five hours the oil bath was turned off and allowed to cool to room 
temperature.   
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 Once room temp was reached the apparatus was disassembled and the collected product 
was sealed with a rubber septa and connected to an N2 (g) line.  The product was then filtered to 
remove any residual solid dicyclopentadiene.  A Büchner funnel, closed off to the atmosphere 
with a rubber septa, was attached to a 250 mL RBF that was set in a dry ice/acetone bath.  The 
funnel was then connected to vacuum.  The product was then cannulated via negative pressure 
into the funnel and filtered into the new RBF.  The filtered product was then stored in a -78oC 
freezer.  
  
 Reaction 2 
 1,4-benzoquinone (105.72 g) was placed in a tared, dried, 1L two-necked round bottom 
flask (2N-RBF) containing a magnetic stir bar.  The 2N-RBF was then sealed with two rubber 
septa and placed under vacuum.  Freshly distilled CH2Cl2 (350 mL) was then cannulated via 
negative pressure into the 2N-RBF.  The reaction mixture was then placed in a MeOH/ice bath 
atop a magnetic stir plate.  The contents of the flask were cooled and maintained at a temperature 
range between -10oC to 5oC with constant stirring and N2 (g) atmosphere.  Cyclopentadiene (83 
mL) was then collected in a dried 100 mL glass syringe while under N2 (g) atmosphere and 
dispensed into the reaction mixture over a period of two hours via syringe pump.  Once the 
addition of the cyclopentadiene was complete, the reaction mixture was allowed to stir for an 
additional two hours.  After two hours the resulting solution was tested via TLC for the presence 
of starting material.  The plate was run in 1:4 Ethyl Acetate:Hexane solution and developed 
using KMnO4 stain.   
 
 The reaction mixture was then transferred to a 2L round bottom flask (RBF) and the 2N-
RBF was washed three times with CH2Cl2.  The RBF was then placed on a rotary evaporator to 
remove the volatiles.  A reddish brown oil was produced and upon addition of Hexane (1 L) a 
brown solid formed.  The RBF was placed back on roto vap to remove the remaining volatiles.   
Once the volatiles were removed, a recrystallization of the brown solid was performed by adding 
hexane (1 L) to the RBF and heating the solution to a high temperature via heat gun while 
continuously swirled.  This process produced a yellow organic layer with a red oil on bottom.  
The yellow organic layer was then filtered off of the oil using a fine frit Büchner funnel filtration 
apparatus.  Before the solution was poured through the filter, it was heated to the same 
temperature as the organic layer to avoid crystallization during filtration.  The oil was left in the 
RBF and discarded.  The yellow organic layer was allowed to cool slowly to room temperature 
and then sealed with a rubber septa once room temp was reached.  The flask was left to 
crystallize overnight.  The product was recrystallized until light yellow crystals were formed.  H1 
and C13 NMR samples were prepared from these crystals using chloroform-D. 
 
 Reaction 3 
 A 1 L round bottom flask (RBF) equipped with a magnetic stir bar was charged with 
compound A (116.63 g) and benzene (435 mL).  The flask was then sealed with a rubber septa, 
placed in a water bath, and set atop a magnetic stir plate.  The reaction mixture was stirred while 
purged with N2 (g). Triton-B (23.39 mL) and t-butyl hydroperoxide (102.73 mL) were then 
added to the mixture via syringe.  The reaction mixture was left to stir overnight. 
The following day the reaction mixture was tested via TLC for the presence of starting material.  
It was determined that the reaction needed additional reaction time.  The water bath was removed 
and the reaction was left for an additional two hours and then tested again for starting material.  
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Additional reaction time was needed and the reaction was left for an additional five hours.  After 
this time the reaction was tested via TLC one more time for starting material.  Minimal was 
detected and the reaction workup was begun.  
 
 DI-H2O (450 mL) was added to the RBF containing the reaction mixture which was then 
transferred to a 2L separatory funnel.  The RBF was washed three times with ether, each time the 
organics were added to the sep funnel.  Additional ether (450 mL) was then added to the sep 
funnel to extract the desired product.   
 
 Due to the formation of an emulsion during the extraction process the addition of brine 
was necessary in order to break it up.  Once the emulsion was broken, the aqueous layer was 
collected in a 3 L Erlenmeyer flask.  The ether layer was collected in a 2 L Erlenmeyer flask.  
The aqueous layer was washed an additional three times with ether (300 mL), each time added to 
the collected organic layer.  The aqueous layer was then discarded and the organic layer was 
dried with MgSO4.   
 
 The organic layer was then filtered off of the MgSO4 using a course frit Büchner funnel 
filtration apparatus.  The collected organic layer was the placed on a rotary evaporator to remove 
the volatiles.  Once the volatiles were removed a pale yellow solid was obtained which needed to 
undergo recrystallization in order to yield a white crystalline solid. 
Recrystallization was performed using minimal amounts of ethanol, which was added to the RBF 
containing the product and fiercely heated via heat gun until all the solid product was dissolved 
into solution.  The hot solution was left to cool slowly to room temperature.  Once room temp 
was reached the RBF was sealed with a rubber septa.  The recrystallization process was repeated 
until a white crystalline solid was produced.  A 1H NMR sample of the purified product was then 
prepared using chloroform-D. 
 
 A portion of the crystals were never fully purified despite many recrystallization 
attempts, these crystals were collected separately and a 1H NMR sample of these crystals was 
prepared separately from the pure crystals using chloroform-D.  
 
 Reaction 4 
A 2L round bottom flask (RBF) equipped with a magnetic stir bar was charged with B (58.54 g) 
and then sealed with a rubber septa.  The RBF was then purged with N2 (g) and then placed 
under vacuum.  Freshly distilled MeOH (500 mL) and CH2Cl2 (500 mL) were then cannulated 
into the RBF via negative pressure.  The RBF was then placed in a dry ice/acetone bath and set 
atop a magnetic stir plate.  The reaction mixture was stirred and cooled to -78oC.   
Tetrabutyl ammonium borohydride (43.84 g) was then placed in a 100 mL RBF equipped with a 
magnetic stir bar and sealed with a rubber septa.  The RBF was then purged with N2 (g) and then 
placed under vacuum.  Freshly distilled CH2Cl2 (70 mL) was then cannulated into the RBF via 
negative pressure.  The reaction mixture was then purged with N2 (g) and stirred until all of the 
solid dissolved.   
 
 Once the tetrabutyl ammonium borohydride was dissolved the mixture was collected in a 
dried 100 mL glass syringe and dispensed over a period of two hours via syringe pump into the 
2L RBF containing B.  After two hours the dry ice was removed from the acetone bath and the 
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reaction mixture was allowed to warm to a temperature above -40oC.  Once a temperature above 
this was achieved the reaction mixture was tested via TLC, ran in 3:7 Ethyl Acetate:Hexane and 
developed in KMnO4, for the presence of starting material. 
The reaction mixture was then quenched with aqueous ammonium chloride by adding NH4Cl 
(aq) (500 mL) to a 2L separatory funnel and then adding the reaction mixture to the sep funnel.  
The RBF was washed three times with CH2Cl2 each time added to the sep funnel.  Due to the 
bubbling produced from the quenching process the mixture was allowed to calm before the 
extraction process was carried out.  Once bubbling ceased CH2Cl2 (100 mL) was then added to 
the sep funnel and the extraction of the product was carried out carefully.  The organic layer was 
collected in a 2L Erlenmeyer flask and the aqueous layer was washed three times with CH2Cl2 
(100 mL).  Each time the organic layer was collected in the 2L Erlenmeyer flask.  The aqueous 
layer was discarded and the organic layer was dried with MgSO4. 
 
 The dried organic layer was then filtered off of the MgSO4 using a course frit Büchner 
funnel filtration apparatus.  The collected organic layer was then placed on rotary evaporator to 
remove the volatiles.   
 
 Once the solvent had been removed a dark brown red oil remained.  The impure product 
was then purified on a 8X50 cm column over SiO2 gel (1500 mL) using a gradual shift in solvent 
systems, starting with 3:7 EA:HEX and gradually increasing the polarity to 2:3 EA:HEX.  The 
fractions containing the desired product were collected into a 1L RBF and reduced via roto vap.  
Once the volatiles were removed, the product was placed on vacuum in order to prepare a 1H and 
13C NMR sample with chloroform-D.  Once the product was completely dry a white solid 
remained. 
 
 Reaction 5 
 A 250 mL 2N-RBF was charged with a stir bar, C (14.83 g), and diphenyl ether (Ph2O) 
(220 mL).  A reflux condenser was then attached to the 2N-RBF and the system was then sealed 
with a rubber septa and placed over a magnetic stir plate.  A ventilation needle was placed in the 
condenser’s septa and the system was stirred and purged with N2 (g) for a period of thirty 
minutes.  While C stirred in the Ph2O, a silicon oil bath was heated to 170oC.  Once the oil bath 
reached the desired temperature, the 2N-RBF was placed in the oil bath and the entire system 
was closed off with aluminum foil.  The oil bath was then heated to 220oC.  Once the oil bath 
reached 220oC the reaction mixture was left to stir for two hours.  After two hours the reaction 
was tested via TLC in 2:3 EA:HEX for reaction progression.  After two hours the 2N-RBF was 
removed from the oil bath and the reaction mixture was slowly cooled to room temperature with 
continuous stirring and N2 (g) atmosphere.   
 
 Once the reaction mixture was completely cooled, the Ph2O was removed on a 5.5X40 
cm column over SiO2 gel (500 mL) and hexanes.  The Ph2O was indicated by the appearance of a 
UV spot on TLC.  Once all of the Ph2O was removed, the polarity of the column was gradually 
increased to 2:3 EA:HEX to flush the desired product off of the column.  Once the product was 





 The red oil was purified on a 5.5X40 cm column over SiO2 gel (400 mL) using 3:7 
EA:HEX and gradually increased to 2:3 EA:HEX.  Fraction collection began once a UV spot 
appeared via TLC.  Once the desired product was removed from the column the collected 
fractions were combined and reduced via rotary evaporator and then placed on vacuum in order 
to prepare a 1H and 13C NMR sample with chloroform-D.  Once the product was completely dry 
an off-white crystalline solid remained. 
 
 Reaction 6: Option 1 
 A mixture of distilled water (DI-H2O) (3 mL) and D (0.1583 g) were placed in a 
microwave (mw) reaction vial equipped with a magnetic stir bar and the system was then closed 
off with a mw reaction vial cap.  The vial was then placed in the microwave reactor under the 
following conditions: Time 24 hours, Power 200 watts, Temperature 80oC, Pressure 17 bars. 
Once the reaction trial was complete the reaction mixture was tested via TLC in 1:9 
MeOH:CH2Cl2.  The aqueous reaction mixture was then washed with ether (3 mL) three times to 
remove initial impurities, the organic layer was discarded.  The aqueous layer was then 
combined with acetonitrile (15 mL) and placed on a rotary evaporator until completely reduced.  
The product was then dissolved in methanol (MeOH) (3 mL) and filtered over AlO2 gel (2 mL), 
the gel was washed three times with MeOH (1 mL).  The collected filtrate was then reduced via 
rotary evaporator and placed on vacuum in order to prepare a 1H and 13C NMR sample with 
MeOD.  Once the product was completely dry a brown solid remained. 
  
 Reaction 6: Option 2 
 A mixture of distilled water (DI-H2O) (3 mL), D (0.1498 g), and ytterbium(III)triflate 
(Yb(OTf)3) (0.0775 g) were placed in a microwave (mw) reaction vial equipped with a magnetic 
stir bar and the system was then closed off with a mw reaction vial cap.  The vial was then 
placed in the microwave reactor under the following conditions: Time 8 hours, Power 200 watts, 
Temperature 80oC, Pressure 17 bars. 
 
 Once the reaction trial was complete the reaction mixture was tested via TLC in 1:9 
MeOH:CH2Cl2.  The aqueous reaction mixture was then washed with ether (3 mL) three times to 
remove initial impurities, the organic layer was discarded.  The aqueous layer was then 
combined with acetonitrile (15 mL) and placed on a rotary evaporator until completely reduced.  
The product was then dissolved in methanol (MeOH) (3 mL) and filtered over AlO2 gel (2 mL), 
the gel was washed three times with MeOH (1 mL).  The collected filtrate was then reduced via 
rotary evaporator and placed on vacuum in order to prepare a 1H and 13C NMR sample with 















Figure 1: TLC ran in 1:4 EA:HEX and developed in KMnO4. 
 
Figure 2: 1H NMR of Reaction 2. 
 
Rf Values for Rxn 2 
 Starting Material Co-Spot A A 
Top 0.36 0.38 0.24 0.24 
Bottom - 0.24 - - 
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Figure 3: 13C NMR of Reaction 2. 
 
Reaction 3 
Figure 4: TLC 1,2, and 3 ran in 1:4 EA:HEX and developed in KMnO4. 
 
 
Rf Values for Rxn 3 TLC 1 
 Starting Material Co-Spot B B 
Top 0.29 0.49 0.41 0.41 
Middle - 0.32 - - 
Bottom  0.14 0.11 0.14 
Rf Values for Rxn 3 TLC 2 
 Starting Material Co-Spot B B 
Top 0.26 0.39 0.39 0.39 
Middle - 0.29 0.31 0.31 




Figure 5: 1H NMR of from Reaction 3. 
 
Reaction 4 
Figure 6: TLC ran in 3:7 EA:HEX and developed in KMnO4. 
 
Rf Values for Rxn 3 TLC 3 
 Starting Material Co-Spot B B 
Top 0.29 0.48 0.46 0.49 
Middle - 0.32 0.33 0.34 
Bottom  0.12 0.12 0.12 
Rf Values for Rxn 4  
 Starting Material Co-Spot C 
Top 0.63 0.63 - 
Bottom - 0.29 0.29 
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Figure 7: Average TLC plate of collected fractions for purification. 
  











Rf Values for Rxn 4 TLC Purification 




Figure 9: 13C NMR of purified product. 
 
Reaction 5 
Figure 10: TLC 1 and 2 ran in 40:60 EA:HEX under UV-light and developed in KMnO4. 
 
 
Rf Values for Rxn 5 TLC 1 
 Starting Material Co-Spot D 
Top - 0.81 0.81 
Bottom - 0.26 0.26 
Rf Values for Rxn 5 TLC 2 
 Starting Material Co-Spot D 
Top 0.37 0.37 0.33 
Bottom - 0.26 0.26 
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Figure 11: Average TLC plate of collected fractions for purification. 
 











Rf Values for Rxn 5 TLC Purification 




Figure 13: 13C NMR of purified product. 
 
Reaction 6 – Option 1 
Figure 14: TLC ran in 1:9 MeOH:CH2Cl2 and developed under UV-light. 
 
Figure 15: TLC of purified product ran in 1:9 MeOH:CH2Cl2 and developed under UV-light. 
 
Rf Values for Rxn 6 
 1 2 3 
Top 0.70 0.67 0.70 
Middle 0.30 0.32 0.30 
Bottom 0.17 0.16 0.16 
Rf Values for Rxn 6 
 1 2 3 
Bottom 0.16 0.16 0.16 
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Figure 17: 13C NMR of purified product. 
 
Reaction 6 – Option 2 










Rf Values for Rxn 6 
 1 2 3 
Top 0.78 0.75 0.78 
Bottom 0.11 0.11 0.13 
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 A growing interest in the application of microwave radiation to the field of organic 
chemistry has been an expanding area of study since the early 1980s.  The ability to heat 
reactions quickly by use of a microwave that would otherwise be heated by traditional methods, 
such as the use of a hot water bath or other heating medium, caused great interest and provided 
many advantages to organic synthesis.  Microwave radiation provides a greater rate of 
production of products for a given reaction; therefore, use of such a reaction medium as a heating 
source is ideal for reaction 6 (6).  The ability to shorten the reaction time provided a great 
solution to the problems associated with the original conditions.  A great percentage of the loss 
of product is attributed to side reactions and decomposition of material due to the extreme length 
of the original reaction time of 4 days.   
 
 A second modification, of the epoxide ring opening, to further decrease the reaction time 
was the proposed use of a Lewis acid as a catalyst.  The use of lanthanide triflates as Lewis acid 
catalysts has been an increasingly used practice in organic synthesis due to their solubility, 
recyclability, catalytic activity, and stability in aqueous media due to the increasing practice of 
green chemistry (7,8,9).  These properties are ideal for use in reaction 6 due to the high polarity 
of the starting material and use of water as the solvent and nucleophile.   
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 The goal of the project was to optimize the conversion of D to E using a microwave 
reactor along with the addition of a Lewis acid catalyst. Current literature report reaction yields 
at 41%, which can be attributed to decomposition and side reactions, leading to loss of product 
during purification (1).  Due to these problems, options 1 and 2 for reaction 6 were designed to 
improve the overall reaction production and potentially eliminate unnecessary purification to 
help improve the overall yield.  Within option1 the original reaction temperature reported in 
literature was used along with water as the nucleophile and solvent within a microwave reactor, 
the reaction time was decreased to 24 hours from a 4 day reaction time.  The reaction under these 
conditions produced a 16% increase in product yield.  Option 2 was carried out with similar 
conditions within a microwave reactor but included a 10 mol% addition of Yb(OTf)3 as the 
lanthanide triflate Lewis acid catalyst, the reaction time for this study was decreased to 8 hours 
from the 24 hour reaction time of option 1.  However, the production of product for this reaction 




Optimization of D to E will be continued in the future through continued modifications of 
reaction conditions.  Options 1 and 2 of reaction 6 will be further modified by adjusting the time 
and power within the microwave reactor, along with varying the types of Lewis Acid catalysts.  
The use of various Lewis Acid’s as a catalyst will also be expanded to the bench top with 
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Fast-Scan Cyclic Voltammetry and Redox Cycling for the Detection of 
Serotonin 





A new approach for electrochemical detection of serotonin was investigated in vitro, with 
an interest in ultimately transferring the method for in vivo detection.  Experiments were 
first performed by the use of fast-scan cyclic voltammetry to compare to literature 
responses and a new method of redox cycling was evaluated.  Fast-scan cyclic voltammetry 
was completed at gold microband and glassy carbon microdisk electrodes at scan rates up 
to 200 V s-1.  Evidence from scans of buffer alone suggests adsorption of 5-HT resulting in 
further amplification of signal by concentrating 5-HT at the electrode.  Redox cycling was 
accomplished with chronoamperometry method at devices having different separations 
between generator and collector microband electrodes.  Smaller gaps provided a higher 
amplification factor and collection efficiency.  Fabrication of interdigitated arrays with 
smaller separations is needed in future studies to detect the requisite physiological 




5-Hydroxytryptamine (5-HT), or serotonin, is an indolamine neurotransmitter found in 
the mammalian brain that has demonstrated a significant role in neurological disorders (1).  
Victims of suicide as well as patients diagnosed with major depression and schizophrenia have 
impaired serotonergic function (2).  To understand how neurotransmitters such as 5-HT play an 
important role in brain function and behavior, a method of detection and quantification would be 
of immense importance.  This report will address two methods, fast-scan cyclic voltammetry and 
redox cycling for 5-HT in the presence and absence of ascorbic acid (AA) (1).   
 
 Fast-scan cyclic voltammetry (FSCV) is a widely applied technique that involves rapid 
scan rates to detect and distinguish between various neurotransmitters.  This is suitable for in 
vivo studies where numerous repetitive scans are needed to detect miniscule concentrations of 
neurotransmitters (3,4).  Performing FSCV also prevents easily oxidize-able species such as 5-
HT from adsorbing to the electrode surface by decreasing the interaction time of the oxidized 
form of the species with the electrode (1).  However, FSCV has limitations.  When ions associate 
or disassociate at the electrode surface (i.e. charging), forming the double layer, while the 
potential changes during an FSCV experiment, background current is formed.  Faster scan rates 
produce higher charging current.  FSCV requires extensive subtraction of this background 
current also known as charging current (3).  Due to the necessary background subtraction, FSCV 
can only measure transient changes in neurotransmitter concentration.  In addition, some 
electroactive compounds have similar cyclic voltammograms and cannot be distinguished by 




 Redox cycling is another electroanalytical technique; however, it is not as prominent as 
FSCV.  Redox cycling uses two electrodes, a generator and collector, placed in close proximity 
to each other so that their diffusion layers overlap during the time scale of an experiment.  The 
analyte is oxidized at the generator and re-reduced at the collector.  One advantage to redox 
cycling is that it amplifies the faradaic current (5).  This technique is also desirable for detection 
of neurotransmitters, because a common electroactive interferent that is much higher in 
concentration, ascorbic acid, oxidizes irreversibly and therefore cannot “recycle”.  Ascorbic acid 
concentrations are about 100-1000 μM and those of 5-HT are about 0.1-1 µM (6,7).  However, 
since AA will oxidize readily but will not re-reduce, the only product received at the collector, 
during redox cycling, is result of the neurotransmitter.  Finally, as FSCV can only measure 
transient changes in neurotransmitter concentrations, redox cycling has the potential to measure 
basal and more slowly changing levels of neurotransmitters.  To our knowledge, this is the first 




2.1. Chemicals and Materials 
 
All chemicals were reagent grade and used as received.  Aqueous solutions were prepared 
with reagent grade water (Ricca Chemical Company, Arlington, TX).  Sodium chloride, calcium 
chloride, sodium dihydrogen phosphate, sodium sulfate, and ascorbic acid were obtained from 
Alfa Aesar (Ward Hill, MA).  Magnesium chloride and hexaamineruthenium(III)chloride 
(Ru(NH3)6Cl3) were obtained from Sigma-Aldrich (St. Louis, MO).  TRIS (NH2C(CH2OH)3) and 
potassium chloride were obtained from J.T. Baker (Phillipsburg, NJ) and EMD Chemicals 
(Darmstadt, Germany), respectively.  5-Hydroxytryptamine hydrochloride was obtained from 
Sigma-Aldrich (St. Louis, MO) and MP Biomedicals (Solon, Ohio).  Solutions containing 5-HT 




The 10 µm glassy carbon disk electrode was purchased from Cypress Systems 
(Chelmsford, MA).  The carbon interdigitated array (IDA) was purchased from CH Instruments 
Inc. (Austin, TX).  A picture of the carbon IDA is given in Figure 1 (8).  The Ag/AgCl (in 
saturated KCl) reference electrodes and platinum flag counter electrodes were constructed in-
house.   
 
The gold microband arrays were designed and fabricated by the Fritsch Group at the 
University of Arkansas High Density Electronics Center, Fayetteville, AR.  Gold microband 
arrays were fabricated via photolithography using photoplot masks.  Twelve chips were 
fabricated on a single 125 mm diameter Si wafer with oxidized layer.  The electrode layer on the 
Si wafer consisted of 50 Å Cr for adhesion and 500 Å Au.  Both were deposited by Edwards 306 
Auto thermal evaporator without ceasing vacuum between depositions.  Gold covered wafers 
were spin coated with 4+ µm photoresist (AZ4330RS, Hoechst-Celanese, Bridgewater, NJ) and 
then patterned using a photoplot mask.  The exposed areas were dissolved by AZ400K 
photoresist developer (Hoechst-Celanese, Bridgewater, NJ).  To remove the gold that was not 
patterned, a wet metal etching process was conducted.  Gold was etched for 1 min with KI (50 g) 
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and I2 (12 g) in 500 mL water.  Chromium was etched with CEP-100 Chrome Etchant 
(Microchrome Tech., San Jose, CA).  Photoresist was removed with acetone.  To apply 
benzocyclobutene (BCB) to insulate the leads, the wafer was spin coated with 5 µm BCB.  A soft 
bake was done at 70 °C for 20 min.  BCB was patterned using another photoplot mask and 
unexposed areas were removed with DS2100 developer (Dow Chemical Co., Midland, MI)  The 
layer was cured at 150 °C for 15 min and 250 °C for 60 min.  The polymer residue was removed 
by descumming with reactive ion etching for 90 s using a mixture of O2 (32 sccm) and SF6 (8 
sccm) at 250 mtorr and 200 W RF power (Unaxis Plasma Therm SLR 720f).  The wafer was 
then diced into individual chips.  A picture of a microband array is given in Figure 2 (9).  Each of 
the final fabricated individually addressable electrodes is 20.5 μm wide and 2 mm in length.  
Electrodes are separated by 29.5 μm gaps.  Dimensions were determined using optical 
microscopy. 
 
2.3. Electrochemical Measurements 
 
All electrochemical measurements were performed using a CH Instruments bipotentiostat 
model 750A equipped with a picoamp booster and faraday cage (CH Instruments Inc., Austin, 
TX).  Studies were controlled by PC and compatible CHI software.  All experiments involving 
air sensitive species were completed in a glove bag under argon atmosphere to minimize 
oxidation.  Characterization was completed with a model species 1 mM Ru(NH3)63+ in 0.5 M 
KCl.  Various concentrations of 5-HT were studied in TRIS buffer (pH 7.4). The TRIS buffer 
consists of 15 mM TRIS, 140 mM NaCl, 3.25 mM KCl, 1.2 mM CaCl2, 1.25 mM NaH2PO4, 1.2 
mM MgCl2, and 2.0 mm Na2SO4 (6).  A three electrode setup was used with external reference 
and counter as stated previously.  Background subtraction of cyclic voltammograms was 
performed using the CHI software.   
 
All devices were cleaned between each run and after completion of every experiment.  
The glassy carbon electrode was cleaned by acetone-ethanol-deionized water rinse, in sequence, 
and stored in deionized water to prevent fouling.  Polishing was done with 0.05 µm 
deagglomerated alumina and rinsed with deionized water intermittently during experimentation 
(if residue was apparent) and also at the conclusion of every experiment.  The gold band 
microarray was similarly rinsed between uses, but sonicated (Branson 1510, Branson Ultrasonic 
Corporation) for 30 s in acetone, ethanol, and deionized water, respectively, at the end of an 
experiment.  The array was stored in isopropyl alcohol when not in use.  The carbon IDA was 
rinsed and stored in water only.  No organic solvents could be used to clean the surface as 
instructed by manufacturers.   
 
Results and Discussion  
 
3.1. FSCV: Characterization using Ru(NH3)63+ 
 
Characterization of electrodes was always performed with 1 mM of a model redox 
species, hexaamine ruthenium (III) chloride , in 0.5 M KCl electrolyte, first, before studies of 5-
HT were carried out.  Current magnitude and shape of the electrochemical responses were 
compared to theoretical expectations to confirm that the electrodes were functioning properly.  
Fast-scan cyclic voltammetry was conducted in this solution to determine the response of a gold 
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microband electrode.  The model species produced peak shape behavior at a scan rate range of 
0.1 V s-1 to 500 V s-1.  Example background subtracted cyclic voltammograms are shown in 
Figure 3a-b.  Table 1 gives values for calculated (Calcd) and observed (Obs) peak current in the 
forward sweep (reduction in the case of Ru(NH3)63+).  The equation used for linear-diffusion-
limited current is 
2/1*2/12/35 )1069.2( vCADnxip =  (10) 
 
where n is the number of electrons per mole of species transferred during electrolysis, A is the 
area of the electrode, D is the diffusion coefficient of the species, C* is the concentration of the 
species in bulk solution, and v is the scan rate.  The diffusion coefficient of Ru(NH3)63+used in 
the above equation is 7.8 x 10-6 cm2 s-1 (11).  The observed peak current is higher than the 
theoretical value at all scan rates, which confirms the presence of passive conductance.  The 
FSCV square root scan rate curve (Figure 4a) was linear with R2 value of 99.7 % over a range of 
three orders of magnitude, with the exclusion of 200 V s-1.  The linear relationship between scan 
rate and peak current confirms that Ru(NH3)6 does not behave as an adsorptive species on gold 
(See Figure 4b).   
 
Increasing noise was observed with increasing scan rate. For scan rates 50 V s-1 and 
greater, the noise became significant and could not be eliminated by changing the sensitivity.  
This is likely due to a limitation of the instrumentation.  
  
3.2. FSCV: Serotonin Detection on Gold Microband 
 
5-HT was detected by FSCV on a single gold microband electrode of the array.  The scan 
rate range reported is 1 V s-1 to 200 V s-1.  The scans were performed over a potential range of -
0.4 V to 0.8 V.  Background subtracted cyclic voltammograms of 200 μM 5-HT in TRIS are 
shown in Figure 5a-h.  Oxidative and reductive peaks are clearly visible for scan rates greater 
than 10 V s-1.  Slower scan rates depict pseudosteady state behavior.  Table 2 gives values for 
calculated and observed peaks.  The diffusion coefficient used for 5-HT was 5.4 x 10-6 cm2 s-1 
(12).  The observed values of charging current and faraday current are higher than the expected.  
For example, at a scan rate of 200 V s-1, the observed value of charging and faraday current are 
4.92 μA and 2.05 μA, respectively.  These are higher than the calculated values of 3.02 μA 
(charging current) and 1.38 μA (faraday current).  The higher charging current and faraday 
current are due to the change in surface chemistry of the electrode and passive conductance, in 
that order.  Figures 6a displays a graph of faraday current versus square root scan rate.  Figure 6b 
displays a graph of faraday current versus scan rate.   The correlation of faraday current against 
scan rate, 99.4 %, is higher than that of faraday current against square root of scan rate, 97.2 %.  
This suggests adsorption of 5-HT to the gold microband surface.  The study was conducted with 
scan rates in descending order (200 V/s first and 0.01 V/s last, or short to long time scales) to 
minimize the accumulation of 5-HT on the electrode surface.  The background current in TRIS is 
also fairly linear with scan rate (Figure 6c) with the exception of smaller scan rates. This is due 
to adsorption of 5-HT on WE, more so during smaller scan rates.  
  




5-HT was also detected by FSCV on a glassy carbon microdisk electrode.  The scan rate 
range was identical to the experiments performed on the gold microband electrode.  The 
potential window for glassy carbon scans was -0.2 V to 0.9 V.  Background subtracted cyclic 
voltammograms of 200 μM 5-HT in TRIS are shown in Figure 7a-h.  Excessive noise is seen in 
scan rates of 100 V s-1 and 200 V s-1. All oxidative and reductive peaks are captured in the 
potential window, as stated previously.  Table 3 gives values for calculated and observed peaks.  
The observed values of charging current and faraday current are higher than the expected.   
For example, at a scan rate of 200 V s-1 the observed value of charging and faraday current are 
34.4 nA and 13.0 nA, respectively.  These are higher than the calculated values of 9.42 nA 
(charging current) and 3.93 nA (faraday current).  Figures 8a displays a graph of faraday current 
versus square root scan rate.  Figure 8b displays a graph of faraday current versus scan rate.   The 
correlation of faraday current against square root scan rate, 97.3 %, is lower than that of faraday 
current against scan rate, 97.5 %.  This data suggests that 5-HT is less adsorptive on glassy 
carbon as it is on gold.  Although the adsorption may seem to be less on glassy carbon than gold, 
it is still evident.  Over the course of the glassy carbon microdisk electrode experiment, a 
decrease in faraday current is apparent.  This phenomenon can be explained by fouling of the 
glassy carbon surface, thus decreasing the active surface area.  The study was conducted in 
descending order of scan rates (200 V s-1 to 0.01 V s-1), so more adsorption is expected in the 
later part of the study.  Again, background current in TRIS is also fairly linear with scan rate 
(Figure 8c), as expected, but with the exception of smaller scan rates.  
 
3.4. Redox cycling: Characterization using Ru(NH3)63+ 
  
The model compound was used again to characterize each device.  However, a solution 
of 0.1 mM Ru(NH3)6Cl3 in 0.5 M KCl was prepared.  Both cyclic voltammetry and 
chronoamperometry methods were used.   
 
The electrode setup for the gold microband array, or Device 1, with 29.5 µm gaps is 
shown in Figure 9.  The width to gap ratio is 1:1.44.  Cyclic voltammetry was performed at scan 
rates of 0.1 V s-1, 0.05 V s-1, 0.01 V s-1, 0.005 V s-1.  The generator was swept from 0.2 V to -0.3 
V while the collector was held at 0.2 V.  The cyclic voltammograms for the model compound at 
all scan rates are given in Figure 10.  Experiments on Device 1 gave peak currents and charging 
currents higher than expected.  Amplification factors and collection efficiencies were calculated 















Measurements were taken at maximum current values on non-background subtracted cyclic 
voltammograms.  Table 4 gives amplification factors and collection efficiencies for all applied 
scan rates.  Collection efficiency increased with decreasing scan rate as expected.  Slower scan 
rates provided more time for redox species to diffuse to collector thereby increasing collector 
current.  Amplification factors also increased with decreasing scan rate.  The generator current 
with collector turned on showed increase in current, as expected, due to passive conductance.  
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With longer time scales, diffusion layers are allowed to overlap and redox cycling may then take 
place.  However after some point, increasing time scales, or decreasing the scan rate, will no 
longer affect the collection efficiency and amplification.  
The electrode setup for the carbon IDA with 5 µm gaps (2:1 width to gap ratio), or 
Device 2, is shown in Figure 11.  The scan rates and parameters for the generator and collector 
were identical to those of the experiments with Device 1.  The cyclic voltammograms for the 
model compound at all scan rates are given in Figure 12. Experiments on Device 2 gave peak 
currents higher than expected and charging currents lower than expected.  Table 5 gives 
amplification factors and collection efficiencies for all applied scan rates.  Similar patterns of 
results are seen on Device 1 as Device 2.  Collection efficiency as well as amplification 
increased with decreasing scan rate.  However, the smaller gaps show much great collection 
efficiency and amplification than the larger gaps, as would be expected.   
 
Chronoamperometry, another method of redox cycling, was used on the model 
compound.  Chronoamperometry, at long time scales, should provide the same steady state 
current as the slow cyclic voltammetry experiments.  The electrode setups remained the same for 
both devices.  On the Device 1, the generator and collector were held at -0.3 V and 0.2 V, 
respectively.  Figure 13 shows the chronoamperometry scan at 180 seconds.  The time scale for 
the experiment was calculated by solving for t in the following equation for diffusion length (δ) 
Dt2=δ  
 
where D is the diffusion coefficient for the model compound.  The diffusion length value used 
was 5 μm, or the separation of microelectrodes.  Excess time was given to ensure diffusion of the 
species.  The amplification and collection efficiency for the device is also shown on Figure 13.  
The chronoamperometry data is comparative to that of cyclic voltammetry.  There is a small 
difference in generator current of chronoamperometry mode due to Ru(NH3)6Cl33+ catalyzing 
oxygen reduction and therefore increasing current at the generator.  The collector currents are 
similar.  Oxygen reduction does not occur at the collector due to the potential held at 0.2 V.   
 
For the Device 2, the generator and collector were held at the same relative potentials as 
Device 1.  Figure 14 shows the chronoamperometry scan for 180 seconds.  The amplification and 
collection efficiency are also shown on Figure 14.  As expected, the amplification and collection 
efficiency for the model compound on the Device 2 were much higher than those of Device 1.  
The smaller the gap the less time it takes for the redox species to reach the opposing electrode.  
The chronoamperometry data proved dissimilar from cyclic voltammetry data.  The CA currents 
were 3 times greater than CV currents.  Additional work is needed to establish a reason for this 
result.   
 
3.5. Redox cycling: Serotonin Detection with 29.5 μm Gap 
 
 Redox cycling for serotonin was only done via chronoamperometry method.  The 
generator was held at 0.7 V and the collector was held at -0.2 V.  The chronoamperometry scan 
of 1 mM 5-HT in TRIS for 180 seconds on the Device 1 is shown in Figure 15a.  Figure 15b 
shows chronoamperometry scan of a 1:1 concentration mixture of 5-HT:AA in TRIS.  The 
calculated amplification and collection efficiency are 0.94 and 4.74 %, respectively.  Due to such 
a large gap between the generator and collector, the time it takes for the redox species to reach 
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the collector from the generator is much longer.  Therefore, the redox cycling observed is 
minimal. 
 
3.6. Redox cycling: Serotonin Detection with 5 μm Gap 
  
 For Device 2, the generator was held at 0.8 V and the collector was held at -0.2 V.  The 
chronoamperometry scan of 1 mM 5-HT in TRIS for 180 seconds on the Device 2 is shown in 
Figure 16a.  Figure 16b shows chronoamperometry scan of a 1:1 concentration mixture of 5-
HT:AA in TRIS.  The calculated amplification and collection efficiency are 1.12 and 79.73 %, 




FSCV was successfully completed for 200 µM 5-HT.  Evidence from our studies 
suggested the adsorption of 5-HT resulted in further amplification of signal by concentrating at 
the electrode.  Higher currents produced at higher scan rates suggest detection of lower 
concentrations of 5-HT.     
 
The first time use of redox cycling to detect serotonin was completed on two devices with 
different gaps.  Amplification and collection efficiency were obtained for the model compound 
as well as 5-HT.  Both values were greater for the device with smaller gaps.  The difference in 
amplification and collection efficiency is result of the difference in the gap of generator and 
collector electrodes.  By decreasing the gap between the generator and collector, the current also 
increased.  Therefore, fabrication of similar devices with smaller gaps will aide in lowering the 
detection limit of 5-HT.  The results of these studies open possibilities of excluding 
interferences, like AA, amplifying signals and detecting on very short time scales.  Opportunities 
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Equations used for FSCV on microband:   
2/1*2/12/35 )1069.2( vCADnxip =  
dcc AvCi =  ; Cd is capacitance (60 x 10-6 F) 
Table 1. FSCV Data for Ru(NH3)63+ on mircroband electrode 
Scan rate  sqrt (scanrate) Obs ip ΔEpeak Calcd ip 
V/s sqrt (ν) µA mV µA 
500.00 22.3607 7.38 140 5.5145 
200.00 14.1421 3.47 148 3.4877 
100.00 10.0000 3.27 121 2.4662 
50.00 7.0711 2.01 100 1.7438 
25.00 5.0000 1.68 90 1.2331 
1.00 1.0000 0.41 97 0.2466 
0.10 0.3162 0.22 130 0.0780 
Table 2. FSCV data for 200 µM 5-HT in TRIS on microband electrode 
Scan 
















V/s sqrt (V/s) µA mV nA mV µA µA µA µA 
0.01 0.10 0.0155 695 --- --- 0.0005 0.0145 0.0002 0.0287 
0.10 0.32 0.0433 693 --- --- 0.0037 0.0458 0.0025 0.0385 
1.00 1.00 0.0965 692 --- --- 0.0257 0.1450 0.0246 0.0581 
10.00 3.16 0.2220 582 14.300 224 0.2232 0.4585 0.2460 0.1189 
25.00 5.00 0.3270 697 102.60 237 0.5151 0.7249 0.6150 0.2036 
50.00 7.07 0.5060 712 151.10 203 1.0079 1.0250 1.2300 0.4417 
100.00 10.00 0.3906 710 92.0 186 1.7775 1.4498 2.4600 -2.6122 























Equations used for FSCV on microdisk: 
2/1*2/12/35 )1069.2( vCADnxip =  
dcc AvCi =  
  rnFDCiss



























Figure 1  
Picture of interdigitated array, Device 2 
Table 3. FSCV data for 200 μM 5-HT in TRIS on microdisk electrode 
Scanrate SQRT (ν) Obs ip Obs icc Obs Ep Calcd ip Calcd icc 
V/s sqrt (V/s) nA nA mV nA nA 
0.01 0.10 0.093 0.103 363 0.0278 0.0005
0.10 0.32 0.298 0.436 394 0.0878 0.0047
1.00 1.00 0.953 3.063 441 0.2776 0.0471
10.00 3.16 3.040 9.371 521 0.8778 0.4710
25.00 5.00 4.159 10.852 566 1.3879 1.1775
50.00 7.07 5.295 16.114 611 1.9628 2.3550
100.00 10.00 7.592 22.548 707 2.7758 4.7100
200.00 14.14 13.00 34.408 833 3.9256 9.4200
Table 4 Redox cycling of Ru(NH3)63+ on Device 1 
 Redox cycling 
Scanrate sqrt (ν) 8 G / 0 C i 8 G i 7 C i Af Ce 
V/s sqrt (V/s) nA nA nA  % 
0.1000 0.3162 132.66 132.64 24.98 1.00 18.833
0.0500 0.2236 131.28 120.8 10.89 0.92 9.0149
0.0100 0.1000 91.04 102.11 55.03 1.12 53.893
0.0050 0.0707 75.77 95.94 56.67 1.27 59.068
Table 5 Redox cycling of Ru(NH3)63+ on Device 2 
     Redox cycling     
Scanrate sqrt (ν) 8 G / 0 C i 8 G i 7 C i Af Ce 
V/s sqrt (V/s) nA nA nA  % 
0.1000 0.3162 746.90 917.09 497.30 1.23 54.23
0.0500 0.2236 597.90 874.80 514.00 1.46 58.76
0.0100 0.1000 347.03 745.60 587.60 2.15 78.81





Picture of microband array, Device 1 
Figure 3 
Background subtracted cyclic voltammograms of 1 mM Ru(NH3)6Cl3 in 0.5 M KCl on a 
microband array at (a) 500 V s-1 and (b) 0.1 V s-1.  
 
Figure 4 
Comparison of dependence of peak current on scan rate: (a) as a function of square root of scan 
rate, and (b) as a direct function of scan rate.  Markers indicate experimental data (FSCV of 1 
mM Ru(NH3)6Cl3 in 0.5 M KCl on microband array) and solid lines represent the least squares 
best fit to a line through the data points.   
 
Figure 5 
Background subtracted cyclic voltammograms for 200 μM 5-HT in TRIS on microband array at 
a scan rate of: (a) 200 V s-1, (b) 100 V s-1, (c) 50 V s-1, (d) 25 V s-1, (e) 10 V s-1, (f) 1 V s-1, (g) 
0.1 V s-1, and (h) 0.01 V s-1 
 
Figure 6 
Comparison of dependence of peak current on scan rate: (a) as a function of square root of scan 
rate, and (b) as a direct function of scan rate.  Dependence of background current on scan rate is 
shown in (c).  Markers indicate experimental data (FSCV of 200 µM 5-HT in TRIS on 
microband array) and solid lines represent the least squares best fit to a line through the data 
points.   
 
Figure 7 
Background subtracted cyclic voltammograms for 200 μM 5-HT in TRIS on microdisk electrode 
at a scan rate of: (a) 200 V s-1, (b) 100 V s-1, (c) 50 V s-1, (d) 25 V s-1, (e) 10 V s-1, (f) 1 V s-1, (g) 
0.1 V s-1, and (h) 0.01 V s-1. 
 
Figure 8 
Comparison of dependence of peak current on scan rate: (a) as a function of square root of scan 
rate, and (b) as a direct function of scan rate.  Dependence of background current on scan rate is 
shown in (c).  Markers indicate experimental data (FSCV of 200 µM 5-HT in TRIS on microdisk 
electrode) and solid lines represent the least squares best fit to a line through the data points. 
 
Figure 9 
Setup of microband array used for redox cycling.  Electrodes 3-10 were shorted together to form 
the generator and electrodes 11-17 were shorted together to form the collector.  Each electrode 
(20.5 µm wide x 2 mm long) is separated by a 29.5 µm gap. 
 
Figure 10 
Cyclic voltammetry method of redox cycling for Ru(NH3)63+ at 29.5 µm gaps for scan rates of: 
(a) 0.005 V s-1, (b) 0.01 V s-1, (c) 0.05 V s-1, (d) 0.1 V s-1. The thin line indicates the generator 
current with the collector off.  Thick lines indicate collector current (top) and generator current 







Setup of interdigitated array used for redox cycling.  The generator consists of 65 (grey) 
electrodes and the collector consists of 65 (black) electrodes.  Each electrode (10 µm wide x 2 
mm long) is separated by a 5 µm gap. 
 
Figure 12 
Cyclic voltammetry method of redox cycling for Ru(NH3)63+ at 5 µm gaps for scan rates of: (a) 
0.005 V s-1, (b) 0.01 V s-1, (c) 0.05 V s-1, (d) 0.1 V s-1. The thin line indicates the generator 
current with the collector off.  Thick lines indicate collector current (top) and generator current 
with collector on (bottom).   
 
Figure 13 
Chronoamperometry method of redox cycling of Ru(NH3)63+ at 29.5 µm gaps for 180 s. 
 
Figure 14 
Chronoamperometry method of redox cycling of Ru(NH3)63+ at 5 µm gaps for 180 s. 
 
Figure 15 
Chronoamperometry method of redox cycling of 1 mM 5-HT in TRIS for 180 s at (a) 29.5 µm 
gaps and (b) 5 µm gaps. 
 
Figure 16 
Chronoamperometry method of redox cycling at 5 µm gaps for 180s for (a) 1 mM 5-HT in TRIS 
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Single-site Mutagenesis within A Cluster of Positive Residues Could Expose 
An ‘Achilles Heel’ of Human Fibroblast Growth Factor-1 
Andrew Robertson, Texas State University 




Fibroblast growth factors (FGFs) consist of a family of polypeptide growth factors that 
have a diverse range of pleiotropic effects on cells, including cellular proliferation, 
differentiation, apoptosis, and migration. These intense mitogenic properties endow FGFs 
with a crucial wound healing function. The biological properties of FGF-1 cause it to be 
thermodynamically unstable at a physiological temperature and pH, thus providing an 
immediate challenge for its use as a theraputical. This study will attempt to optimize the 
wound healing function of human FGF-1 by exposing a weak area of the protein and 
stabilizing it. Single-site mutagenesis will be performed in a notably dense cluster of 
positive charges near the N-terminus of the protein, 23- KKPK -26. Dense clusters of 
positive charge are regions of instability due to charge repulsion. Single-site mutation 
K24E will introduce a negative charge in the region in hopes of reversing repulsion. K24R 
will introduce a positive residue in order to increase repulsion. K24Q will introduce a non-
polar residue to neutralize repulsion. Purification of mutants K24E and K24Q 
demonstrated a dramatic increase in expression levels for FGF-1 in E. coli.  ITC data 
demonstrates that a point mutation within the cluster of positive charges in the K23K to 
K26 region does not significantly affect binding affinity. Thermostability and resistance to 
proteolytic degradation was not increased by any of the mutant variants. The three-




 Fibroblast growth factors (FGFs) are ubiquitous with many of the most important 
biological actions of life. FGFs consist of a family of polypeptide growth factors that are 
essential in both vertebrate and invertebrate development and are used to regulate a diverse range 
of biological processes (1, 2). In vertebrates, there are 23 members of the FGF family, ranging 
from FGF-1 to FGF-23, making it the largest family of growth factors currently known, 
however, not all 23 members are present in every organism (humans lack FGF-15, for example). 
Vertebrates share a common molecular weight range for FGFs between 17 kDa to 34 kDa (2). 
FGFs exhibit the typical beta-trefoil fold with 12 anti-parallel beta sheets arranged in a triangular 
formation (3).   
  
  FGF signaling is mediated by the binding, dimerization, and subsequent activation of a 
cell surface tyrosine kinase receptor called a fibroblast growth factor receptor (FGFR) (4, 5, 6). 
FGFs can bind to 4 isoforms of FGFR, which are differentiated as FGFR1 to FGFR4, 
respectively (6, 7). The binding to its receptor is significantly enhanced by the binding of heparin 
sulfate proteoglycans (HSPGs), which are present on the cell surface and within the extracellular 
matrix (5). The binding of heparin is thought to enhance the stability of the protein by protecting 
against degradation via proteases, and denaturation due to heat and non-optimal pH (6, 8). Once 
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bound to its receptor, a signaling cascade induces a range of pleiotropic effects, including 
cellular proliferation, differentiation, apoptosis, and migration (1, 5, 7).  
 
FGFs diverse affects on cellular regulation give it powerful mitogenic properties. FGF 
signaling provides essential roles during embryonic development, angiogenesis, and adult 
homeostasis. Furthermore, FGFs substantial mitogenic properties make FGFs an essential part of 
tissue repairs, endowing FGF with a critical wound healing function (5, 7). Human FGF-1 
exhibits the broadest spectrum of FGF activity due to its ability to bind to all four isoforms of the 
FGFR (3, 5, 9).  This study aims to evaluate the potential for the wound healing function of 
human FGF-1 to be optimized for medical applications. 
  
 The medical importance of an improved wound healing agent is very high due to the 
challenge presented by the current population demographic of the United States as well as the 
majority of other developed countries. Due to the aging of the ‘Baby Boom’ generation and also 
because of improvements in medical care within developed countries, the geriatric population is 
increasing substantially. Within the elderly population, problems that result from impaired skin 
integrity, lack of mobility, and vascular disease can lead to the development of chronic wounds. 
The most common chronic wounds are ulcers. The development of pressure ulcers (bedsores) is 
one of the most detrimental types of chronic wounds, and occurs at a notably higher frequency in 
the geriatric population. Pressure ulcer wounds have an impeded ability to initiate the molecular 
signaling required for healing, thus the wound will heal poorly, or not at all, and can lead to 
complications that can kill (10). This impediment is due to a deficiency in growth factors (9, 10). 
In order to encourage the healing of chronic wounds, various cytokines have been used in 
previous studies to induce the wound healing process with variable degrees of success (9, 10). 
FGF-1 is of particular interest for this application due its wide-spread mitogenic activity, and 
consequently, strong wound healing potential (9). However, the biological properties of FGF-1 
provide an immediate challenge for its use as a theraputical.    
 
 A significant problem with utilizing biomolecules for medical application is that their 
physiochemical properties may cause them to be unstable for industrial development, storage, 
and administration (11). FGF-1 is thermodynamically unstable at a physiological temperature 
and pH, and has a short half-life in vivo (12).  In order to be effective, FGF-1 must be able to 
exist in a non-optimal temperature and pH (such as those in the human body), have extended 
resistance to degradation by proteases, and also have a half-life long enough to remain active in 
the body for a significant amount of time after administration. It is therefore desirable to engineer 
an FGF-1 mutant with optimized physiochemical properties which increase its conformational 
stability. 
 
 The engineering of proteins with increased stability has been performed previously with 
the design of mutant variants via the introduction of point mutations in the wild type. In FGF-1, 
point mutations at Q40, S41, H21, L44, H93, H102, and F108 have successfully shown to 
increase stability (11, 12, 13). Also, it has been speculated that a single point mutation can not 
only significantly affect the stability, but it may improve the yield of pure protein per liter of 
bacterial culture. However, this has not been experimentally verified yet. In previous studies, 
design of stabilizing mutations was based on consensus homology sequencing. This approach 
relies on the assumption that a conserved series of amino acids within evolutionarily-related 
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proteins are more important for protein stability than residues which occur less frequently. This 
approach is semi-rational. Even if it can be predicted that the introduction of a more 
evolutionarily conserved AA will stabilize a particular region in the protein, an accurate 
prediction of the consequences of such a mutation on the rest of a protein cannot be made with a 
high degree of certainty (14). In this study, a fully rational strategy is employed in the design of 
the mutant.    
 
 Single-site mutagenesis will be performed to a residue in a region estimated to be of high 
significance to FGF-1 stability. It is well understood that clusters of positive residues can disrupt 
protein stability (15, 16). A high density of positive charges causes positive residues to act in 
repulsion to one another. FGF-1 has a notably dense cluster of positive charges near the N-
terminus of the protein, 23- KKPK -26. This cluster is particularly dense due to the presence of a 
proline residue which pulls local residues into closer proximity to one another. Three mutations 
point mutations will be designed to assay the effect of this region on hFGF-1 instability. Single-
site mutation K24E will introduce a negative charge in the region in hopes of neutralizing 
repulsion. K24R will introduce a positive residue in order to increase repulsion. K24Q will 
introduce a non-polar residue which could neutralize the repulsion. If stability is significantly 
affected by any of the variants, then a weak point in FGF-1 structure will be exposed. The 
stability of the variants will be assayed by evaluating their thermostability, the affinity for 
heparin, and their ability to resist proteolytic degradation. Furthermore, proteins with low 
stability are typically expressed in lower yields. It has been hypothesized that a single mutation 
in FGF-1 could significantly affect the yield of pure protein per liter of bacterial culture. To 
validate this, we will evaluate the difference in yield of pure protein per liter of bacterial culture 
for each mutant variant.  
 
Materials and Methods 
 
Materials 
 Taq polymerase, NdeI, DPN, and XhoI enzymes were purchased from Promega. 
Bl21(DE3)pLysS E. coli cells and pET20b(+) were obtained from Novagen. Sucrose octasulfate 
(SOS) was purchased from Toronto Research Chemicals. The heparin-Sepharose affinity column 
was purchased from Amersham Biosciences. Isotopically labeled 15NH4CL and D2O were 
purchased from Cambridge Isotope Laboratories. All additional chemicals used were purchased 
from Sigma. All chemicals used were of the reagent grade.  
 
Expression of WT FGF-1, K24E, K24Q, and K24R 
 The WT FGF-1 was transformed into pLysS E. coli cells containing the pET18b plasmid. 
All cultures were incubated at 37 ºC on a shaker at 170 rpm in LB medium at a concentration of 
25 g/liter containing 0.1 % ampicilin and chloramphenicol. Pre-culture cells were grown from a 
stock solution of glycerol. Large scale expression was performed by inducing the cultures with 
1mM isopropyl β-D-1- thiogalactopyranoside (IPTG) after the optical density at 600nm had 
reached ~ 0.6, after which, colonies were allowed to grow for an additional 4-5 hours before 
harvesting. Samples of un-induced and induced culture were retained for SDS-PAGE analysis to 
assay effectiveness of induction. Cultures were centrifuged at 6000rpm for 20 minutes and 
resuspended in a 10mM phosphate buffer containing 1mM sodium azide, triton, beta-
92 
 
mercaptoethanol, and ethylenediaminetetraacetic acid (EDTA) at pH 6.5. All proteins were 
stored at -80 ºC.  
 
Purification of WT FGF-1, K24E, K24Q, and K24R via Heparin Affinity Chromatography 
 Resuspended cell cultures were thawed from -80 ºC in a water bath. After thawing, 
proteins were kept continually on ice until loaded on column. Protein was extracted from cells by 
sonification. Further impurities were removed by centrifugation at 16 000 rpm for 20 mins. The 
heparin-sephrose column was washed with 10mM phosphate buffer containing 1mM sodium 
azide at pH 6.5. The supernatant was loaded onto the column and the flow through was collected. 
The column was washed with 10mM phosphate buffer containing 1mM sodium azide at pH 7.2 
until a baseline was established, all of the wash was collected. The column was then washed with 
10mM phosphate buffer containing 0.8M NaCl and 1mM sodium azide at pH 7.2, fractions were 
collected once an absorbance at 280nm was measured by the detector, and fraction collection 
was stopped once a baseline was reestablished. This was then repeated with 10mM phosphate 
buffer containing 1.5M NaCl and 1mM sodium azide at pH 7.2. SDS-PAGE analysis was 
performed on all fractions to assay for protein purity. Dialysis was performed on 1.5M NaCl 
wash due to high protein purity as visualized via SDS-PAGE analysis. Dialysis buffer contained 
10mM Phosphate buffer, 50mM NaCl, 50mM ammonium sulfate (AMS), and 1mM sodium 
azide at a pH of 6.5. Buffer was exchanged three times every three hours, and then exchanged for 
a fourth time for 12 hours. The dialyzed sample was centrifuged at 6000 rpm for 20mins.   
 
Plasmid DNA Extraction 
 Isolation of WT and mutant plasmids was accomplished via Qiagen plasmid purification 
kit. The protocol 'Plasmid DNA purification using QIAprep in Miniprep Kit and a 
Microcentrifuge' was followed. 
 
Mutagenesis 
 The K24E mutation was introduced using a site-directed mutagenesis kit 
(QuickChange™) obtained from Stratagene. Polymerase chain reaction (PCR) was performed 
following the standard QuickChange protocol. The forward and reverse primers were mutagenic 
oligonucleotides of 30 base pairs from Integrated DNA Technologies and were used in 
combination in the PCR reaction (see appendix for primer sequences). Amplified PCR product 
was digested by adding Dpn restriction enzyme to reaction mixture and incubating at 37ºC for 1 
hour. Recombinant protein was transformed into XL1-Blue super competent cells and incubated 
at 37ºC for 1 hour. 
 
 The K24R and K24Q mutants were constructed by overlap extension PCR, as described 
elsewhere. The forward primers were mutagenic oligonucleotides of 66 base pairs which 
contained an Nde1 restriction site from Integrated DNA technologies, and the reverse primer was 
a T7 terminator. The PCR reaction product generated an insert which would be ligated into a 
pET20b vector by digestion of Nde1 and EcoR1 restriction enzymes. Success of PCR was 
assayed by agarose gel electrophoresis. DNA was extracted from the gel using a Qiagen gel 
extraction kit. The amount of recombinant plasmid DNA to be used in the ligation was quantified 
by analyzing the relative band intensity of the plasmid on an agarose gel. The recombinant 




  Transformation of recombinant proteins from competent cells into expression cells was 
performed at 42ºC in E. coli B121(DE3)pLysS strain obtained from New England Biolabs.      
 
Differential Scanning Calorimetry of WT and Mutants With and Without SOS 
 All experiments were performed in a Nano 3 DSC (Calorimetry Sciences Corp.).  A 
buffer vs. buffer run was performed prior to each experiment to establish a baseline. Sample and 
reference microfilament was filtered with 300 ul of water each before loading sample. Sample 
was degassed for 5 minutes before loading. Chamber was pressurized to 3.03 atm once power 
was between -50 and 50 uW. The number of scans for each sample was 2 at 1°C /min from 10 to 
90 °C. The concentration of protein was 1.5mg/ml. Data plots were performed in CpCalc 
software.   
 
Isothermal Titration Calorimetry of WT and Mutants With and Without SOS 
 All experiments were performed in a VP-ITC titration microcalorimeter. All samples 
were degassed and equilibrated in a vacuum at 25°C before each run. All samples were at a 
concentration of 50uM in 10mM phosphate buffer containing 100mM NaCl and 50mM 
ammonium sulfate, and all ligand was at a concentration of 20mM in the same buffer. The 
reference cell was loaded with water. The ligand was injected 50 times in 6 ul aliquots with an 
injection rate of 300 s intervals between each injection. Titration curve was calibrated and 
analyzed using Microcal software.  
 
Proteolytic Digestion Assay 
 A limited trypsin digestion was performed on WT and mutant FGF-1 with and without 
SOS. Protein concentration was brought to 0.5mg/ml for the experiment. The FGF-1 to SOS 
mixture was 1:1 molar ratio, and the FGF-1 mixture to trypsin was at a 1:10 molar ratio. A total 
of 18 samples were collected for each experiment which represented 18 time points, ranging 
from 0-90 minutes, in 5 minute increments. The 0 time point had no trypsin added and serves as 
a control. All samples were placed in a 1.5ml eppendorf tubes on ice which contained 10% 
tricholoroacteic acid (TCA). Stability was assayed by running all 18 samples on an SDS-PAGE 
gel and comparing the relative intensity of the 16kDa band to the band at the 0 time point using 
denstrometric scanning software (UV-SCAN-IT tm).  
 
Results and Discussion 
 
Expression and Purification of FGF-1  
 All mutants were capable of being over-expressed and all were eluted from a heparin-
affinity column in the 1.5M NaCl wash (Figure-1). The level of expression of FGF-1 in E. coli 
was not uniform among WT and the mutant variants. This is demonstrated by the varying yields 
of pure protein after heparin- affinity column purification (Figure-2) Yield of pure protein in WT 
and K24R was around 0.7 mg/ml, in K24E it was 2.48 mg/ml, and in K24Q it was 3.4 mg/ml. 
This data implies that mutants K24E and K24Q were able to dramatically increase expression 
levels of FGF-1 in E. coli. This significant improvement in expression levels could be due to 
increased stability in the K23 to K26 region. This conclusion is supported by the fact that the 
K24R mutant had a yield of pure protein which was very similar to the WT, which should be 
expected as substituting a lysine for an arginine could not possibly negate the charge to charge 
repulsion in this region.   
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SOS Binding Affinity to FGF-1 
 Isothermal titration calorimetry (ITC) is a valuable technique for the quantification of the 
thermodynamic parameters of protein–protein or protein–ligand interaction. ITC data provides 
precise quantification of the stoichiometry, binding affinity, and heat changes that occur during 
protein–ligand binding reactions in solution (17). This instrument when applied to SOS/FGF-1 
binding generates a unique binding isotherm profile which serves as a comparison for all mutant 
variants. Figure 3 illustrates the result of ITC for the wild type and all mutants. In all cases, the 
stoichiometry between FGF-1 and SOS is 1:1, and the reaction proceeds with the evolution of 
heat (exothermic). The binding affinity (Kd) of wild type FGF-1 to SOS is 1.2 x 10-6 (Figure 
3,Panel-A ). The binding affinity (Kd) of K24E FGF-1 to SOS is 6.45 x 10-6 (Figure 3, Panel-B), 
indicating a slight decrease in affinity for heparin. Point mutations K24Q and K24R 
demonstrated Kd  values that did not deviate significantly for the WT (Figure 3, Panel-C and 
Panel D). ITC data demonstrates that a point mutation within the cluster of positive charges in 
the K23K to K26 region does not significantly affect binding affinity. 
 
Thermostability of FGF-1 
 Differential scanning calorimetry is a thermo-analytical technique useful for measuring 
the thermodynamic properties of a protein. By measuring the difference in the amount of heat 
required to maintain equal temperature between a sample and a reference cell, the heat 
transitions of a biomacromoleule can be precisely determined (18). In this context, the melting 
temperature of WT FGF-1 and all mutant variants will be assayed. An increase in melting 
temperature can be attributed to an overall increased in thermostability. Experiments were run in 
the presence of SOS and without SOS. The WT FGF-1 demonstrated a melting temperature of 
49.2 ºC without SOS (Figure 4, Panel-A) and a melting temperature of 62.6 ºC with SOS (Figure 
4, Panel-B). All mutant variant did not significantly deviate from the WT melting temperatures 
(Figure 4, Panel-A and Panel-B), indicating that the overall thermostability of the protein did not 
significantly increase.  
 
Proteolytic Digestion of FGF-1 
 The biological activity of proteins is greatly dependent on its susceptibility to proteases. 
The ability of a protein to resist proteolytic degradation correlates strongly with its stability (12, 
13). Proteolyitc digestion experiments were carried out on the WT and K24E both with and 
without SOS to assay if any structural changes in the mutant variant have lead to an increase in 
proteolytic resistance. Since FGF-1 is rich in arginine and lysine residues, a limited trypsin 
digestion was carried out to probe structural changes. The products of the digestion were 
visualized by SDS-PAGE and staining with Coomassie blue dye. Comparing the digestion 
patterns of WT and WT with SOS demonstrates that the addition of SOS in solution with FGF-1 
significantly increases resistance to proteolytic degradation. Densitometric scans were performed 
on the SDS-PAGE bands for both the WT and K24E digestions. Plotting this data (Figure 5) 
indicates that there was no significant difference in proteolytic stability between the WT and 
K24E. 
 
Visualization of Chemical Perturbation on Mutants  
 NMR spectroscopy can be used to visualize structural changes between proteins and 
proteins bound to ligands. Using the 1H-15N HSQC spectrum, an essential blueprint of the 
conformational state of WT FGF-1 was generated. This spectrum was used to analyze significant 
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structural shifts in the mutant variants. Comparing the cross peaks of K24E (Figure 6) 
demonstrated that there was significant perturbation at the site of mutation, and at the heparin-
binding region of the protein (C-terminus). The K24R mutant demonstrated no changes (Figure 
7), with the exception of the mutation site itself. This is predictable since lysine and arginine 
does not differ significantly in size or charge. The K24Q mutation also demonstrated 
perturbation around the mutation site, and showed significant perturbation in the heparin binding 
region of the protein (Figure 8). Despite the perturbation observed for K24R and K24Q, 




 Site-specific mutants of hFGF-1 have been generated in the cationic segment (K23 to 
K26). Reversal and nullification of charge on K24 dramatically increases the yield of pure 
protein per liter of bacterial culture. Introduction of negative charges in the cationic segment 
does not appear to have a significant effect on the thermodynamic stability of the protein. Charge 
reversal and nullification of K24 does not significantly perturb the three-dimensional structure of 
the protein. Results of this study suggest that protein expression yields can be modulated by 
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Figure 1. SDS–PAGE depicting the overexpression and purification of WT (panel-A) K24E 
(panel-B), K24Q (panel-C), and K24R (panel-D) of FGF-1 in E. coli. Lane M represents the 
molecular weight marker; lane 1-uninduced fraction of FGF-1 expression; lane 2-induced 
fraction of FGF-1 expression; lane 3-flow through; lane 4-10 mM phosphate buffer elution; lane 
5- 0. 8 M NaCl elution; lane 6- 1.5 M NaCl elution.  
 
Figure 2. A bar graph depicting the yields of pure protein per liter of bacteria culture for WT and 
all mutant variants. WT = 0.78 mg/ml; K24E = 2.48 mg/ml; K24Q = 3.4 mg/ml; K24R = 
0.71mg/ml. 
 
Figure 3.  ITC curves showing the binding of SOS to wild type (panel-A), K124E (panel-B), 
K24R (panel-C) and K24Q (panel-D) of hFGF-1 at 25 °C. The upper panels show the raw data 
representing hFGF-1 – SOS titration. The bottom panels show the integrated data obtained from 
the raw data after background subtraction. The solid line in the bottom panels represent the best-




Figure 4. Differential scanning calorimetry representing the unfolding of wild type and all 
mutant variants of hFGF-1 with SOS (pamel-A) and without SOS (panel-B). The protein (1.5 
mg/mL) was dissolved in 10 mM phosphate buffer (pH 7.2) containing 100 mM NaCl and 50 
mM ammonium sulfate. The experiments were performed at a scan rate of 1°C/min with 3 scans.  
 
Figure 5. Limited trypsin digestion of the wild type hFGF-1 and the mutant variant K24E in the 
presence and absence of SOS. The relative band intensity was measured for each band on the 
SDS-PAGE which corresponded to a time point. Intensity of band (arbitrary units) is plotted 
against time (mins). Protein concentration was 0.5 mg/ml, with a 1:1 molar ration with SOS and 
a 1:10 molar ratio with tyrpsin. 
 
Figure 6 Chemical perturbation effects caused by K24E mutation. Panel-A- 1H-15N HSQC 
spectra of K24E type hFGF-1 (red) overlayed with wild type (green). Significant chemical shift 
perturbation observed indicates changes in local stability in proximity to K24. Panel-B-1H-15N 
chemical shift perturbation of residues in K24E FGF-1 in comparison to WT FGF-1. 
Significantly perturbed residues include, K24E, S52, Q54, H55, S61, I70, H107, H138, and L49. 
Panel-C- MolMol representation of the structure of hFGF-1 (grey). Colored residues indicate 
significant perturbation. Red: K24E, Green: K26, Yellow: S52, Cyan: Q54, Magenta: S61, 
Orange: I70, Dark Green: H107,  Aquamarine: K138, L49: Brown. 
 
Figure 7 Chemical perturbation effects caused by K24R mutation. Panel-A- 1H-15N HSQC 
spectra of wild type K24R obtained in the absence (red) and presence (green) of SOS. No 
significant chemical shift perturbation is observed other than at the mutation site. Panel-B-1H-
15N chemical shift perturbation of residues in K24R FGF-1 in comparison to WT FGF-1. No 
residues were significantly perturbed other than the mutation site. Panel-C- MolMol 
representation of the structure of hFGF-1 (grey). Colored residue indicates significant 
perturbation. Red: K24R. 
 
Figure 8 Chemical perturbation effects caused by K24Q mutation. Panel-A- Overlap of the 1H-
15N HSQC spectra of K24Q (red) and wild type hFGF-1 green). Significant chemical shift 
perturbation observed indicates that local stability in proximity to K24E is not as greatly affected 
as stability at the C-terminus of the protein. Panel-B -1H-15N chemical shift perturbation of 
residues in K24Q FGF-1 in comparison c to WT FGF-1. Significantly perturbed residues include 
Q54, H107, H116, G124, K127, H138, and A143 .  Panel-C- MolMol representation of the 
structure of hFGF-1 (grey). Colored residues indicate significant perturbation. Dark Green: 
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Synthesis of Variable Size CdTe/ZnS Core/Shell Quantum Dots 
Hayden Self, Shorter College 




Research into the usage of quantum dots in Förster resonance energy transfer (FRET) 
imaging techniques for bio-labeling has seen many improvements in recent history. 
Although most calculations involving the determination of both FRET efficiencies and 
Förster distances use an estimated value for the refractive index of the core, shell, and 
solution combined, this study is designed to supplement further investigations by this group 
of the role of the refractive indices of each of the various structures in the overall 
calculations of FRET efficiency and Förster distance by providing a method to synthesize 




Fluorescent bio-labeling has been a vital tool for the understanding of biological 
dynamics on the nanometer scale since its introduction as a viable process in the 1920’s.1 The 
use of fluorescent markers attached to biologically significant molecules has been a fruitful tool 
for research2,3,4,5 with rapid advances occurring continuously.5 Although this represents an old 
technology, new and innovative techniques2,3,4 have allowed for the transformation of this 
process into an extremely accurate and unparalleled method to monitor and explain movements 
and behavior of molecules on the nanometer scale. In particular, fluorescence resonance energy 
transfer or Förster resonance energy transfer (FRET) imaging techniques have been invaluable 
in their contributions to understanding the behaviors of biological processes such as protein 
folding,6 protein motions,7 DNA polypex assembly,8 and membrane functionality.2 Their ability 
to allow for general detection of behaviors at the nanoscopic level for non-biological processes 
has also earned FRET imaging a place outside of biochemical applications, as well.9,10  
 
FRET imaging is a process that utilizes the excitation of electrons within the molecular 
orbitals of a donor molecule by the absorption of photons. The absorption of the photon excites 
an electron in the molecule that can then resonate via non-radiative dipole interactions to an 
acceptor molecule in close proximity. Once this resonance occurs, the acceptor molecule then 
releases a photon of higher wavelength with less energy than the original donor absorbed photon 
due to loss of slight amounts of energy to other non-radiative processes. Bio-labeling utilizes this 
resonate mechanism to allow for non-radiative acceptors to become activated and emit when in 
close proximity to the donating molecules, which is an excellent tool for determination of 
structural parameters of interest in many biological systems.2,6,7,8  
 
The process of FRET imaging has become an even more prominent tool for fluorescent 
spectroscopic analysis of biological pathways due to the recent development of colloidal 
spherical semiconducting nanocrystals, or quantum dots (QD).11 QDs generally have narrow 
emission spectra, are brighter and more stable than traditional dyes, and are more resistant to a 
commonly observed effect in organic dyes known as photobleaching.5 Because QDs are 
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Figure 1: Schematic representation 
of the difference in bandgaps of the 
CdTe/ZnS core/shell QD. The shell 
acts as protection against oxidation 
and an amplifier of quantum 
confinement effects because of the 
effect of the wider bandgap material.
This particular ZnS shell also makes 
the QDs more biologically friendly 
by providing a barrier that confines 






composed of semiconductor materials of small diameter, their 
emission spectra are directly related to the size of the cores due 
to quantum confinement effects, with increases in radii causing 
increases in wavelength emission, which was originally 
observed in colloidal systems by Murray et al.12 and further 
explored by others.13 The introduction of semiconductor shells 
of materials with higher bandgaps allows for the amplification 
of quantum confinement effects.5 (Figure 1) These effects 
subsequently increase the QDs resistance to photobleaching 
and further helps to confine excitation to the core.5 
 
These qualities make core/shell QDs an attractive 
choice for replacing or supplementing traditional organic dyes. 
Although some have reported problems with the solubility of 
group II-VI core QDs for biological labeling purposes without 
surface modifications such as thiolated capping ligands,13 
CdTe QDs have been reported to be water soluble after the 
addition of water-soluble thiolated capping ligands and can be 
used with or without shells in conjugation for measuring 
biological processes in an aqueous environment without 
unnecessary loss of fluorescence.9,10 This has proven to be a 
major advantage in the study of FRET-QD systems, allowing 
for more direct measurements and observations to be made 
without unnecessary modification to the physical and chemical 
characteristics of the QD.9,10  
 
This study hopes to further supplement the current 
project underway by this group in the understanding of the factors affecting total FRET 
efficiency E in conjugated CdTe/ZnS – dye systems across variable distances of the radii of core 
material and shell material by providing a pathway for the proper synthesis of the nanocrystal 
materials needed for the FRET analysis. (Figure 2) 
 
Once these materials are properly 
synthesized and bioconjugated, the 
FRET effificency can be determined 
experimentally by using the actual 
distance between the donor and acceptor 
in 3-space r and Förster distance R0 , 
which are the intermolecular distances 
between the donor and acceptor 
molecules that allows for 50% FRET 
efficiency to the acceptor molecular dye. 
This is modeled as: 
 
 
Figure 2: Schematic representation of the types of samples 
required for proper determination of the shell/core radii on 
FRET efficiency. Note that by maintaining a consistent dye and 
static length single type of protein, determination of the  
core/shell effect on the Förster equation becomes dependent 
upon thickness of the shell and size of the core. This will 
manifest itself within the refractive index n of the equation and 
can substitute for the normally estimated value of n = 1.33. 
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This distance R0, in Ǻ, can then be calculated by characterizing four factors that affect the 
model: average refractive index of the medium n, quantum yield of the donor molecule ΦD, 
overlap of the donor emission and acceptor absorption spectra measured J(λ) where λ is 




The determination of R0 in the CdTe/ZnS core/shell QD bio-conjugate has previously 
been based upon assumption that water is the primary determinant of total refractive index, n = 
1.33. However, this assumption fails to take into consideration the effect of the total core radius 
and the total shell thickness. By observing the relationship between R0 and the refractive indices 
of the various structures involved in the physical FRET process through accurate quantization of 
overlap of the donor emission and acceptor absorption spectra J(λ), quantum yield of the donor 
molecule ΦD, and the rotational orientation of the dipole interactions between the donor and 
acceptor К2, further understanding of the effect of the radii of the core and shell on Förster 
distance R0 and total FRET efficiency E can be mathematically modeled. 
 
The creation of these type-I heterostructures with zinc-blende core and wurzite shell 
lattice structures via coating with ZnS has been suggested to decrease total quantum yield against 
other similar core/shell lattice combinations, as observed in comparison with zinc-blende 
core/shell heterostructures.14 This, however, has been assumed to bear no significance upon the 
nature of FRET efficiency and has also been previously suggested to be more biologically 





  Tellerium (99.8%), Cadmium Oxide (99.998%), 1-octadecene (ODE, technical grade, 
90%), tri-n-octylphosphine (TOP, technical grade, 90%), and tri-n-octylphosphine oxide (TOPO, 
98%), Zinc oxide (metals basis, 99.9%), Sulfur powder (sublimed, -100 mesh, 99.5%), 3-
mercaptopropionic acid (MPA, 99%),  and stearic acid (98%)  were purchased from Alfa Aesar 
and used without any further purification. n-octadecylphosphonic acid (ODPA, 97%) was 
purchased from Strem Chemicals and used without any further purification. Oleylamine (>40%) 
was purchased from TCI America and used without any further purification. Fluorescein in 
dimethylsulfoxide (DMSO) was purchased from Invitrogen and was dissolved in 0.1 NaOH for 
further use as a reference dye. 
 
Quantum Dot Core Synthesis 
 The method of synthesis was the as prescribed in the literature16 with slight 
modifications. In a glove box under Ar atmosphere, 0.066g of elemental Te powder was 
dissolved in 2g of tri-n-octylphosphine (TOP) to generate a Te precursor. 0.052g of CdO, 0.25g 
of n-octadecylphosphonic acid (ODPA), and 2g of tri-n-octylphosphine oxide (TOPO) was 
dissolved in 2g 1-octadecene (ODE) to generate a Cd precursor. The Cd precursor was then 
heated to 300°C - 320°C in a 25mL round bottom flask under an Ar atmosphere until the solution 
became a characteristic milky clear. This solution was then allowed to cool to room temperature 
and injected via micropipette with 2g oleylamine. It was then reheated to 270°C upon which it 
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was then injected via syringe with Te precursor and immediately cooled to 250°C until specific 
fluorescent signatures were detected, indicative of the particular size of the synthesized 
nanocrystals in solution.17 
 
Quantum Dot Shell Synthesis 
 The layering of the ZnS shells on the CdTe cores was performed using the successive ion 
layering adsorption and reaction via thermal cycling (SILAR-TC) method as outlined in the 
literature.18 ZnO and stearic acid in a 1:5 molar ratio were heated under Ar atmosphere to 250°C 
and allowed to react until the evolution of O2 and H2O had ceased for 20 min. The stock Zn 
stearate was then dissolved in ODE to form a 0.02 g/mol solution of Zn precursor. Elemental 
sulfur was dissolved in ODE to form a 0.001 g/mol solution of S precursor. The precipitated QD 
core solution was re-dissolved in 5mL ODE and 1mL oleylamine and heated to 60°C under an 
Ar atmosphere. Theoretical amounts of the total volume of both the Zn solution and S solution 
needed for each monolayer were calculated using appropriate and widely accepted calculations 
and were injected alternating in 5 min intervals with a fraction of the shelled QDs in the round 
bottom flask removed every 10 minutes just before the injection to create the next monolayer.  
 
Purification 
 After each core and shell synthesis was completed, unless otherwise stated, each sample 
was transferred to a centrifuge tube and 15 mL of hexane and 15 mL of methanol were added to 
the samples. The tubes were centrifuged at approximately 6,000 rpm for 3 min and the methanol 
was removed. This process was repeated 1-3 times until the supernatant became translucent with 
minimal precipitation to ensure purity. Afterwards, the remaining hexane solution was mixed 
with 15 mL of acetone and centrifuged to allow for complete QD precipitation. The resulting 
purified QDs were stored in darkness at 10°C until further use.  
 
Ligand Exchange 
 After every sample had been successfully shelled and purified, each sample was 
dissolved in approx 7 mL chloroform and 7 mL Millipore purified water and injected along with 
2.0 mL MPA into a round bottom flask. The flask was heated to 70°C for 1 hour under reflux 
conditions in an Ar atmosphere. For the samples of shell layer 1, 3, & 4 this process was 
repeated twice due to failure of the entire sample to become water soluble. Afterwards, the water 
layer was removed via glass pipette and centrifuged at 10,000 rpm for 5 min with 7 mL ethyl 
acetate. The precipitant was then removed and dissolved in 1 mL of water and was mixed with 
15μL – 30μL of 0.2g/mL TMAHP in water and instrumentally analyzed for absorption and 
visually analyzed for fluorescence. 
 
Optical Measurements 
Absorbance of the QD solutions of each core radius and shell thickness was measured 
using a Hitachi U-3310 Spectrophotometer. Fluorescence of the QD solutions was measured 
using a Hitachi F-2500 Fluorescence Spectrophotometer. Each measurement was taken between 
500nm – 700nm and photoluminescent quantum yields (QY) were measured in comparison to 
fluorescein as a standard reference with each sample concentration diluted to an absorbance of 
0.005 at 490nm. This data, in conjunction with TEM imaging, was then also used to verify 
predicted QD sizes and shell thicknesses, as described in the literature.17 
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Figure 3: CdTe core and CdTe/ZnS core/shell samples
diluted to an absorption of 0.005 at 490nm under UV
light. The pattern of red shifted fluorescence and QY
characteristics (brightness) from left to right is
indicative of each successive addition of shell material,
and can be reflected in the ABS graph (Figrue 4), PL
graph (Figure 5), and the QY graph (Figure 6).
Figure 4: Fluorescence measurements of CdTe core and
CdTe/ZnS core/shell samples before ligand exchange. This
pattern of peak size and shift is characteristically found in
the literature14 and indicative of successful shell growth. 
 
Figure 5: Absorption measurements of CdTe core and CdTe/ZnS
core/shell samples before ligand exchange. Although at differing
concentrations, the pattern of red shift is still observed amongst the
samples with increasing shell thickness. 
Transmission Electron Microscopy (TEM) 
 TEM images were obtained using a JEOL 100CX transmission electron microscope with 
an acceleration voltage of 100kV. All samples were precipitated using the previously mentioned 
purification method and re-dissolved in toluene. The diluted solutions in which the first optical 
peak measured less than 0.01 from the baseline where carefully placed over Formvar film or 
carbon film coated copper grids via glass pipette. Selected area electron diffraction patterns 





Quantum Dot Core/Shell Synthesis 
 The one-pot CdTe core 
synthesis yielded very luminescent 
monodisperse nanocrystals of almost 
completely uniform size distribution. 
(Figure 3) The combination of the 
temperature and the materials used 
allowed for a relatively fast nucleation 
process and slow growth that permitted 
the resolution of particular sized cores 
based on visual properties of the 
reaction. One core size with a 3.41nm 
diameter with fluorescence emission 
peak at a wavelength of 568nm was 
successfully synthesized and shelled 
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Figure 6: (Left) Quantum
Yield measurements
plotted as a function of
shell thickness. This
pattern of increasing and
then decreasing QY has
been attributed to the
lattice mismatch between
the CdTe core and ZnS
shell.14 Figure 7: (Right)
Peak maxima as a
function of shell
thickness. This is also
consistent with the
literature.19 
Figure 9: Emission spectra of the only fluorescent
samples left from the shelling proceedure after ligand
exchange. The distinct peaks are slightly blue shifted
from their orginal position before the ligand exchange
and are currently thought to simply be a consequence of
the addition of the thiol ligands.  
Figure 8: Absorption spectra obtained immediately the
1st ligand exchange for the core and 2nd shell samples
and the 2nd ligand exchange for the 1st, 3rd, and 5th.
Noticeable concentration discrepancies can be seen that
has been thought to lead to the loss of fluorescence of
the 1st, 3rd, and 4th shell samples.  
with 4 layers of ZnS to yield various CdTe/ZnS samples with variable diameter. UV-Vis and 
Fluorescence measurements of each of the samples also provided further evidence of successful 
synthesis, with each red shift upon subsequent addition of both Zn and S precursors indicative of 
successful ZnS shell layering.M (Figure 4, Figure 5)  
 
 Subsequent ligand exchange proved successful with fluorescence detected in the water 
layer that was purified and removed from the mixture. However, attempts to resolve the sample 
for precise QY measurements failed with most of the samples being lost during the resolution 
processes and becoming unrecoverable. Data providing supporting evidence for the phase 













Figure 10: Photograph of the water soluble MPA coated
CdTe/ZnS core/shell nanocrystals under UV lighting. Only
the core sample and 2nd shell sample exhibit fluorescence,
most likely due to having a considerably higher concetration
than the 1st, 3rd, and 4th samples. 
DISCUSSION 
 
Quantum Dot Core/Shell Synthesis 
Mechanism 
 As the original solution containing 
CdO is heated to 300°C - 320°C, dissociation 
occurs between the Cd and O, with Cd 
complexing with ODPA while O2 gas is 
evoluted out of the system. This complexation 
stabilizes the Cd and allows for easy and 
controlled reaction with the TOP completexed 
ionized Te precursor. As the Te solution is 
injected into the system, the high 250°C 
temperature allows the TOPO in solution to 
form small spheres of hydrophilic volume in 
the hydrophobic ODE solution (reverse 
micelles), which then allows for the nanocrystals to nucleate and allows for relatively slow and 
controlled growth of the CdTe nanocrystals as the complexed Cd and Te in the micelles 
crystallize to the surface of the growing nanocrystals. As the temperature is lowered, the NH2 
functional groups on the oleylamine molecules in solution act as surface ligands, reacting with 
the crystals’ dangling surface bonds and passivating the surface. It is noteworthy that failure to 
maintain the reaction under an inert atmosphere allows for fluorescence quenching due to the 
oxidation of the QDs. 
 
 The formation of the ZnS shell occurs through the surface passivating ligands located on 
the CdTe cores dissociating from the dangling bonds due to purification and allowing for the 
epitaxial growth of the ZnS crystals on the surface in evenly distributed layers.14,19 As the Zn 
from the Zn stearate dissociates, it migrates to the surface of the CdTe and as the surface 
passivating ligands dissociate, the elemental S and Zn form a shell around the core.14,17,18 The 
formation of these monolayers is thermally controlled at a range of 60°C - 70°C and is dependent 
upon the total amount of precursor injected.18 This reaction is usually mediated by the injection 
of excess oleylamine, which helps to slow the reaction and further passivate the surface. If too 
few surface passivating ligands are in solution, which is usually the product of over-purification, 
the reaction will occur instantaneously and uncontrollably upon injection and aggregation will 
occur.  
 
 Although other temperatures were used in the shelling process, it was found that 60°C 
under an Ar atmosphere yielded the best results. One synthesis, in particular, was carried out at 
130°C with multiple ZnS layers placed over a CdTe core that emitted at 615nm. The emission 
spectra (Figure 11) of the shelled samples showed a mysterious second peak that forms after the 
1st shelling of the sample. The absorption and emission spectra (Figure 12) of the cores, however, 
suggest that only one monodisperse size of core sample was made, thus suggesting that the 




Figure 12: Combined absorption and emission spectra of the 615nm
CdTe core used in the 150°C shell synthesis attempts. It is apparent
from these spectra that the crystal are fairly monodisperse and do not
show wide arrays of QD sizes in solution. 
Figure 11: Emission spectra of the ZnS shelled samples created with of
the 615nm red CdTe cores. The sample after the first shelling exhibits
normal, predicted growth, however a radical shift occurs beginning with
the 3rd injection that causes a migration of fluorescence upfeild. 
Currently,further investigations into 
the cause of these phenomena are 
underway. The current hypotheses 
suggests that contamination from 
trace amounts of air remaining 
within the system and in the 
precursor solutions may allow for 
oxidation of the QDs to occur more 
rapidly at higher temperatures. 
Another possibility is that the higher 
temperature caused the core and the 
shell to alloy into a single material 
with a different bandgap. Since the 
only major changing factor is the 
reaction temperature, it would 
suggest that perhaps this is the underlying cause of the effect. 
 
Other measurements of 
samples created at 60°C revealed a 
bizarre blue shift in the shelling 
process after the addition of the 1st 
layer of shell material that isn’t well 
documented in the literature. (Figure 
13) Although the cause for this 
apparent shift in fluorescence 
emission wavelength is not well 
known as of yet, it has been 
consistently been observed in both 
CdTe/ZnS QDs and CdSe/ZnS QDs 
synthesized by this group. Further 
research into this behavior will 
hopefully provide insight into the 
causes behind it. 
 
Ligand Exchange 
 The ligand exchange returned 
mixed results, with three fifths of the 
samples loosing fluorescence and the 
other two fifths becoming highly 
fluorescent. This is perhaps attributed to the dilution of the 1st, 3rd, and 4th shell samples which 
were reduced because of transfer loss in the second ligand exchange. Because all five samples 
were identical in all other aspects except for their concentrations, it is suspect that the samples 
are simply too dilute to reveal any fluorescence. It has also been suggested that because of the 
relatively uniform amounts of base (TMAHP) injected into each solution to deprotonate the 
carboxyl groups of the MPA-QDs, the more dilute samples may have perhaps suffered from an 
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Figure 13: Emission spectra
(left) of the various size
core/shell samples shown in
contrast with the core. A
noticeable blue shift is
observed after the addition of
the 1st layer of shell material
and is not currently well
understood.  Figure 14: Peak
maxima as a function of shell
thicknes (below) graphically
illustrate the dramatic blue
shift and gradual recovery by
addition of shell material. 
etching effect which caused a blue shift in emission that was observed dramatically for some of 
the more dilute samples and only slightly in the more concentrated core and 2nd shell samples.  
 Although the base TMAHP was added after the ligand exchange in these experiments, it 
has been suggested that it is best to have the water layer in the exchange reaction contain the 
TMAHP whilst the reaction is occurring. A pH of approximately 8-10 is preferential in order to 
allow for proper deprotonation of the carboxylic group that can, in turn, become properly soluble 
in an aqueous environment. The solubility of the 1st, 3rd, and 4th shell samples in water was poor 
after the first series of ligand exchanges, thus suggesting that the TMAHP plays a pivotal role in 
allowing for complete dissolution in water. 
 
 A slight blue shift was observed in the peak maxima for both the core and 2nd shell 
samples after ligand exchange. (Figures 7 & 8) Although the reason for this is elusive at the 
moment with further investigations being undertaken, the current hypothesis suggests that 
perhaps excess TMAHP has etched the surface of the QDs due to the compound’s strong 
basicity. This process is further documented in the literature.18 
 
Characterization of Core/Shell Quantum Dots 
 Using the equations described in the literature, evaluation of the differing sizes of the 
core diameters could be executed.17 After obtaining the results from the spectrophotometric 
observations of the QDs, the average core diameters of each sample D were quantified as a 




 From these diameters, it was possible to determine the total amount of Zn and S 
precursors needed to create individual monolayers through SILAR-TC using extinction 




The value of the extinction coefficient allowed for the determination of the concentration 
of the QDs in solution which was vital to the overall calculations of the total volume of each 
shell precursor injection needed to generate specific monolayers from our stock solutions. With 
the absorption strength A, the path length L, and the extinction coefficient  all determined, the 




As the individual monolayers were added in carefully measured amounts, the aliquots 
from the reaction were examined using absorption spectroscopy and it was determined via these 
optical measurements and TEM imaging that the core and shell diameters were of acceptable and 
differentiable values. 
 
Shell Synthesis Calculations 
The calculations needed to determine the total amount of each precursor solution required 
to generate a single monolayer varied as there are numerous methods that approach the problem. 
The method used by this group required a simplifying assumption that the QDs were perfectly 




Where VC denotes the volume of the core and rC is the radius of the core, which was 
gathered from the equations available in the literature through absorption measurements.O This 
revealed the volume of the core that could then be subtracted out from the total volume of the 
core/shell system, measured by the addition the radius of the shell rS. For each ZnS monolayer, 
this was described as rS = 0.31nm. This then evaluated the total volume VT of the core/shell 
system itself:  
 
 
Which was next used to find the volume of the shell VS by the subtraction of the volume 




 This process proved to be easily repeatable for each monolayer by setting VC = VT from 
the calculations used for each preceding monolayer and running through the above equations 
again. After the volume of the shell VS had been calculated, multiplication of this by the recorded 
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 This value mQD was then multiplied by the total number of QDs in the solution which was 
determined by taking the concentration C from the Beer-Lambert Law and multiplying it by the 
total volume of the sample VL and Avogadro’s number 6.022x1023 to generate the total mass mT 




 This, however, was only valid for growth on monolayers on a sample not being 
partitioned into subsamples. Because of the removal of aliquots after each monolayer formation, 
more complex calculations were required to account for the loss of QDs from the original 
sample. As the sample diminished in concentration, less Zn precursor and S precursor were 
needed for each injection. Compensating for this was a simple task as the total number of QDs in 




For simplicity, each amount ideally diminished by a fraction that was proportional to the 




That assumption fundamentally changed the total mass mT of ZnS required for each 
injection for a static total amount of QDs in solution in order to account for the creation of 




 These changing values could then be stochiometrically combined with the separate 
concentrations CI in g/mL of the stock Zn precursor and S precursor solutions to generate the 





Quantum Yield Calculations 
 Quantum yield (QY) of the CdTe cores and CdTe/ZnS core/shell heterostructures was 
determined by using organic dyes with well characterized emission and absorption behaviors as 
standard solutions for direct fluorescence comparason.20 One dye in particular, fluorescein, was 
utilized as a standard reference with its QYs pre-determined: 
QYFluorescein = 0.92 
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 The utilization of this known value was used in the mathematical definition of QY, which 
is described by the intensity of photons emitted from the sample IE divided by the number of 




 By setting the absorbance of both the QD sample being measured and the reference dye 
being utilized at the particular excitation wavelength, it could be justifiably assumed that both 
variables of absorption IA were equal to each other for their respective QY equations. This was 










 As the QY of the dye QYdye is already known, the variables of photon emission intensity 
IEQD and IEdye were determined by integrating the area under the fluorescence spectra. These 
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Improving the Clark Type Electrode 





Cyclic Voltammetry (CV) was performed on gold, platinum and graphite electrodes.  The 
data from these CV’s were formatted into a calibration curve for the reduction of oxygen. 
Pencil lead electrodes were found to be highly sensitive to oxygen reduction (127 μA/(cm² 
ppm Oxygen)).  For harder lead, oxygen is reduced at a lower potential.  A catalyst, E-Tek 
C-13, was applied to the pencil lead and CV’s were collected of this electrode as well.  The 
application of the Etek-13/Nafion coating to the 4H 0.5 mm graphite in 0.1 M KCl 




  Leland Clark is the inventor of the Clark type electrode which is seen in almost all 
amperometric type dissolved oxygen sensors.  The Clark type electrode (Figure 1) utilizes a gold 
cathode and silver/silver chloride anode immersed in an electrolyte, typically KCl.  Oxygen 
diffuses from solution through a semi-permeable membrane to contact the cathode, and fixed 
potential is applied from a voltage source. The oxygen surrounding the cathode is subsequently 
reduced.  This causes a current to travel through the circuit, which is then measured.  The 
dissolved oxygen concentration is directly proportional to the current.  
  
 Oxygen has several possible pathways to reduce depending upon the situation.  For the 
transfer of four electrons there are 2 pathways.1 
O2 + 2H2O + e-→ 4OH-  Eº=0.4 V (Basic Solution) 
O2 + 4H+ + 4e- → 2H2O  Eº=1.2 V (Acidic Solution) 
For the transfer of two electrons, intermediates are involved, the pathways are 
O2 + H2O + 2e- → HO2- + OH-  Eº=-0.07 V (Basic Solution) 
Followed by the reduction of peroxide  
HO2- + H2O + 2e- → 3OH-  Eº=0.87 V 
Also chemical decomposition of peroxide can occur 
2HO2- → 2OH- + O2 
O2 + H2O + 2e- → H2O2  Eº=0.67 V (Acidic Solution) 
This is this followed by either 
H2O2 + 2H+ + 2e- → 2H2O  Eº=1.17 V 






Figure 1-Clark Type Electrode 
A. Gold Cathode, B. Silver/Silver Chloride Anode, C. Electrolyte, D. Semi-permeable Membrane, E. Ring 
to Maintain Semi-permeable membranes position, F. Potential Source, G. Galvanometer 
 
The major problem with the current Clark type electrode is in that it requires an 
application of a high fixed potential (0.7 V).  This large overpotential is applied to increase the 
electron transfer kinetics of the oxygen reduction, which is slow relative to other reduction 
reactions.  The large overpotential reduces other species present in solution along with oxygen 
and so the current that is read is not only from the oxygen being reduced.  The Paul group is 
looking to improve the existing Clark type electrode by finding an electrode that has a high 
sensitivity to oxygen and reduces oxygen at a low potential by applying a catalyst to the surface 
of the cathode. 
 
At the beginning of the summer of 2009 the group was researching various carbons in 
carbon paste electrodes (CPE’s).  The method used to pack the CPE’s was erratic, leaks would 
appear, and the  nujol binder that was used appeared to cause large backgrounds.  Because of 
these complications a new carbon that did not require a binder was looked for.  Pencil lead 
sticks, a solid carbon mixed with various amounts of clay depending upon which hardness the 
lead is, became the electrode material the group researched.   
 
Recently tremendous amount of research has been conducted on catalysts for oxygen 
reduction.  Platinum is theorized to be the best catalyst for such a reaction 2.  E-Tek C-13 is the 
catalyst the Paul group is looking into.  It utilizes platinum and ruthenium particles covering a 
high surface area carbon known as Vulcan XC-72.  E-Tek C-13 is used over pure platinum as Pt 
is rather expensive and can corrode over constant oxygen reduction.  The Ru makes the complex 
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more robust and less likely to corrode, while Pt particles are inexpensive when compared to pure 




 A 2 mm bare gold working electrode was polished by diamond then alumina polishing.  
A 3 electrode cell using 0.1 M KCl as the electrolyte, a saturated calomel electrode reference, a 
platinum auxiliary electrode, and all were included in the cell and connected to a CHI 830 
potentiastat.  The scan settings were set to 
Initial E 0.5 V  Sweep Segments 2 
High E 0.5 V  Sample Interval 0.001 V 
Low E -1.0 V  Quiet Time 2 s 
Scan Negative  Sensitivity 1e-5 A/V 
Scan Rate 0.1 V/s 
 A dissolved oxygen meter was calibrated for use in the 0.1 M KCl, was inserted into the cell.  
The cell was then deoxygenated, slowly with nitrogen gas while stirring.  Once the oxygen 
concentration reached roughly 2 ppm the nitrogen gas and stir bar were turned off, and a 
voltammagram (the current versus potential sweep plots)  was collected.  The stir bar was turned 
back on.  Several other voltammagrams were taken at roughly 0.75 ppm oxygen intervals until 
5.50 ppm oxygen was reached.  The collected voltammagrams (CV) were then converted into 
text. A constant oxygen reduction peak occurred at -0.2 V and therefore the current was read at 
this potential and plotted against the ppm oxygen (Oxygen calibration curve experiment).  The 
scan settings were changed to  
Initial E 1.0 V  Sweep Segments 2 
High E 1.0 V  Sample Interval 0.001 V 
Low E -0.6 V  Quiet Time 2 s 
Scan Negative  Sesnitivity 1e-5 A/V 
Scan rate 0.1 V/s 
Then another oxygen calibration curve was conducted on a 2 mm platinum electrode. 
 
Pentel’s Hi-Polymer 0.5 mm by 60 mm pencil lead sticks of hardness’s 2B, HB, H, 2H, 
3H, and 4H and were created by applying a nonconductive coating to 1/3 of the electrode 
completely covering the section.  This was allowed to dry for an hour.  The tip of the coated end 
was then sanded down using 600 grit sand paper, then an oxygen calibration curve experiment 
was performed on each of the graphite electrodes with the current being taken at -0.9 V.   
  
Two new 4H 0.5 mm pencil lead electrodes were created.  They were inserted into the 
same cell used in the oxygen calibration curves with the same scan settings and CV’s were 
collected.  10 mg of Vulcan XC-72 was sonicated for 5 minutes with 1 ml of Nafion.  The 
sanded tips of the electrodes were dipped into this mixture and dried for one hour and then 
additional CV’s were taken and saved.  The tips of the electrodes were diamond and then 
alumina polished.  10 mg of E-Tek C-13 was sonicated with 1 ml of Nafion for 5 minutes 3.  The 
4H 0.5 mm by 60 mm pencil lead electrode was then dipped into the mixture and allowed to dry 




Three more 4H 0.5 mm graphite electrodes were created and dipped into a Nafion/Vulcan 
XC-72 mixture and allowed to dry.  Oxygen calibration curve experiments were then conducted 
on these 3 electrodes.  The tips were then polished via diamond and alumina polishing.  The 
electrodes were then dipped in a Nafion/E-Tek-13 mixture and had oxygen calibration curves 































Figure 3-Oxygen Calibration Curve for a 2 mm Bare Au electrode (19 μA/(cm2 ppm oxygen)
 
Oxygen Calibration Curve for Bare Pt Electrode in 0.1 M KCl






















Figure 4-Oxygen Calibration Curve for a 2 mm Bare Pt Electrode (78 μA/(cm2 ppm oxygen) 
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Oxygen Calibration Curve for HB 0.5 mm 
Graphite in 0.1 M KCl




















Figure 5-Oxygen Calibration Curve for 0.5 mm HB Graphite Electrode ( 178 μA/(cm2 ppm 
oxygen) 
 
Oxygen Calibration Curve for 2B 0.5 mm 
Graphite in 0.1 M KCl
































Figure 7-Oxygen Calibration Curve for a 0.5 mm 2H Graphite Electrode ( 144  




































4H 0.5 mm Graphite
Electrode in 0.1 M KCl
4H 0.5 mm Graphite
electrode Coated with
Nafion/Vulcan XC-72 in 0.1 M
KCl
4H 0.5 mm Graphite
Electrode Coated with
Nafion/Etek-13 in 0.1 M KCl
 
Figure 10-A voltammagram was collected of an unaltered 4H graphite electrode, then 
Nafion/Vulcan XC-72 was coated on the surface and another was collected.  The surface of the 
electrode was polished (to remove the first coat) and then an E-Tek-13/Nafion coating was 
applied and another voltammagram was collected. 
  
Oxygen Calibration Curve 4H A 0.5 mm Graphite Nafion/Etek-13 
in 0.1 M KCl
























Figure 11-Oxygen Calibration Curve for a 0.5 mm 4H (Trial A) Graphite Electrode with Applied 





Oxygen Calibration Curve for 4H A 0.5 mm graphite 
Nafion/Vulcan XC-72 in 0.1 M KCl

























Figure 12- Oxygen Calibration Curve for a 0.5 mm 4H (Trial A) Graphite Electrode with 
Applied Background (1900 μA/(cm2 ppm oxygen) 
 
Oxygen Calibration Curve 4H B 0.5 mm graphite 
Nafion/Etek-13 in 0.1 M KCl
























Figure 13- Oxygen Calibration Curve for a 0.5 mm 4H (Trial B) Graphite Electrode with 






Figure 14- Oxygen Calibration Curve for a 0.5 mm 4H (Trial B) Graphite Electrode with 
Applied Background (818 μA/(cm2 ppm oxygen) 
 
 
Oxygen Calibration Curbe for 4H C 0.5 mm graphite 
Nafion/Etek-13 in 0.1 M KCl























Figure 15- Oxygen Calibration Curve for a 0.5 mm 4H (Trial C) Graphite Electrode with 






Figure 16- Oxygen Calibration Curve for a 0.5 mm 4H (Trial C) Graphite Electrode with 





Table 1-Comparison of Sensitivities of Different Electrodes 






Bare Pt 63 
Bare Au 19 
Electrode 
Number 
Sensitivity to Oxygen Reduction with 
Nafion/Vulcan XC-72  Sensitivity to Oxygen Reduction with Nafion/E-Tek 13 
A 1900 μA/(cm² ppm Oxygen) 1900 μA/(cm² ppm Oxygen) 
B 818 μA/(cm² ppm Oxygen) 109 μA/(cm² ppm Oxygen)  
C 11 μA/(cm² ppm Oxygen) 258 μA/(cm² ppm Oxygen) 







 Pencil lead is highly sensitive to oxygen reduction, even more so than platinum.  It does 
not reduce at as high of a potential (4H reduces at -0.8 to -0.9 V Figure 2) as platinum (-0.17 V) 
or gold (-0.2 V).  The pencil lead ran into reproducibility issues at times and is presumed to vary 
in composition significantly even in the same hardness level.  Also, different types of polymer 
may have been used in each stick.  Pentel refused to give out any information pertaining to their 
product so this could not be confirmed.   
  
 4H was found to reduce oxygen at the lowest potential (-0.8 to -0.9 V) and still be 
reproducible.  It was also hard enough to withstand the rigors required of electrode polishing.  
Because of this, it was the chosen hardness level to test the Nafion/E-Tek C-13 catalyst.  The 
application of the catalyst suffered some difficulties in that it would crack upon slight contact 
and occasionally by drying.  This lead to erratic results in the oxygen calibration curve 
experiments performed on them.  In one experiment  the sensitivity decreased, another had its 
sensitivity increase, and the third stayed the same.  A new solution for E-Tek C-13 and Nafion 
needs to be found by either changing the method of application or by changing the concentration 
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Peptide Quantification by Liquid Chromatography/Mass Spectrometry 





Using MS techniques to quantify LC separated peptides is a direct method of measurement 
complementary to classical UV detection. With LC/MS no chemical derivatization step is 
needed that might be required to render the peptide detectable by optical methods.  The 
Liquid Chromatography provides the separation component while the Mass Spectrometry 
serves as the detection device.  In preparation for work with biological systems we began by 
working with model two peptides.  This work is in preparation for a microdialysis study of 
similar peptides.  Using [Met5]-Enkephalin and [Leu5]-Enkephalin, this project aims to 
reconfigure a nano-flow HPLC to provide reliable retention times, sample delivery, and 
optimization of HPLC parameters as well as demonstrate linear response for quantitation 
of peptides by Electrospray Ionization Mass Spectrometry from approximately 500 pgs to 
50 ngs on the column using rugged analytical columns rather than nano- or micro-flow 
columns.  To this end, the reproducibility of the retention time and intensity were improved 
by modifications to the HPLC system.  Eventually a linear relationship between peptide 
quantity and signal level was achieved confirming quantitation of this sort could be 




Analysis of peptides by HPLC/MS often employs on line (in series) UV detection for 
quantification and uses the MS for identification.  Development of MS-based approaches for 
quantification provides a secondary method for quantitative analysis, and allows quantification 
of peptides not having suitable UV chromophores and provides a possible approach to the 
quantification of co-eluting peptides by mass/intensity monitoring.  
 
Using the LC/MS technique a sample first becomes introduced to the HPLC and then the MS. 
The type of liquid chromatography implemented here is reverse phase due to the retention 
reproducibility of which is of primary concern.1 Within the HPLC the analyte is subject to 
pressurized flow. As the analyte travels through the sample loop within the HPLC, it approaches 
the ion source of the mass spectrometer after first becoming separated due to being eluted from 
the column.  Because the solvent (solution of water and acetonitrile) in the mobile phase is 
mixed with formic acid, the analyte is given a charge at this point and undergoes the electrospray 
ionization phenomenon. Electrospray Ionization disperses a liquid into small droplets via an 
electric field. Here, the analyte ions are pumped into a heated chamber through a capillary. These 
are dragged through the chamber by the electric field while continuously loosing solvent due to 
evaporation and eventually the droplets shrink, leading to an increase in charge density on the 
surface of the ions.2 This process is done repeatedly until the analyte is completely dissolved and 
transferred into the mass analyzer, both the quadrupole and time of flight one. While undergoing 
the electrospray the mass analyzer, the analyte is accompanied by a nebulizing gas to allow the 




Elegant nano-flow MS/MS methods have been developed for peptide quantification.3   However, 
simple methods using standard columns and single stage MS can provide greater ruggedness and 





Two peptides: [Met5]-Enkephalin, [Leu5]-Enkephalin, and were purchased from Anaspec, Inc. 
These peptides were run with both a gradient and an isocratic solvent consisting of water and 
acetonitrile with both solvent bottles having .1% formic acid present.   
 
Instruments 
For all experimentation and procedures an Agilent 1200 Series nano/microflow HPLC and 
Bruker ultroTOFq Mass Spectrometer were used. The column that was implemented was the 
Agilent Eclipse XD8-CI8 (5μm) reverse phase with dimensions 4.6mm x 150mm.  
 
HPLC-MS Settings and Methods 
Within the HPLC, many different settings and methods were tested. These settings consisted of 
using a 100μL and 20μL controller for flow, attaching a cell to detect a UV trace and ultimately 
bypassing both the flow cell and controller for certain runs. Flow rates tested were 100μL/min, 
200μL/min, both of which were ran via a controller, and 500μL/min which was not.  
 
Also, the use of a particular gradient was important when running the samples of peptides. A 
gradient was initially used containing a changing composition of acetonitrile and water. For 
acetonitrile, the percentage was as follows: from 0-5 minutes the percentage was 10% 
acetonitrile; from 5-21 minutes the percentage was a linear increase up to 90% acetonitrile; from 
21-29 minutes the percentage was held at 90% acetonitrile; from 29-31 minutes the percentage 
was a linear decrease to 10% acetonitrile; and from 31-36 minutes the percentage was held at 
10% acetonitrile. In addition to the gradient, an isocratic solvent was used during the sample 
runs. This solvent had a fixed composition, containing 70% water and 30% acetonitrile. Both 
were spiked with .1% formic acid to give the analyte a charge upon entering the mass 
spectrometer. 
 
Two different autosampler methods were used for the testing of reproducibility of retention time 
and intensity for the peptides. The first autosampler program was the default program for the 
HPLC. It did not employ any external needle wash and flowed mobile phase through the sample 
loop which is 8μL long for 5 minutes. The back pressure raised steadily on the HPLC column 
while the mobile phase flowed through the sample loop. In the second autosampler program an 
external needle wash was implemented to remove residual analyte from the column and mobile 
phase was flowed through the sample loop for 30 seconds. The back pressure was reduced due to 
less time spent in the sample loop. 5μL of sample were injected during each run. Once sample 
runs were finished, an Extracted Ion Chromatogram (the mass of the peptide plus a proton, 
MH+,) was used to find the appropriate retention time and intensity of the peptide. Following this 









Figure 1: The two figures above show the mass spectrums of both of the peptides that were 
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Stacked Extracted Ion Chromatogram [Leu5]-Enkephalin
Isocratic/autosampler program 2 
Flow rate=500μL/min 
Conc.=0.00125mg/mL4 Replicates
Intensity %Rel. Std. Dev.=5.21%
Retention Time=3.6 min 
 Stacked Extracted Ion Chromatogram of [Leu5]-Enkephalin 




Isocratic/autosampler program 1 7 Replicates
Extracted Ion Chromatogram-[Met5]-Enkephalin




Intensity %Rel Std. Dev.=110.2%
Retention Time=15.83±.05 min 
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Figure 2: The four chromatograms above display how the reproducibility of the results vary with 
respect to flow rate (A & B) and autosampler method (C & D). A and B were obtained using the 
gradient described in the Methods section while C and D were obtained using the isocratic 
method. 
In A, neither the retention time nor intensity of the peaks is duplicated. In B, the retention time is 
replicated but the intensity is not.  
In C, the retention time is constant but the intensity still varies somewhat. In D, the outside of the 
sample injection needle is washed twice and the flow time through the sample injection loop is 
decreased an order of magnitude.  Both the retention time and intensity are constant showing the 




Figure 3: The chromatogram above shows the reproducibility of [Met5]-Enkephalin at the 
500μL/min flow rate and the autosampler program 2 with an isocratic solvent. Both the retention 
time and intensity are constant. 



















Stacked Extracted Ion Chromatogram [Met5]-Enkephalin
Isocratic/autosampler program 2 
Flow rate=500μL/min
Conc.=1.25mg/mL 6 replicates




Figure 4: This graph shows all five concentrations of [Leu5]-Enkephalin that were tested (1.25, 
.125, .0125, 0.00125, and 0.000125mg/mL). The most concentrated sample, 1.25mg/mL, does 
not have a linear response in relation to the other samples. This concentration is so high that it 
saturates the detector within the LC/MS.  
Leu5-Logarithmic Calibration Plot
















Figure 5. Log/Log plot of intensity vs. concentration of [Leu5]-Enkephalin (.125, .0125, 




Figure 6. Diagram showing mixture of 0.0125 mg/mL [Leu5]-Enkephalin and 0.00125 
mg/mL[Met5]-Enkephalin and the ratio of intensities between the two peptides 
 







Met5Leu5 Mixture Log-Log Plot Intensity Ratio vs. Mass Ratio 




















Figure 7: Log/Log plot of intensity vs. quantity for a mixture of [Leu5]-Enkephalin and [Met5]-  
                Enkephalin showing the linear relationship (Met5 acting as a surrogate standard.) 
 
The best setting seemed to include bypassing both the flow controller and flow cell and running 
the samples at a flow rate of 500μL/min. This flow rate gave the best runs which could be 
replicated time and again with the peaks being very narrow eluting the same retention times over 
and over again. The retention time for [Met5]-Enkephalin as seen above in Figure 3 has retention 
time of 3.2 minutes at this flow rate and [Leu5]-Enkephalin has retention time 3.6 minutes as 
seen in Figure 2 with the 500μL/min flow rate. 
 
It was found that the retention time of each respective peptide was dependent on the percentage 
of organic solution that was contained within the solvent mobile phase. Increasing the amount of 
acetonitrile with respect to water decreased the time the peptide would elute from the column. As 
long as the peak didn’t appear in the dead volume the percentage of organic phase would work 
for the experiment. A gradient was initially used containing a changing composition of 
acetonitrile and water and this didn’t yield the best results. Therefore it was decided that an 
isocratic gradient should be utilized and performed when running the samples of peptides. The 
isocratic gradient was crucial in replicating the retention time of such peptides much better than 
before. The dead time for the isocratic runs was 3 minutes.  
 
The method which seemed to solve the problem that had to do with intensity included applying 
an autosampler method involving the washing of the needle prior to injection of the sample vial 
to be tested. This prevented any air bubbles from existing within the syringe prior to injection 
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which allowed for a lower percent relative standard deviation. Upon first starting this 
experiment, plastic inserts were placed inside the 2mL-autosampler vials to house the samples of 
peptides. After numerous runs it was found that these led to an unsteady measurement of 
intensity as the syringe could possibly come in contact with the bottom of the insert where no 
solution remained and thereby cause an inaccuracy when monitoring intensity. Because of this 
possibility which surfaced often during the first run of each sample as in Figure 2C, samples 
were made at a higher scale without employing the plastic inserts which is viewable in Figure 
2D. Testing the vials without inserts in them, each run’s intensity was measured at a much 
steadier and accurately reproducible manner.  
 
In running samples at the high flow rate, it was possible to find the retention time of 
concentrations of 0.000125mg/mL. By injecting volumes of 5μL it is possible to find that there 
must contain 625 picograms to 50 nanograms on the column at a specific time due to the 5 orders 
of magnitude between varying concentrations. 
 
Mixing peptides together, as in Figures 6 and 7, helped for quantitation purposes. When a 
surrogate standard was applied in this case, [Met5]-Enkephalin, it would be possible to 
determine the concentration of an unknown peptide that is in solution with the surrogate using 




With the peptides [Met5]-Enkephalin and [Leu5]-Enkephalin reproducibility of retention time, 
peak shape, and intensity improved with increasing flow rate and modification of the injection 
method within the HPLC. Reduction of column back pressure in changing the autosampler 
method likely enhanced the system performance and allowed for better results. Also, the linear 
relationship as shown above confirms that the concentration of an unknown peptide could be 
detected and determined to 1pM based on the addition of a surrogate standard and entails that the 
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Characterization of Cdc42 and Its Mutant Cdc(T35A)
Robynetta Hargrave1 and  Paul Adams2
1Spring Hill College, Mobile, AL
2University of Arkansas, Fayetteville, AR
Materials
Methods
•LB Plates were streaked with e. coli containing DNA that encodes for Cdc42,       
CdcT35A, and PBD46
•Cdc42 and CdcT35A were expressed overnight, the cells harvested, and stored in -
80°C
•PBD46 was expressed for 4 hours maximum, the cells harvested, and stored in -
80°C





•The protein was lyophilized
•GMPPCP was added to have a final concentration of 0.5mM
•EDTA was added to have a final concentration of 5mM
•Incubated for a hour
•Remove excess of nucleotide and DNA using PD10 column 
•MgCl2 was added to have a final concentration of 10mM
•1 mM Cdc42-GMPPCP was reacted with sNBD at room temperature for 1 hour
•Centrifuge  to clear precipitate and unreactive sNBD at 10,000 rpm for 20 min
•The supernatant was poured on PD10 column using the Gravity Flow Method
Discovering the role of oncogenic ras proteins can give understanding to the 
pathogenesis of human cancer. Ras proteins control cycling between Guanosine 
triphosphate (GTP) where the protein is in its active state and Guanosine 
diphosphate (GDP) where the protein is in its inactive state. When the Ras protein 
exists in an over-active state, caused by abnormal cycling between GTP- and GDP-
bound states, cell proliferation and transformation can occur. The protein cell division 
cycle protein Cdc42, a member of the Rho subfamily of Ras proteins, is involved in 
cell morphogenesis through a Ras GTPase cycle to activate basic cellular functions. 
The protein has been shown to stimulate DNA synthesis and initiate a protein 
cascade that begins with the activation of the p21-activated serine/theorine kinases 
(PAK)(Guo et al. 1998). Cdc42Hs has been shown to interact with a minimal GTPase-
binding domain peptide of p21-activated kinase, PBD46, with a KD of approximately 
20nM. An important amino acid in the Switch I binding region of Cdc42, T35, is 
believed to play a role in protein stabilization that might affect its ability to interact with 
PBD46. This goal of this work was to express, purify, and label a mutant protein, 
Cdc42T35A, with a site-specific fluorophore, sNDB, in order to examine the mutant 
protein’s ability to bind PBD 46 relative to wild type.
•Better understanding of the structure and protein interaction involving Ras proteins
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Figure 1. GTP/GDP Cycle of Cdc42
Figure 2. Cdc42 bound to PBD46
Figure 3. Switch I Region of Cdc42 
(A) and Switch I Region of Cdc(T35A)
Figure 4. Cdc(T35A)
Even though there was a challenge in protein purification, Cdc42 and 
Cdc(T35A) were expressed. PBD46 was successfully expressed and purified.
Protein purification was done using the FPLC. GST (glutathione S-transferase)-
PBD46 was purified and combined with thrombin. GST was cleaved leaving PBD46 
and thrombin. Thrombin was removed by the heparin column leaving purified 
PBD46.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
used to show the continuation of protein throughout the experiment. The 
protein expression gel shows good banding for successful cultures. For 
protein purification there was a challenge to find a band for PBD46. After 
noticing no band for the protein using the dialysis bag, thrombin was used to 
remove the protein instead. This process showed faint banding at 6 kDa for 
PBD46.  
• Includes studies of other Cdc42 mutants to compare with Cdc42 wild type
•The use of fluorescence to monitor binding affinity of Cdc(T35A) and other 
mutants
Figure 1. SDS-PAGE analysis of protein expression for 
Cdc42, Cdc(T35A), and PBD46
Figure 2. SDS-PAGE analysis of the purification of PBD46 
using a dialysis to cleave GST-PBD. 
Figure 3. SDS-PAGE analysis of the purification of PBD46 
by adding thrombin.





































































































1 H2O 14‐50, 52 4.55
1 H2 15‐50 4.25
2 H2O 46‐50, 54‐55, 57 3.02
2 H2 41, 44‐45, 49, 54 3.55








1 H 4‐6, 5‐6, 6‐7, 7‐5, 7‐7, 8‐6 4.74
1 CH3COOH, CH3, H2O 5‐5 25.13
1 CHO 7‐7 4.86
2 C4H9OCH3, CH4, 3(H2) 10‐12 5.79
2 2(CH3OH), H2O, H2 12‐11 3.75
2 C2H2O2 12‐12 1.73
2 C4H9OC4H9, CO, C2H2 13‐10 2.22
2 2(C2H2O2) 13‐11, 13‐12 2.88
2 C4H9OC4H9, CH3OCH3, CH3OH, H2O 13‐12 5.28
2 C4H9OC4H9, C2H2, CO 13‐12 2.75
2 3(C2H2O2) 13‐12 2.77
2 C4H9OC4H9, CH3OH, 3(H2) 13‐12 0.80
2 C4H9OC4H9 13‐12 3.56
2 C9H18 13‐12 3.89
2 C4H9OCH3 13‐12 1.42
2 C2H2O2 13‐12 2.41
2 C3H4 13‐12 7.44










































































































































































































































1 H 12‐26 2.69
2 ‐ 26‐33, 35‐50, 52‐53 4.13
3 ‐ 38‐62, 64 2.83




In Vivo Microdialysis Modeling Incorporating Insertion Trauma 
in COMSOL Multiphysics
Chris Keathley and Julie A. Stenken
Department of Chemistry & Biochemistry, University of Arkansas, Fayetteville, AR 72701
Introduction and Overview
•In vivo microdialysis sampling is an invasive sampling procedure that takes
advantage of diffusion. Recently it has seen a large growth in the subject of
neurochemistry.
•As microdialysis has become a more popular research method questions have
been raised about trauma that occurs due to it’s invasive nature.
•One purpose of this research is to further the knowledge on microdialysis by
creating a model using computer aided design (CAD) and finite element analysis
(FEA). The second is to incorporate insertion trauma into the model in order to
determine how it affects the relative recovery of the sample.
National Science Foundation CHE-0851505







•COMSOL Multiphysics was the software chosen to do the modeling for several reasons.




•For this model it was decided to use multicomponent modeling
•Utilize multiple physics engines
•Trauma implantation was not correctly modeled
•Possibly due to issue with stiff spring method.
•A solution to this problem could be to not use a 
multicomponent model.  This would allow 
COMSOL to handle all of the math.  While this 
solution might be simpler there is a lot of 
customizability that is lost with this method.
•Microdialysis works, sans trauma layer
•Concentration is highest at edge of membrane
•The faster the flow rate is the less the 
concentration diffuses into the rest of the analyte  






•The stiff spring method was used to develop equations relating the flux 

















•M is a theoretical velocity and K is the partition coefficient
D = 1E-6 [cm^2/s] Dm=.2D [cm^2/s] Decs = 2.4E-6 [cm^2/s]
•Microdialysis model worked correctly
•Largest amount of concentration is next to the membrane
•Correctly incorporates fluid flow and diffusion physics engines
•Implementing insertion trauma was harder to accomplish
•Have not been able to get accurate results
Figure 1 – Schematic of microdialysis model showing 
diffusion coefficients and physics engines needed in each section
Figure 2 – Microdialysis Model
Figure 3 – Microdialysis model showing only probe concentration.




Catalytic Dynamic Thermodynamic Resolution of N-Boc-2-Lithiopiperidine
Trent Parker1, Timothy K. Beng2, and Robert E. Gawley2*
1Department of Chemistry, Saint Louis University, Saint Louis, Missouri, USA
2Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas, USA
Conclusions
Abstract Effect of Varying [6] on DTR 
of 4
Background
Time Evolution of (S)-4
Effect of Varying [TMEDA] on Enantiomerization of 4
The activation parameters for enantiomerization and dynamic 
thermodynamic resolution (DTR) of N-Boc-2-lithiopiperidine 4 have been 
measured, revealing significant differences in the variation of ΔG‡ with 
temperature for the processes and the role of TMEDA.  The 
enantiomerization and DTR are catalytic and first order in [TMEDA] within a 
given concentration range. A rare case of a catalytic dynamic 
thermodynamic resolution using a chiral diaminoalkoxide, 6, has been 






































































Racemization with 1.0 eq TMEDA
DTR with 2 eqTMEDA + 1.0 eq 6
DTR with 1.0 eq 6
Free Energy of Activation versus Temperature
Observed er (squares) and predicted er (circles) vs Amount of 
chiral ligand 6 for DTR of 4.6 in the presence of TMEDA (1.2 equiv.) 












Catalytic DTR of N-Boc-2-lithiopiperidine with 0.15 equiv. 6 and 1.2 






















•Asymmetric induction in chiral organolithiums can be promoted in two ways; 
Asymmetric deprotonation1 or Asymmetric substitution2.
•It is necessary that the organolithium be configurationally stable in the former but vice 
versa in the latter. Dynamic resolutions are examples of an asymmetric substitution 
reaction.
•DTR occurs when enantiomeric substrates react with a chiral reagent L* to afford a 
thermodynamic mixture of two diastereomers. The two diastereomers SL* and RL* 
interconvert but it doesn’t matter whether this happens by direct epimerization or by 
loss of L* followed by enantiomerization.
•In  DTR, equilibration and resolution can be achieved in separate controllable steps.
•The rate of electrophilic quench is faster than the rate of equilibration between the 
diastereomeric complexes but the product ratio depends on kR[RL*] and kS[S·L*] as 
well as the percent conversion to products.
•For high yields to be achieved in DTR, carbanion inversion is required in the presence 
of a chiral ligand hence the need to understand the barriers to inversion.
•The DTR can be catalytic if addition of substoichiometric L* leads to higher 
enantiomer ratios that predicted statistically. 
•The half-life to DTR depends on temperature, ∆G‡ and ∆G0 (which in turn depends on 
the equilibrium constant, Keq). 
•Knowing Keq and the activation barriers to DTR and racemization, the resolution can 
be rendered catalytic by careful control of temperature and time. Shorter times would 
minimize organolithium decomposition but the resolution may be too slow. 








1.2 eq TMEDA, Et2O
1.2 eq nBuLi / -78 oC / 1h






1.2 eq TMEDA, Et2O
1.2 eq nBuLi / -78 oC / 1h
x eq 6 / -55 oC / 5hSnBu3 SiMe3
•Added rac-N-Boc-2-(tributylstannyl)-piperidine 
and TMEDA to dried, septum capped tubes.
•Added n-BuLi (1.2 equiv) at -78 °C for 1 hour to 
effect tin-lithium exchange, affording rac-
4·TMEDA
•Transferred to -55 C bath and added 6
•If ligand exchange occurs, diastereomeric 
complexes R-4·6 and S-4·6 enter the equilibrium. 
•At various times, cooled tubes to -78 C and 
quenched rapidly with excess Me3SiCl
•After 4 h, added MeOH, extracted into Et2O
• Purified by flash chromatography on silica gel 
(Hexane/EtOAc; 98:2)
•Evaluated er by CSP-GC, (S)-5 elutes before 
(R)-5.






































































Linearity implies 1st-order in 
TMEDA 
Intercept = TMEDA 
uncatalyzed DTR (slow)
Acknowledgements and Funding
•Enantiomerization of 4 is 1st-order, catalytic in TMEDA up to 1.0 equiv, 
but slower with > 1.0 equiv.
•DTR is 1st-order, catalytic in TMEDA.
•DTR with substoichiometric 6 gives higher er than predicted statistically.
•(S)-4 builds up and maintains configurationally stability under catalytic 
DTR conditions.











































L = TMEDA, L* = 6
4
Figure 5





Determination of Kinetic order in TMEDA for the catalytic DTR of N-Boc-2-






































emblematic of higher 
order in TMEDA 
Inset: kobs vs  
[TMEDA]2 shows 
linearity  implying 
2nd-order 
dependence
1P. Beak, D. J. Gallagher, S. Wu and N. A. Nikolic, J. Org. Chem., 1995, 60, 8148-8154






Toward the Total Synthesis of Antascomicin B
Erika D. Pollard, John M. Hutchison, and Matthias C. McIntosh*
Department of Chemistry and Biochemistry
University of Arkansas, Fayetteville, AR 72701
Proposed Approach to C25—C34 Fragment
Antascomicin B
- A member of a family of macrolides
isolated from a strain of the gram-
positive bacterium, Micromonospora.
- Exhibits FKBP 12 binding activity as 
potent as rapamycin and FK-506, but 
antagonizes the immunosuppresant 
effect.
- Antascomicins and simpler analogs 
may offer a useful chemotherapeutic 
approach for neurodegenerative 






















• Antascomicin B, part of a 
small family of macrolides, 
possesses potent FKBP12 
binding activity but lacks the 
effector domains of rapamycin 
and FK506 that lea  to 
immunosuppressive effects.1
• Antascomicins may exhibit 
neur r gen rative properties 
which potentially may be 
useful for the treatment of 
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Retrosynthesis
Methods
Figure 1: 1H NMR  of B in CDCl3
Figure 2: 1H NMR of D in CDCl3
National Institute of Health (RR – 15569)
The goal of the project was to optimize 
the conversion of D to E. Current literature 
report reaction yields at 41%, which can be 
attributed to decomposition and side reactions, 
leading to loss of product during purification.  
Due to these problems, conditions 1 and 2 were 
designed to improve the overall reaction 
production and potentially eliminate 
unnecessary purification to help improve the 
overall yield.  Thus far the results are 
inconclusive.
Optimization of D to E will be continued in the 
future through continued modifications of 
reaction conditions.  Options 1 and 2 will be 
further modified by adjusting the time and 
power within the microwave reactor, along 
with varying the types of Lewis Acid catalysts.  
The use of various Lewis Acid’s as a catalyst 
will also be expanded to the bench top with 
intentions to improve the purity and yield of E 































































Successfully completed for 200 µM 5-HT
Evidence suggests adsorption of 5-HT resulting in further 
amplification of signal by concentrating 5-HT at electrode
Higher currents at higher scan rates suggest detection of lower 
concentrations of 5-HT
Redox Cycling
FIRST time use of redox cycling on 5-HT; opens new 
opportunities for in vivo detection
Possibilities of excluding interferences, amplifying signals and 
detecting on very short time scales
Af and Ce obtained for model compound and serotonin on two 
devices
Decreasing the gap between the generator and collector 
increases the current on the collector.  This will help in lowering 
the detection limit of redox species.
Best results with device 2:  5 µm gaps
Difference in amplification and collection efficiency is result of 
the difference in the gap of generator and collector electrodes  
Fast-Scan Cyclic Voltammetry and Redox Cycling for Detection of Serotonin
Melanie N. Pund, Anupama Aggarwal, Ingrid Fritsch
Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701
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Serotonin (5-hydroxytryptamine, 5-HT)
Indolamine neurotransmitter 
Influential in neurological diseases
Found in concentrations 0.01-1 µM 
Fast-Scan Cyclic Voltammetry (FSCV)
Used currently for in vivo and brain slice studies 
Utilizes rapid scan rates to detect and distinguish between 
various neurotransmitters (200 V/s ~ 20 ms time resolution)
Measures transients (release and uptake) in concentrations well
Requires extensive background subtraction  
Interference of ascorbic acid (concentrations from 100-1000 µM) 
increases difficulty in detection1,2
Redox Cycling3
New approach 
Does not require background subtraction
Uses two electrode setup (see above)
A common interferent, ascorbic acid, will not interfere due to its 
irreversibility (will not cause a result at the collector) 
Might be possible to capture release events faster than FSCV 
(5 µm gap ~ 25 ms time resolution; 2 µm gap ~ 4 ms)








Left:  Picture of 
Device 1




To understand the electrochemical behavior of serotonin with a 
new method of redox cycling to distinguish it from other species
To use the amplification and steady state nature of redox cycling 
to avoid background subtraction and yet obtain fast experiments 
(due to small gaps between electrodes)
Compare sensitivity and detection limits of FSCV and redox 
cycling for 5-HT
Investigate effectiveness of redox cycling to exclude increasing 
concentrations of interferents, like AA
Fabricate interdigitated electrodes with smaller gaps between 
generators and collectors to lower detection limits
Carbon IDA electrode setup
Generator electrode:  65 bands (red)
Collector electrode:  65 bands (black)
Gold Microband array electrode setup  
Generator:  bands 3-10








Below:  Redox cycling on device 2 of 1 mM 5-HT in TRIS (left) and an overlay 
of 5-HT in TRIS and 1:1 5-HT:AA (right) using chronoamperometry mode.  
Ascorbic acid does not interfere with the collector signal.  Higher collection 
efficiency results in higher signals.  
Methods
A CH Instruments bipotentiostat equipped with a Faraday cage 
was used to perform FSCV and redox cycling.
A three electrode setup was utilized.
Reference:  Ag/AgCl in saturated KCl
Counter:  Platinum flag
Working:  
10 μm glassy carbon (GC) disk 
Device 1, 29.5 µm separation between 20.5 µm x 2mm 
(width x length) gold bands 
Device 2, 5 µm separation between 10 μm x 2 mm bands on   
carbon interdigitated array (IDA)
TRIS buffer was the electrolyte for all experiments.  
Hexaamine ruthenium (III) chloride (Ru(NH3)6Cl3) in 0.5 M KCl 
was used as the model compound redox species. 
Experiments with 5-HT were done inside glove bag under argon 
atmosphere.  
To our knowledge, this is the first attempt of redox cycling for detection of 
serotonin.  
Above:  FSCV of 200 μM 5-HT on microband in 
device 1.  Faradaic current is a small signal riding 




FSCV Band Electrode 200 V/s 
Above:  Background subtracted FSCV of 200 μM 
5-HT on microband in device 1.  Oxidative (O) and 
reductive (R) peaks are clearly visible.
Background Subtracted FSCV 
















Left:  The graphs 
show correlation of 
background 
subtracted current of 
5-HT with square 
root (scan rate) from 
0.1-200 V/s for 
microband on 
device 1 and 0.1-
100 V/s for disk 
electrode.  This 
suggests that 5-HT 
is diffusion limited.

















SQRT(Scan Rate) / SQRT(V/s)
Faraday Current (Anodic) of 200 µM 5-HT vs. 
Sqrt (Scan Rate) on Band Electrode





















SQRT(Scan rate)  / SQRT (V/s)
Faraday Current (Anodic) of 200 µM 5-HT vs 







Below:  Slow cyclic voltammetry of model compound at 0.005 V/s ensures 
overlap of generator and collector diffusion layers.  For all model compound 
studies, the generator was held at -0.5 V and the collector was held at 0.2 V.  (Af, 
amplification factor; Ce, collection efficiency)
Below:  Redox cycling of model compound 0.1 mM Ru(NH3)6Cl3 in 0.5 M KCl 
using chronoamperometry mode.
5-HT PQIPQI 5-HT PQI     5-HT 
GeneratorDiffusion Diffusion
+ 2 e- + 2 e-- 2 e-
Collector Collector
Below:  Redox cycling of 1:1 mixture of 5-HT to AA using chronoamperometry 
mode.  
Af = 1.27
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Ce = 71.33 %
Collector current
Generator current Collector on
Generator current Collector off
Af = 1.38
Ce = 46.64 %
Collector current
Generator current Collector on
Generator current Collector off
Generator held at 0.7 V
Collector held at -0.2 V
Collector current
Generator current Collector on
Generator current Collector off
Af = 0.94
Ce = 4.74 %
Generator held at 0.8 V
Collector held at -0.2 V
Collector current
Generator current Collector on
Generator current Collector off
Af = 1.12
Ce = 79.73 %
Af = 0.60
Ce = 57.70 %
Collector current
Generator current Collector on








Above:  FSCV of TRIS alone at 50 V/s after many 
scans of 5-HT.  The peaks present in background 






Single-site Mutagenesis Could Expose An ‘Achilles Heel’ of Human FGF-1 
Andrew Robertson, Rebecca Kerr, D. Rajalingam and T.K.S. Kumar*, Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas 72701
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Background
Methods
Single-site mutagenesis for K24E was performed by QuikChange XL Site-
Directed Mutagenesis Kit from Stratagene. K24Q and K24R were designed by
overlap extension PCR.
Wild type and all mutant variants of hFGF-1 were purified via heparin-affinity
chromatography.
Differential scanning calorimetry was used to assay thermostability of WT and
mutants. Experiments were performed using a Nano III DSC (Calorimetry
Sciences Corp.)
Heparin/SOS binding affinity experiments were carried out using a VP-
Isothermal titration calorimeter.
Limited trypsin digestion of wild type and all mutant variants of hFGF-1 was
performed to assay resistance to proteolytic degradation.




BFibroblast growth factors (FGFs) are ubiquitous with many of the most
important biological actions of life. FGFs consist of a family of polypeptide
growth factors that are essential in both vertebrate and invertebrate
development and are used to regulate a diverse range of important biological
processes. FGF signaling is mediated by the binding, dimerization, and
subsequent activation of a cell surface tyrosine kinase receptor known as the
fibroblast growth factor receptor (FGFR). FGFs can bind to 4 isoforms of
FGFR, which are differentiated as FGFR1 to FGFR4, respectively. The binding
to its receptor is significantly enhanced by the binding of heparin sulfate
proteoglycans (HSPGs), which are present on the cell surface and within the
extracellular matrix. The binding of heparin is thought to enhance the stability
of the protein by protecting against degradation via proteases, and denaturation
via heat and non-optimal pH. Once bound to its receptor, a signaling cascade
induces a range of pleiotropic effects, including cellular proliferation,
differentiation, apoptosis, and migration. FGFs strong affects on neighboring
cells gives it powerful mitogenic properties. FGF signaling provides essential
roles in embryonic development, angiogenesis, and adult homeostasis.
ITC curves showing the




and K24Q mutant (panel-
D) at 25 °C. The upper
panels show the raw data
representing hFGF-1 –
SOS titration. The bottom
panels show the integrated
data obtained from the raw
data after background
subtraction. The solid line
in the bottom panels
represent the best-fit curve
of the experimental data,




Differential scanning calorimetry representing the unfolding of wild type and all mutant variants of hFGF-1
with SOS (panel-A) and without SOS (panel-B). The protein (1.5 mg/mL) was dissolved in 10 mM
phosphate buffer (pH 7.2) containing 100 mM NaCl and 50 mM ammonium sulfate. The experiments were
performed at a scan rate of 1 C/min with 3 scans per sample.
Stability Monitored by DSC
A
Panel-A- 1H-15N HSQC spectra of
K24E type hFGF-1 (red) overlapped
with wild type (green). Significant
chemical shift perturbation observed
indicates changes in local stability in
proximity to K24
Panel-B-1H-15N chemical shift perturbation
of residues in K24E FGF-1 in comparison to
WT FGF-1. Significantly perturbed residues
include, K24E, S52, Q54, H55, S61, I70,
H107, H138, and L49
A
Panel-A- 1H-15N HSQC spectra of wild
type K24R obtained in the absence (red)
and presence (green) of SOS. No
significant chemical shift perturbation is
observed other than at the mutation site..
Panel-B-1H-15N chemical shift perturbation
of residues in K24R FGF-1 in comparison
to WT FGF-1. No residues were
significantly perturbed other than the
mutation site.
Panel-A- Overlap of the 1H-15N HSQC
spectra of K24Q (red) and wild type
hFGF-1 (green). Significant chemical
shift perturbation observed indicates
that local stability in proximity to
K24E is not as greatly affected as
stability at the C-terminus of the
protein.
Panel-B -1H-15N chemical shift perturbation
of residues in K24Q FGF-1 in comparison c
to WT FGF-1. Significantly perturbed
residues include Q54, H107, H116, G124,
K127, H138, and A143 .
Identification of Perturbed Residues on hFGF-1
Panel-C- MolMol representation of the
structure of hFGF-1 (grey). Colored residues
indicate significant perturbation. Red: K24E,
Green: K26, Yellow: S52, Cyan: Q54,
Magenta: S61, Orange: I70, Dark Green:





Human FGF-1 exhibits the broadest spectrum of mitogenic and angiogenic properties
within the FGF family, endowing it with a critical wound healing function during tissue
repair. The substantial wound healing function of hFGF-1 is of significant medical
interest due to its potential therapeutical application. Applications extend to the healing
of chronic wounds, prevention of scarring after surgery, and treatment of cardiovascular
disease. However, a significant problem with utilizing biomolecules for medical
application is that their physiochemical properties often cause them to be unstable for
industrial development, storage, and administration. FGF-1 is thermodynamically
unstable at a physiological temperature and pH, and has a short half-life in vivo. It is
therefore desirable to engineer an FGF-1 mutant with optimized physiochemical
properties which increases its conformational stability. It is well understood that clusters
of positive residues can disrupt protein stability. A high density of positive charges causes
positive residues to act in repulsion to one another. FGF-1 has a notably dense cluster of
positive charges near the N-terminus of the protein, 23- KKPK -26. This cluster is
particularly dense due to the presence of a proline residue which pulls local residues into
closer proximity to one another. Three point mutations will be designed to assay the
effects of this region on hFGF-1 instability. Single-site mutation K24E will introduce a
negative charge in the region in hopes of reversing the charge. K24R will introduce a
positive residue that should increase repulsion. K24Q will introduce a non-polar residue
which could neutralize the repulsion. If stability is significantly affected by any of the
variants, then a weak point in FGF-1 structure will be exposed. The stability of the
variants will be assayed by evaluating their thermostability, the affinity for heparin, and
their ability to resist proteolytic degradation. Furthermore, proteins with low stability are
typically expressed in lower yields. It has been hypothesized that a single mutation in
FGF-1 could significantly affect the yield of pure protein per liter of bacterial culture.
Variants that contribute to protein stability can be expected to express protein in higher
yields than the wild type.
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WT K24E K24Q K24R
M                 1   2     3    4    5    6 M   1        2     3      4       5    6 M                1    2    3   4   5   6 M   1    2    3    4    5   6
SDS–PAGE depicting the overexpression and purification of WT and
all mutant variants of FGF-1 in E. coli. Lane M represents the
molecular weight marker; lane 1-uninduced fraction of FGF-1
expression; lane 2-induced fraction of FGF-1 expression; lane 3-flow
through; lane 4-10 mM phosphate buffer elution; lane 5- 0. 8 M NaCl
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Site-specific mutants of hFGF-1 have been generated in the cationic segment (K23 to 
K26).
Reversal and nullification of charge on K24 dramatically increases the yield of pure 
protein per liter of bacterial culture.
Introduction of negative charges in the cationic segment does not appear to have a 
significant effect on the thermodynamic stability of the protein.
Charge reversal and nullification of K24 does not significantly perturb the three-
dimensional structure of the protein.
Results of this study suggest that protein expression yields can be modulated by stabilizing 
regions in the protein that are prone to charge-charge repulsions.
Panel-C- MolMol representation of the
structure of hFGF-1 (grey). Colored residue
indicates significant perturbation. Red:
K24R.
Panel-C- MolMol representation of the
structure of hFGF-1 (grey). Colored residues
indicate significant perturbation. Dark Green:
H107,Dark Violet: K127, Aquamarine:
H138, Kahki: A143.
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Results and Discussion – Shell GrowthBackground and Introduction
Nanocrystals, or Quantum Dots (QDs) have been in the
foreground research of many nanotech institutes since their
inception. Many applications have been found for the QDs, but in
particular, their use as biomarkers for FRET analysis have made
them of particular interest to our group, Because QDs generally
have narrow emission spectra, are brighter and more stable than
traditional dyes, and are more resistant to a commonly observed
effect in organic dyes known as photo-bleaching, they are replacing
or supplementing many traditional bio-marking methods. The
introduction of semiconductor shells of materials with higher band-
gaps allows for not only greater bio-compatibility but also the
amplification of quantum confinement effects. (Figure 1) The





Figure 1: Schematic representation of
the difference in band-gaps of the
CdTe/ZnS core/shell QD. The shell
acts as protection against oxidation
and an amplifier of quantum confine-
ment effects. This shelling also makes
the QDs more biologically friendly by
providing a barrier that confines the

















CdTe core and CdTe /ZnS
core/shell samples after
successive addition of ZnS
shell material, This pattern




Results and Discussion – Ligand Exchange
Methods and Materials
Figure 3: Photograph of the
CdTe core and subsequent
CdTe/ZnS core/shell QDs with
shell thickness increasing left
to right. The pattern of
increasing red shift and
brightness is indicative of
successful shell growth, and
is plotted in Figures 3 & 4.
Synthesis of Variable Size Water Soluble CdTe/ZnS Core/Shell 
Quantum Dots.
Hayden Self, Jose Aldana, Colin Heyes, University of Arkansas
Fayetteville, Arkansas 72701
Future Research
The results of this investigation will contribute to a study of the
FRET efficiency of conjugated QD/Protein/Organic Dye systems with
variable size shell thicknesses by laying foundational groundwork for
a reproducible synthesis method of the prerequisite CdTe/ZnS
core/shell QDs. Although this study revealed problems with the
ligand exchange, future work by this group will expand upon it.
Figure 8: Schematic representation of the
various types of QD samples required for
proper and conclusive determination of
the shell/core radii on FRET efficiency as a
















CdTe core and CdTe
/ZnS core/shell sam-
ples after successive
addition of ZnS shell
material highlighting
the gradual red shift
in the increase in
total QD size.
Figure 6: Graph compar-
ing the Quantum Yield
(QY) of the samples as a
function of shell thick-
ness. The pattern
observed is observed in
the literature for ZnS
shells of various core















Core 1 2 3 4 5
Figure 7: Graph of emission
maximum as a function of shell
thickness. Although no increase
is observed upon the 1st
layering, a noticable increase






















Figure 8, 9, 10: Schematic
representation of water soluble
QDs (left), photograph of
emission from the samples
under UV light (upper left) and
emission spectra of core and













Synthesis of the CdTe cores was executed using elemental Te
and CdO precursor at high temperatures. The addition of the ZnS
shells was executed systematically with carefully measured aliquots
removed after each cycle of injections at low temperature. Ligand





Improving the Clark Type Electrode
Thad Vasicek,  Dr. David Paul, The Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR, 72701
Introduction-
The Clark electrode is a current method for detecting dissolved oxygen in liquid 
solutions.  As shown in Clark’s original drawing in figure 1 the Electrode consists of a 
gold cathode (A), a silver/silver chloride anode (B), a KCl electrolyte (C), a semi-
permeable membrane (D), a ring holding the semi-permeable membrane in position 
(E), a voltage supply (F) and a galvanometer (G).  The method that the Clark electrode 
employs to detect dissolved oxygen is the voltage supply applies a fixed potential and 
when oxygen reduction occurs at the cathode a current directly proportional to the 
dissolved oxygen concentration results. Using this current, the oxygen meter applies an 
internalized calibration curve to determine the ppm oxygen dissolved in solution.  




















4H 0.5 mm Graphite
Electrode in 0.1 M KCl
4H 0.5 mm Graphite
electrode Coated with
Nafion/Vulcan XC-72 in 0.1 M
KCl
4H 0.5 mm Graphite
Electrode Coated with
Nafion/Etek-13 in 0.1 M KCl
Purpose-
The electron transfer kinetics of oxygen reduction is very slow and so the Clark 
electrode applies a large fixed potential to increase the electron transfer rate.  This 
overpotential also reduces other species present in the solution.  If a catalyst could be 
immobilized on the surface of the electrode that would reduce the required potential by 
offering a separate mechanism of reduction
The Paul group is improving upon the Clark electrode by immobilizing a catalyst on the 
cathode to increase the electron transfer kinetics so the large fixed potential need not 
be applied and reduce other species present in solution.  This would lead to a more 
sensitive, precise, and dependable dissolved oxygen sensor.  
Method-
Conducted Cyclic Voltammetry on pencil lead electrode and gold electrodes.  Applied a 
nafion/Etek-13 catalyst to the pencil lead and conducted Cyclic Voltammetry as well.
Conclusion-
Pentel’s hi-Polymer 4H pencil lead has 6 times the sensitivity of that of  a bare 
gold electrode.  Also the application of Etek-13/Nafion dramatically increases the 
charging current over that of Nafion/Vulcan XC-72 background, however a 
method needs to be determined to convert or eliminate the charging current into 
Faradaic current.  
Acknowledgements-
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Table 1-Comparison of Pencil Lead Electrode Hardness’s to Au and Pt
Oxygen Calibration Curves
y = 1.90E-05x - 1.10E-06






















4H 0.5 mm Graphite, 0.1
M KCl
2 mm Bare Au , 0.1 M
KCl
The group discovered that pencil lead is highly sensitive to oxygen reduction.  
The softer lead was to brittle to work with, and never showed signs of oxygen 
reduction.  4H yielded reproducible CV’s, reduced oxygen out at -0.9 V and 
was hard enough to withstand the rigors of electrode polishing.  It also has 6 
times the sensitivity of a bare gold electrode (19 μA/ (cm² ppm oxygen) 
compared to 127 μA/ (cm² ppm oxygen)).
Results and Discussion-
The group previously was experimenting with 0.5 mm carbon paste 
electrodes using acetylene/nujol paste.  The nujol appeared to give high 
backgrounds. This resulted in researching carbon electrodes.   
2H
Multiple CV’s of graphite and gold were 
performed at various dissolved oxygen 
concentrations. The currents of the oxygen 
reduction peaks were plotted against the 
concentrations of oxygen to compare the 
oxygen reduction sensitivities.
CV’s of unaltered graphite were compared to those of Nafion/Vulcan coated 
graphite and Nafion/Etek-13 coated graphite (Vulcan is a high surface area 
carbon and Etek is Pt and Ru particles on Vulcan).  The charging current 
increased with both Etek (highest) and Vulcan
The slope of each oxygen calibration curve for each tested electrode were 
compiled and compared against each other.  HB consistently had the highest 
sensitivity, yet like the other soft leads never showed signs of oxygen reduction.  














Peptide Detection with High Performance 
Liquid Chromatography/Mass Spectrometry 
Matthew A. Weaver, Julie A. Stenken, and Jackson O. Lay Jr.
Department of Chemistry & Biochemistry, Benedictine College, Atchison, KS 66002
Purpose
Reconfiguration of a nano-flow HPLC to provide reliable retention times, sample 
delivery and optimization of the HPLC parameters
Demonstrate linear response for quantitation of peptides by Electrospray Mass
spectrometry from approximately 500 pgs to 50 ngs on column  
The reproducibility of the retention time, peak shape, and intensity improved with
increasing flow rate and modification of the injection method. Reduction of column
back pressure likely improved system performance.
The linear relationship in the relative intensities for model peptides confirms that the
concentration of an unknown could be determined to near 1 pM (injected) based on
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Figure 5. Diagram showing mixture of 0.0125 mg/mL [Leu5]-Enkephalin and 
0.00125 mg/mL[Met5]-Enkephalin and the ratio of intensities between the two peptides
Figure 4. Log/Log plot of intensity vs. concentration of [Leu5]-Enkephalin 
(.125, .0125, 0.00125, and 0.000125mg/mL).
Instruments used for LC/MS technique
Agilent 1200 Series nano/microflow HPLC 
Bruker ultroTOFq Mass Spectrometer






























































Figure 1. Top-Structure of [Met5]-Enkephalin 
Bottom-Structure of [Leu5]-Enkephalin
Experimental Procedures
Both gradient and isocratic HPLC runs were examined 
(solvent A=H2O w/ 0.1% FA, solvent B = ACN w/ 0.1% FA) 
gradient : 0-5 min - 10%B     5-21 min - lin. inc. to 90%B     21-29min - hold @ 90%B
29-31 min - lin. dec. to 10%B     31-36 min - hold @ 10%B
isocratic: 30%B for 5 minutes
5μL of sample was injected during each run
The flow rates used were 100, 200, and 500μL/min (prior work used < 100μL/min)
Multiple replicates, concentrations: 1.25, 0.125, 0.0125, 0.00125, and 0.000125mg/mL
Extracted Ion Chromatogram (MH+) used to find retention time and intensity 
Calibrations based upon intensity and concentration for quantitation
Autosampler program 1. This is the default program for the system.  It employs 
no external needle wash and flows mobile phase through the sample loop for
5 minutes.  During this time the back pressure on the HPLC column rises steadily.
Autosampler program 2. An external needle wash was added to remove residual 
analyte and the flow of mobile phase through the sample loop was limited to
30 seconds. Back pressure is reduced due to less time spent in the sample loop.
Reproducibility




Retention Time=16.5 1.93 minIntensity %Rel. Std. Dev.=60.88%




Intensity %Rel Std. Dev.=110.2%
Retention Time=15.83 .05 min 
Stacked Extracted Ion Chromatogram [Leu5]-Enkephalin Flow rate=500μL/min
Conc.=0.00125mg/mL4 replicates
Intensity %Rel. Std. Dev.=5.21%
Retention Time=3.6 min
Stacked Extracted Ion Chromatogram of [Leu5]-Enkephalin 




(Isocratic/autosampler program 1) 6 replicates
Figure 3: The four chromatograms above display how the reproducibility of the results vary 
with respect to flow rate (A & B) and autosampler method (C & D). A and B were obtained 
using the gradient described in the Methods section while C and D were obtained using the 
isocratic method.
In A, neither the retention time nor intensity of the peaks is duplicated. In B, the retention time 
is replicated but the intensity is not. 
In C, the retention time is constant but the intensity still varies somewhat. In D, the outside of 
the sample injection needle is washed twice and the flow time through the sample injection 
loop is decreased an order of magnitude.  Both the retention time and intensity are constant 
showing the reproducibility that is desired.
Concentration Results 






Figure 6. Log/Log plot of intensity vs. quantity for a mixture of [Leu5]-Enkephalin and [Met5]-
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Figure 2. Mass Spectrum of [Leu5]-Enkephalin                                                        





Analysis of peptides by HPLC/MS often employs on line (in series) UV detection 
for quantification and uses the MS for identification.  Development of MS-based 
approaches for quantification provides a secondary method for quantitative analysis, 
allows quantification of peptides not having suitable UV chromophores and provides 
a possible approach to the quantification of co-eluting peptides by mass/intensity 
monitoring.  Elegant nano-flow MS/MS methods have been developed for peptide 
quantification1. However, simple methods using standard columns and single stage 
MS can provide greater ruggedness and sometimes also higher sensitivity.   
1. Na Li, Olga V. Nemirovskiy, Yiqun Zhang, Haodan Yuan, Jianming Mo, Chengjie Ji, Bo Zhang, Timothy G. 
Brayman, Christopher Lepsy, Timothy G. Heath and Yurong Lai, “Absolute quantification of multidrug 
resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry”  
Analytical Biochemistry, 380, 2008, 211-222.
(Isocratic/autosampler program 2)
Leu5-Logarithmic Calibration Plot 7/14/09















Met5Leu5 Mixture Log-Log Plot Intensity Ratio vs. Mass Ratio 
7/16/09
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